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1) Introduction and Ambition 
The merger of biological membranes is a crucial process of life. The fertilisation of an 
egg cell by a sperm and the subsequent development of tissues and organs of the 
embryo imply membrane fusion processes. The maintenance of physiology of the adult 
organism and the threat of vital functions by viruses are also dependent on the merger 
of membranes.[1–4] Lipids represent the basis of membranes which serve as stable 
barriers between cells and compartments within the cell. They enable the establish-
ment of different milieus which are of great importance for physiological functions. 
However, the controlled exchange of substances between cells and compartments are 
not less important. The communication between membrane separated spaces is ena-
bled by membrane proteins. These proteins form ion channels or transfer signals 
through conformational changes from one side of the membrane to the other. 
Endo- and exocytosis are further processes for the exchange of substances. Vesicles 
loaded with substances merge with cell membranes and thereby release their cargo.[5] 
Due to the fact that membranes are not prone to fuse spontaneously, proteins are 
necessary to mediate this process. Specialised proteins have been evolved and ac-
company life since its beginnings by mediating membrane fusion. One of this evolu-
tionary conserved protein families are SNARE (soluble N-ethylmaleimide-sensitive fac-
tor (NSF) attachment protein receptor) proteins which are required for endocytic and 
secretory pathways in multiple organisms.[6] The key actors of neuronal exocytosis of 
rattus norvegicus are the synaptic vesicle (SV) associated synaptobrevin 2 (Syb2), as 
well as syntaxin 1A (Sx1A) and the 25 kDa synaptosome-associated protein 
(SNAP 25) which reside at the plasma membrane of the neuron. Syb2 and Sx1A own 
transmembrane domains (TMDs) connecting the proteins to their membranes. 
SNAP 25 is anchored at the membrane by palmitoylated cysteines in the linkage se-
quence of the two cytosolic domains. Syb2 and Sx1A have one cytosolic domain, re-
spectively, which is linked to the TMD via a linker region (LR). These α-helical SNARE 
motifs form parallel intertwined four-membered coiled coils. However, it has also been 
demonstrated that SNARE motifs can congregate as antiparallel coiled coils.[3,7] The 
formation of parallel four-helix bundles brings the SV membrane in close proximity to 
the plasma membrane of the synapse which is a basic requirement for membrane fu-
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sion.[8] It is thought, that the recognition interaction starts N-terminal and proceeds to-
wards the C-termini including the LRs and TMDs of Syb2 and Sx1A. This is known as 
zippering hypothesis.[9,10] Moreover, it has been supposed that during the recognition 
process resulting in membrane fusion, LRs and TMDs do not serve only as linkage and 
membrane anchors, but have also active roles. It is assumed, that the LRs/TMDs con-
dense lipids which are suitable for the formation of fusion intermediates, deform mem-
branes, perturb lipid packing, interact in a cooperative way during the last steps of 
fusion and relax curvature stress of the initial fusion pore.[11–14]  
In the present study, SNARE mimetics were used to investigate the active role of the 
TMDs of Syb2 and Sx1A. Therefore, natural SNARE motifs were replaced by artificial 
recognition units. Either PNA oligomers or coiled-coil forming E3 and K3 peptides were 
linked to LRs/TMDs of Syb2 and Sx1A.[15,16] PNA oligomers are well controllable con-
cerning parallel or antiparallel recognition, but might not be able to induce zippering 
into the LRs/TMDs due to topological differences. However, the E3/K3 coiled coil sys-
tem is comparable to native SNARE coiled coils and thus C-terminal zippering is con-
ceivable. Both SNARE mimetics were modified concerning their C-terminal amino ac-
ids (aas). The natural aas threonine (Syb2) and glycine (Sx1A) were exchanged 
against glutamate and lysine as carboxylic acids or amides. These modifications 
change the C-terminal charge of the TMDs which are known to be crucial for fusion 
efficiency.[17,18] The model peptides (PNA-LR/TMD and E3/K3-LR/TMD peptide hy-
brids) were used to investigate the influence of parallel and antiparallel recognition on 
the C-terminal modifications and to evaluate charge modifications concerning the last 
steps of fusion which are assumed to be mediated by cooperative interactions of the 
C-terminal parts of Syb2 and Sx1A.[13] FRET based leaflet mixing assays with lipo-
somes and pore-spanning membrane assays were used to determine the fusion effi-
ciency of SNARE mimetics concerning membrane curvature. Furthermore, colloidal 
probe measurements were applied to examine single fusion events and to compare 
SNARE mimetics with the minimal fusion machinery of native Syb2, Sx1A and 
SNAP-25.[19] 
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2) Membranes and Their Fusion  
The basic structural motif of membranes is a bilayer consisting of two layers of lipids. 
The hydrophilic headgroups face the aqueous environment and the acyl chains forming 
a hydrophobic phase between the headgroups.[20] As a key feature of life, lipid bilayers 
separate the interior of cells where vital processes occur from their environment and 
membranes are additionally present within the interior of cells enveloping multiple com-
partments which can be simplified seen as different reaction vessels for vital biochem-
ical reactions. Beside the purpose of cell protection and compartmentation, mem-
branes are involved in a variety of physiological functions like the controlled transport 
of substances (e.g. exo- and endocytosis), signal transduction, the production of en-
ergy and cell-cell adhesion as some examples.[21–23] Therefore, membranes are not 
only structural, but also functional units. The enormous structural variety of membranes 
underlines the intriguing functional variety.  
The fluid mosaic model of the structure of cell membranes by SINGER and NICOLSON 
was one of the first steps in the direction to evaluate biomembranes as functional units. 
They defined biomembranes as two-dimensional fluid structures containing peripheral 
and integral proteins laterally diffusing through the lipids and form functional com-
plexes.[24] However, this concept does not consider sufficiently the complex interac-
tions between membrane components with cytosolic structures (e.g. cytoskeleton), ex-
tracellular receptor-ligand interactions and the interplay between membrane compo-
nents like lipid-lipid, lipid-protein and protein-protein interactions.[22] Moreover, lipid 
compositions of exoplasmic and cytoplasmic leaflets are not identical. Lipids and pro-
teins are asymmetric distributed between the two leaflets, e.g. phosphatidylcholines 
(PC) and glycoproteins are mainly located in the exoplasmic leaflets. Whereas phos-
phatidylethanolamines (PE) can in principle be found in cytoplasmic leaflets.[23] In ad-
dition to the transverse lipid distribution, lipids are also heterogeneously distributed in 
lateral dimensions. SIMONS and IKONEN described tightly packed membrane domains 
which are enriched in sphingolipids and cholesterol. They suggested that these lipid 
rafts diffuse with the otherwise fluid membrane and are involved in protein sorting pro-
cesses.[25] In conclusion, membranes are remarkable complex supramolecular struc-
tures and its functionality depends highly on the organisation of its components.  
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2.1) Membrane Lipids  
Membranes are built up by an astonishing number of different lipids. For instance, the 
membrane of erythrocytes consists of more than 100 lipids.[26] The crucial feature of 
lipids is their amphiphilicity (polar headgroup and apolar acyl chains) which enables 
them to form membranes due to the hydrophobic effect.[27] Membrane lipids consist 
mainly of phospholipids. An illustration of the common phospholipid structure is de-
picted in Figure 2.1-1. Frequently occurring polar headgroup residues are choline, eth-
anolamine, serine, glycerol or inositol. Latter one can also be phosphorylated. In addi-
tion to the variations of the headgroup regions one finds also many variations of the 
acyl chains. Typical acyl chains encompass 14 to 24 carbon atoms (e. g. myristate with 
14, palmitate with 16 or stearate residues with 18 carbon atoms). The chains are sat-
urated or unsaturated (up to four double bonds).[28] Furthermore, phosphoglycerolipids 
can carry different acyl chains (mixed acid lipids).[29] 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1-1 Illustration of the common structure of phospholipids with chemical structures of A) phos-
phoglycerolipids and B) sphingophospholipids (sphingomyelins): The phosphodiester (circled P, blue) 
is connected to the glycerol or sphingosine unit (red) and carry different headgroup residues (Rhg, blue). 
In the case of phosphoglycerolipids, the glycerol unit is linked to two acyl chain residues (Rac, orange), 
which are saturated or unsaturated. For sphingophospholipids only one acyl chain is connected to the 
second carbon atom of the sphingosine unit via an amide bond (based on ref. 30). 
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Beside phospholipids also other lipid groups exist which differ slightly in structure:  
 Ceramides: The hydroxyl group in position one of the sphingosine unit is free. 
 Phosphatidic acid: The phosphate group at the glycerine unit carry no further 
headgroup residues (Rhg). 
 Glycoglycerolipids and glycosphingolipids: The glycerol and sphingosine units 
are bound to sugar residues without phosphodiester bonds. 
Another crucial group of lipidic components are sterols like cholesterol, ergosterol and 
fucosterol.[21] Among sterols, cholesterol is the most common sterol in biological mem-
branes with amounts of 4-40 mol-% cholesterol in eukaryotic cell membranes.[28] Syn-
aptic vesicles (SVs) include 40 mol-% cholesterol making them to one of the most cho-
lesterol-rich organelles in nature.[31] The hydroxyl groups of cholesterol form hydrogen 
bonds to the carbonyl carbons of the acyl chains of phosphoglycerolipids or to the 
hydroxy groups in position three of the sphingosine units in case of sphingolipids.[25] 
The hydrophobic ring system is oriented towards the hydrophobic center of the bilayer 
(corresponds to the length of approximately 10 carbons of saturated hydrocarbon 
chains, Figure 2.1-2).[23]  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1-2 Illustration of the arrangement of cholesterol within a phospholipid bilayer: Dashed lines in 
the upper leaflet indicates hydrogen bonds between two cholesterols and one phosphoglycerolipid (right 
phospholipid). Furthermore, the hydrogen bond between one cholesterol and one phosphosphingolipid 
(left phospholipid) is depicted. In the bottom leaflet, cholesterol fills a gap in the hydrophobic interior of 
the membrane caused by a cis-double bond (based on ref. 25). 
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In the fluid phase cholesterol induces higher amounts of trans-isomers of acyl chains 
and thus leads to thicker membranes. Moreover, cholesterol suppress the gel state 
and induces higher ordering of acyl chains in the fluid phase without significant loss of 
lateral mobility of lipids.[28] Around one third of cholesterol in lipid compositions de-
creases permeability of phospholipid bilayers for small polar molecules and cholesterol 
reduces protein penetrations of the membrane.[32] In conclusion, lipids constitute an 
enormous diverse group of substances and determine together with proteins the shape 
(e.g. thickness, curvature) and physical properties like permeability and thermotropic 
phase behaviour of membranes.  
 
2.1.1) Effective Molecular Shape of Lipids 
The molecular structure of single lipids mainly determines the structure of supramolec-
ular structures above the critical micelle concentration (CMC).  
 
 
 
 
 
 
 
 
Figure 2.1.1-1 Effect of individual lipid shapes on the structure of lipid aggregates: A) Possible aggre-
gate structures of lipids above the CMC in aqueous solutions depend on the ratio (a/p) between the 
space requirements of apolar acyl chains (a) and the polar headgroups (p) (HII: hexagonal phase). 
B) Spontaneous curvature of lipid monolayers depends on the shape of single lipids (based on ref. 33 
and 8).  
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Like already mentioned, lipids consist of apolar acyl chains (a) and polar headgroups 
(p). The ratio of the demand of space of these two parts (a/p) is a useful tool to predict 
the structure of supramolecular lipid aggregates (Figure 2.1.1-1, A). Lipids with an a/p 
ratio of approximately one (i.e. rod-like shaped lamellar lipids) form lamellar bilayers. 
Phosphatidylcholines like dioleoylphosphatidylcholine (DOPC) are an example for this 
group of lipids. If the ratio is smaller than 0.7 (i.e. inverted cone), lipids (e.g. lysophos-
phatidylcholine (LPC)) form micelles. Lipids with a cone-like shape (a/p = 1.3) like 
phosphatidylethanolamines (e.g. dioleoylphosphatidylethanolamine (DOPE)) aggre-
gate as inverted micelles (common designation: hexagonal phase HII) with polar head-
groups residing in the interior.[33,34] However, lipids with a shape of a cone or inverted 
cone (non-lamellar lipids) participate also in lamellar structures. Thus, pure monolayers 
consisting of cone-like or inverted cone-like lipids exhibit so-called spontaneous cur-
vatures, which are a crucial feature concerning the shape of membranes, especially 
during rearrangements like in the process of membrane fusion (Figure 2.1.1-1, B).  
 
2.2) Phase Transition of Membranes 
Like other substances, lipid bilayers occur depending on temperature as different 
phases with different physical properties. In the case of two-dimensional membranes 
crucial physical properties are:  
 Area per lipid molecule and lateral diffusion of lipids. 
 Lipid packing that refers to the average conformation of each carbon atom along 
the acyl chains. 
 Tilt angle of lipids to the membrane normal. 
 Heat uptake during phase transition (important for determination of phase tran-
sitions through differential scanning calorimetry).[21] 
At low temperatures lipid bilayer are usually in the gel phase. At elevated temperatures 
bilayers change to the liquid phase Lα (thermotropic phase transition, Figure 2.2-1). In 
the gel phase, single lipids are tightly packed (all-trans conformation of acyl chains) 
and there is no lateral diffusion of the lipids at all. Above the main transition tempera-
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ture (Tm) contraction of acyl chains takes place and therefore the bilayer expands lat-
erally and becomes approximately 15 % thinner than in the gel phase.[23] Due to re-
duced VAN-DER-WAALS interactions between acyl chains, the lateral mobility of lipids is 
increased. Typical diffusion coefficient of lipids in the liquid phase are in the range of  
10-8 – 10-7 cm2/s.[21] Tm is influenced by polar headgroup structures (surface charge, 
state of protonation) and acyl chains (length, degree of saturation). Partly protonated 
headgroups form hydrogen bonds between the protonated and unprotonated states. 
This results in higher main transition temperatures. The same tendency is observed 
with increasing chain lengths and lower degrees of saturation. Trans-unsaturated 
chains results in higher Tm values than cis-unsaturated chains do. Therefore, cis-un-
saturated acyl chains support the fluid state of membranes. The liquid phase Lα is a 
basic prerequisite for the physiological functionality of biomembranes.[28,33] 
 
 
 
 
 
Figure 2.2-1 Illustration of thermotropic phase transitions of lipid bilayers. In each phase lipids differ 
concerning conformation, packing and lateral diffusion. Abbreviations: Lc: sub-gel phase, Tc: sub transi-
tion temperature, Lβ’: gel phase II, Tp: pre-transition temperature, Pβ: ripple phase, Tm: main transition 
temperature and Lα: liquid phase (based on ref. 28). 
 
However, it is possible that two different phases coexist at the same temperature. This 
coexistence of lipid phases as nanoscopic domains is important for physiological func-
tions like signalling, recruitment of proteins (preferred binding regions for more than 
200 proteins) endo- and exocytosis.[21,35] Lipid domains consisting of sphingomyelins, 
glycosphingolipids, saturated phospholipids and cholesterol (or mixtures that include 
some of these lipids) exhibit resistance to detergent disruption and are of higher order 
than domains of other lipid mixtures. For instance, mixtures of glycosphingolipids and 
cholesterol have high packing densities due to interactions between headgroup carbo-
hydrate residues of the sphingolipids and the hydroxyl groups of cholesterols. Further-
more, cholesterol acts as a stopgap for gaps emerged under the headgroup regions 
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(unsaturated acyl chains or different lengths of acyl chains, Figure 2.1-1).[25] These lipid 
domains are designated as lipid rafts, because a cluster of lipids diffuses through the 
fluid membrane environment. Lipid rafts in one monolayer might induce lipid rafts in 
the underlying monolayer, i.e. rafts span the whole membrane.[36]  
 
2.3) Membrane Thickness 
The thickness of membranes is an important feature concerning the insertion, orienta-
tion, activity and distribution of integral membrane proteins. For instance, due to a hy-
drophobic mismatch (thickness of membrane does not match the length of the hydro-
phobic region of an integral protein) proteins can arrange in clusters.[37] Membrane 
thickness is extremely variable and reach from 3 nm to 10 nm. One must distinguish 
between the thickness of the pure bilayer, the thickness of bilayers with hydration lay-
ers at the surfaces and the thickness of biomembranes with proteins. Pure PC mem-
branes with two identical acyl chains of 14 carbon atoms (myristoleoyl residues) are 
3.2 nm thick, by including the hydration layers a thickness of 4.7 nm was determined. 
Pure PC membranes with acyl chains of 22 carbon atoms and one double bond 
(erucoyl residues) have a thickness of 4.6 nm (6.1 nm with hydration layers). Obvi-
ously, one membrane thickness determinant is the length of the acyl chains. Choles-
terol increases the thickness of PC membranes by ~0.5 nm.[38] Typical biomembranes 
with various proteins have thicknesses of 7.5-10.0 nm.[39] For instance, the erythrocyte 
membrane has a thickness of 8.5 nm.[24]  
 
2.4) Fusion of Membranes 
The fusion process of pure lipid bilayers and biological membranes including proteins 
follow a comparable mechanism.[40] Therefore, first the mechanism of membrane fu-
sion is described excluding the role of proteins. Afterwards, influences and contribu-
tions of proteins during the fusion process of biological membranes are elucidated. The 
initial step of the fusion process is a close intermembrane distance resulting in the so 
called hemifusion stalk (Figure 2.4-1, A-D). This structure is a widely accepted fusion 
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intermediate firstly supposed by PALADE et al. in 1968, theoretically described by KOZLOV 
et al. in 1983 (later refined) and experimentally proved by YANG et al. in 2002 (X-ray 
diffraction).[41–44] The stalk intermediate might expand to a hemifusion diaphragm, a 
structure with distal leaflets in hydrophobic contact (Figure 2.4-1, E). In the last step of 
fusion an aqueous pore (fusion pore) between the membrane encapsulated interiors 
is formed (Figure 2.4-1, F). It is uncertain, whether the fusion pore opening occurs 
directly from the hemifusion stalk (Figure 2.4-1, D) or whether the stalk expands to a 
hemifusion diaphragm and the fusion pore originates from this intermediate or both.[8] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4-1: Supposed mechanism of membrane fusion: A) Apposed membranes separated by a wa-
ter layer of 1-3 nm. B) Closer proximity between membranes, perhaps supported by point-like protru-
sions which minimise hydration forces. C) First hydrophobic contact through a splayed lipid. D) Exten-
sion of the hydrophobic contact area results in a hemifusion stalk. E) Possible extension of the stalk 
structure to a hemifusion diaphragm. F) Fusion pore evolves directly from stalk or transit diaphragm. 
Furthermore, the pore might close after formation and open again (pore flickering) (based on ref. 8 and 
45). 
 
Pure neutral lipid bilayers are separated by water layers of 1-3 nm (determined by 
gravimetric and osmotic stress methods). For instance, apposed DOPC and DOPE 
bilayers exhibit distances of 2.4 nm and 1.5 nm, respectively.[46] At a separating water 
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layer of 0.9 nm, the formation of the hemifusion stalk results in the relaxation of the 
hydration energy.[45] At this close contact and degree of dehydration, it is possible, that 
one acyl chain of a single lipid is transferred from one membrane to the other. This 
constitutes the first hydrophobic contact between the membranes (Figure 2.4-1, C). 
Other lipids join this connection and proximal leaflets merge completely, while distal 
leaflets are still separated (hemifusion).[47] To achieve close contact between mem-
branes, it is necessary to dehydrate the aqueous interstice. It is suggested, that the 
energy for dehydration is the crucial barrier concerning the introduction of the fusion 
stalk. For pure DOPC membranes, the dehydration energy is 173 ± 47 kBT and for an 
equimolar mixture of DOPC and DOPE it is 89 ± 26 kBT (dehydration energies for ar-
eas of 40-50 nm2 at two flat apposed membranes). The energy of dehydrations de-
pends on the area per lipid headgroup, which in turn depends on the headgroup resi-
dues and the degree of unsaturation of the acyl chain. Furthermore, the area per lipid 
is increased through lateral tension (e.g. in case of highly curved SUV membranes) or 
through the addition of cholesterol. For instance, the addition of 30 mol-% cholesterol 
to DOPC membranes results in a dehydration energy of ~105 kBT, which is much lower 
than for pure DOPC membranes (see above). During stalk formation, the thickness of 
the separating water layer increases above 1 nm indicating for favoured hydration con-
ditions. Thus, rather the maximisation of hydration of the stalk intermediate is crucial 
for stalk formation than the minimisation of the intermembrane contact between the 
apposed membranes like it was proposed up to 2012. It was thought, that through a 
highly curved point-like protrusions of the apposed membranes, the contact zone is 
minimised and thus also the hydration repulsion between the membranes.[48] There-
fore, the calculated stalk energy of 40 kBT includes only bending and tilt deformations 
and excludes dehydration energy, which constitutes the main energy barrier for stalk 
formation.[44] This current view on stalk formation is underlined by the observation, that 
the extent of stalk formation is not decreased with increasing acyl chain lengths and 
accompanied bending rigidity but exactly vice versa.[45]  
The stalk intermediate expands and might create a contact zone between the distal 
leaflets. However, energetics for the diaphragm formation are high and therefore its 
formation is unrealistic. Therefore, it is suggested, that radial expansion of the stalk 
structure results in opening of the fusion pore.[49,50] The initial fusion pore is not stable. 
There is an equilibrium between the hemifused membrane and an aqueous pore, 
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which is designated as pore flickering. The fusion pore becomes stable by its expan-
sion.[51,52]  
 
2.4.1) Influence of Lipids on Membrane Fusion 
It must be noted, that the effective molecular lipid shape and therefore the intrinsic 
curvature of lipids is beside dehydration energy another crucial factor for the stalk for-
mation and the ongoing process of membrane fusion, because of the highly curved 
areas of the fusion intermediates. It has been demonstrated by GÜNTHER-AUSBORN et 
al., that the exogenous addition of lipids with a positive spontaneous curvature like 
LPC to the proximal leaflets inhibits stalk formation. This is explainable by the strongly 
negative curved areas of the proximal leaflets in the stalk structure.[53] However, when 
LPC is specifically added to distal monolayers, the fusion pore formation is promoted, 
because the bending stress at the pore rims is reduced. On the other hand, lipids with 
a spontaneous negative curvature like arachidonic acid or DOPE promote fusion stalk 
formation when added to proximal leaflets, but inhibits/reduces fusion pore opening 
when added to distal leaflets.[54] If cholesterol with an intrinsic negative curvature is 
present in both leaflets, it supports the permanent openness of the fusion pore by low-
ering curvature stress.[52,55] In conclusion, specific lipids facilitate the formation of fu-
sion intermediates due to their molecular shapes which are suitable for these interme-
diates. Furthermore, for membrane fusion crucial dehydration energies are affected by 
headgroup structures (Section 2.4). 
 
2.4.2) Contribution of Proteins to Membrane Fusion  
The surface of biological membranes is charged and densely mounted with integral 
and peripheral proteins, which are occasionally linked to sugar oligomers (glycopro-
teins). Such sugar residues are also found in lipidic structures (glycolipids). Thus, the 
actual lipid membrane is covered by a tight layer of biooligomers, which cause addi-
tional steric hindrance and repulsive forces compared to pure lipid bilayers. The dis-
tance between biomembranes approaching each other is usually 10-20 nm.[40,56] 
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Therefore, a protein-free contact zone must be established. Fusion proteins like 
SNAREs overcome this problem by pulling membranes in close proximity (2-3 nm) 
through complex formation and thereby displace sterically hindering proteins.[57] An-
other strategy is the formation of Sx1A and PI(4,5)P rich domains at the fusion sites 
which exclude hindering proteins.[58] Sec/Munc (SM) proteins are thought to introduce 
lipid patches at the vicinity of Syb and Sx TMDs and membrane fusion might be facili-
tated at these patches.[59] Additionally, integral proteins disturb the packing order of 
bilayers and transfer mechanical force on the membrane through conformational 
changes.[60] Furthermore, integral proteins shape membranes, i.e. they induce nega-
tive or positive curvatures depending on the positions of sterically demanding aas like 
tryptophan within the proteins.[61] Peripheral or slightly inserted membrane proteins 
also shape membranes against the intrinsic curvature which originate from the lipid 
composition. During the process of fusion, the cytoskeletal actin (in cooperation with 
other proteins) and dynamin GTPase support the extension of the fusion pore by main-
taining membrane tension.[62,63] Another possibilty making biomembranes prone to 
fuse are proteins like acyltransferases which catalyse lipid modifications and thereby 
establish a fusion-suitable lipid composition. Other proteins recruit suitable lipids. Flip-
pases transfer lipids from one leaflet to the other and create asymmetric membranes 
which are necessary for the formation of fusion intermediates and finally for the fusion 
pore opening (Section 2.4.1).[21,40]  
 
2.5) Natural Fusion Proteins 
Natural fusion proteins are subdivided into two major groups: i) Exoplasmic fusion pro-
teins act in the exterior of cells. For example, viral and cell-cell fusion proteins are 
involved in these types of membrane fusion. ii) Endoplasmic fusion proteins act in the 
interior of cells: atlastins (fusion of ER membranes), mitosins (fusion of mitochondrial 
membranes) and SNARE proteins (endocytic and secretory pathway fusion) are ex-
amples for these proteins. Within the following sections the different proteins are pre-
sented concerning their mechanisms of membrane fusion. 
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2.5.1) Viral Fusion Proteins 
There are four classes of viral fusion proteins which differ in their structural features 
and conformational changes during the process of fusion. However, all of them have 
intermediate hairpin structures in common.[2] Below, the supposed mechanism of 
class 1 viral proteins is briefly presented by means of the well-known glycoprotein he-
magglutinin (HA) of the influenza virus: HA is a trimeric protein (each monomer include 
two disulfide-linked subunits: HA1 and HA2) and is anchored in the membrane of viral 
particles by C-terminal hydrophobic TMDs of the HA2 subunits. In the metastable pre-
fusion state of HA, N-terminal fusion peptides (FP) of the HA2 subunits (kinked am-
phiphilic domains of ~24 aa) are shielded from the aqueous environment by the sur-
rounding receptor-binding HA1 units. Latter units bind to sialic acid residues of the 
cellular membranes and evoke the uptake of the viral particles by endocytosis. In early 
endosomes, the HA proteins are exposed to low pH values (pH = 5.3). Protonation 
induces conformational changes. Thereby, the FP is relieved and inserted into the en-
dosomal membrane (Figure 2.5.1-1, A). Whereby, the first connection between both 
membranes is established. The FP causes defects in lipid packing of the target mem-
brane and makes the membrane prone for early fusion stages.[64] In the postfusion 
state a trimeric coiled coil (length of 13.5 nm) has been formed and the TMDs and FPs 
are localised at adjacent positions within the fused membrane.[65]  
 
 
 
 
 
 
 
Figure 2.5.1-1 A) Supposed mechanism of HA mediated membrane fusion based on crystal structures 
of the metastable prefusion and stable postfusion state (coloured structures). Assumed intermediate 
structures of HA are depicted in grey. B) Two SNARE complexes with zippered SNARE motifs. C) To-
tally zippered SNARE cis-complex (based on ref. 10, 66 and 67). 
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During this not fully elucidated process opposing membranes are pulled into close 
proximity allowing membranes to fuse via a hemifusion stalk (Figure 2.5.1-1, A).[4] The 
proposed intermediate hairpin structure of the HA complex reminds one of the hairpin 
structure of the N-terminally zippered SNARE complex (Figure 2.5.1-1, A and B). Fur-
thermore, the postfusion state of the HA complex resembles also the totally zippered 
SNARE cis-complex (Figure 2.5.1-1, A and C). This might be a hint that both mecha-
nisms have similarities concerning structural and dynamic features and underlines the 
evolutionary relationship between the various types of fusion proteins.[40,66]  
 
2.5.2) Proteins for Cell-Cell Fusion 
Cell-cell fusion promoting proteins like syncytins (class I cell-cell fusion proteins) and 
epithelial fusion failure 1 protein (EFF-1 cell-cell fusion protein of class II) are the sec-
ond important group of exoplasmic fusion proteins. They are involved in crucial pro-
cesses like the formation of the placenta and the generation of the shape of organs 
including its tissues. Both classes of proteins share considerable structural similarities 
to the corresponding classes of viral fusion proteins. 10 % of the human genome orig-
inates from retroviruses explaining the structural relationship between both groups of 
fusion proteins.[66] However, in the case of viral infection, fusion proteins reside only in 
the viral membrane (heterotypic fusion), whereas cell-cell fusion proteins reside partly 
in membranes of both cells (homotypic fusion, Figure 2.5.2-1).[68]  
 
 
 
 
 
 
 
Figure 2.5.2-1 EFF-1 mediated membrane fusion: A) EFF-1 monomers cluster in the region of fusion. 
B) Dimerisation of monomers creates the first contact between the apposed membranes. C) An 
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additional monomer binds to the already existing dimer. D) Domain III (DIII, blue circles) binds at the 
interface of domain I (DI, red circles) and domain II (DII, yellow ellipses), whereby cell membranes are 
pulled towards each other. E, F) N-terminal parts of the TMDs (grey rods) interact with N-terminal regions 
of DII. Afterwards, TMDs might zipper in a SNARE like fashion and thereby open the fusion pore (based 
on ref. 2). 
 
Moreover, it is reasonable to assume that cell-cell fusion takes place directly after re-
ceptor binding without endocytosis. Class II proteins (EFF-1) have no FP and therefore 
another mechanism is expected which resembles more the SNARE mediated fusion 
process (Section 2.5.4):[2] It is supposed that after dimerisation of the extracellular do-
mains, trimerisation of the dimers with single domains takes place moving the apposed 
membranes into spatial proximity (Figure 2.5.2-1, A-C). Conformational changes simi-
lar to viral fusion processes induce membrane curvature at the fusion site (Fig-
ure 2.5.2-1, D-E).[66] The main difference between this mechanism and the SNARE 
mediated mechanism is the orientation of the cytosolic domains after fusion. During 
the supposed EFF-1-mediated mechanism, the recognising domains are directed into 
the centre of the fusion site where they might induce membrane curvature. Concerning 
the SNARE mediated fusion process, the domains are directed apart from the fusion 
site moving membranes into close proximity. The corresponding model for homotypic 
fusion in the case of EFF-1 suggests that after trimerisation of the N-termini, the C-ter-
minal parts of the proteins bind on the surface of the N-terminal parts pulling the mem-
branes in closer contact. Moreover, the TMDs of the three proteins might interact with 
the tips of domain II and zipper towards their C-termini. Last conformational changes 
might be involved in fusion pore opening (Figure 2.5.2-1, E-F).[2] 
 
2.5.3) Endoplasmic Fusion Proteins: Atlastins and Mi-
tosins 
Beside the SNARE proteins, atlastins and mitofusins are two other important endo-
plasmic fusion proteins. Both proteins are members of the dynamin superfamily of 
GTPases. Atlastins are involved in the structural organisation of the endoplasmic re-
ticulum (ER). They are responsible for the maintenance of the ER architecture by pro-
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moting GTP dependent homotypic fusion between ER membranes.[69] This is an im-
portant process beside fission. Mammalian atlastins are integral proteins with N-termi-
nal cytosolic GTPases domains (G), juxtamembrane helical bundles (HB), two closely 
spaced TMDs and C-terminal amphiphilic tails (CT) which extend into the cytosol. At-
lastins can form homodimers within the same ER membrane (cis-homodimers) or be-
tween two opposing ER membranes (trans-homodimers).  
 
 
 
 
 
 
 
 
 
Figure 2.5.3-1 Illustration of the proposed fusion mechanism mediated by atlastins: A) Monomeric at-
lastins (brown and yellow) and free GTP (magenta). B) Dimerisation by binding GTP nucleotides within 
the same membrane (brown) and between apposed membranes (brown and yellow). C) G domains (big 
circles in brown and yellow) are disconnected from the HB domains (big rods in brown and yellow) 
resulting in conformational freedom (indicated by curved black arrows). D) Merged membranes probably 
induced by HB domain dimerisation and supported by membrane perturbing effects of TMDs (small 
brown rods) and CT (small orange circles). E) Dissociation of atlastin dimers (based on ref. 70).  
 
GTP binds to the atlastin monomers and induces rapid dimer formation with the nucle-
otides residing in the interface of the G domains (Figure 2.5.3-1, A-B). The dimers may 
adopt several conformations, but the exact relationship between membrane fusion and 
the sequence of conformational changes is only rarely understood. Dimers bound to 
GTP are relatively unstable, but hydrolysation of the nucleotides allows the association 
of the HB domains resulting in a stable dimer probably accompanied by merger of the 
membranes (Figure 2.5.3-1, C-D). Dissociation of the GDP bound or unbound state of 
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the dimers releases atlastin monomers for further fusion cycles (Figure 2.5.3-1, E). The 
observation of cis-dimers is probably not only a consequence of fusion, because cis-in-
teractions take also place before fusion. Cis-dimers might lower the energy barrier of 
fusion by destabilising membranes at the fusion site. The hairpin structure of the 
closely spaced TMDs in addition to perturbing effects of the amphiphilic CT might sup-
port the creation of fusion-prone membrane sites which collapse when HB domains 
form tight dimers. No other regulatory proteins seem to be involved in the atlastin me-
diated membrane fusion mechanism making it to a relative simple fusion system. How-
ever, SNAREs are found in the ER as well and might constitute another parallel fusion 
pathway which is eventually related to atlastin-mediated fusion.[70] 
Like ER membranes mitochondrial membranes continually divide and fuse. The bal-
ance between these two processes play an important role for the structural and func-
tional maintenance of mitochondria. Mitochondria possess outer and inner membranes 
and therefore it is reasonable that both membranes fuse in a coordinated fashion. Only 
in yeast, a potential candidate for coordination has been found, whereas a mammalian 
counterpart has not yet been identified. Nevertheless, it is known that sometimes only 
the outer membranes fuse, but the physiological relevance has not been explored. The 
human fusion protein of the inner membrane is the Opa1 (Optic atrophy defect) protein 
and mitofusins (Mfn1 and Mfn2) are the fusion proteins of the outer membrane.[71,72] 
Within the N-terminal region human mitofusins have a cytosolic GTPase domain fol-
lowed by coiled-coil forming domains which are separated by two closely spaced 
TMDs. The C-terminal coiled-coil forming domains of mitofusins residing in apposed 
membranes associate into an antiparallel coiled-coil complex tethering the membranes 
with a gap of at least 9.5 nm (length of antiparallel coiled-coil complex).[73] At this dis-
tance, fusion of membranes is unlikely without further interactions bringing the mem-
branes in closer contact. The GTPases domain might be involved in this step, because 
it is known that nucleotide binding and hydrolysis induce trans-domain dimerisation 
and conformational changes of this domain, respectively. Both processes might lead 
to closer membrane contact.[74] However, an exact structural mechanism linking teth-
ering action and conformational changes of mitofusins with membrane merger is cur-
rently missing.  
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2.5.4) SNARE Protein Mediated Membrane Fusion 
Membrane fusion events of the secretory pathway are mediated by SNARE proteins. 
The key elements for protein mediated neuronal exocytosis are Sx1A, SNAP 25 and 
Syb2 and constitute the minimal fusion machinery, i.e. the reconstitution of these pro-
teins in model membranes is sufficient to observe fusion in vitro.[19] Sx1A and SNAP 25 
reside in the plasma membrane of neuronal synapses and form a binary prefusion 
acceptor complex (SNAP 25 contributes two α-helices). Syb2 resides in the membrane 
of the synaptic vesicle (SV). Through complexation of the membrane distal N-terminal 
halves of Syb2 and the acceptor complex a partial zippered four-helix bundle (SNARE 
complex zippers up to the -1-layer) is formed which docks liposomes to the plasma 
membrane.[75] Further complexation into the second halves of the SNARE motifs leads 
to closer intermembrane contact (zipper hypothesis).[9] However, the formation of the 
cytosolic trans-SNARE complex approaches opposing membranes only to distances 
of 2-3 nm (LRs and TMDs are not associated).[57,76] For the establishment of a lipidic 
connection as starting point of the actual fusion process the intermembrane distance 
must be smaller than 1 nm (Section 2.4).[45] Therefore, the zippering process pro-
gresses into the LRs and TMDs of Syb2 and Sx1A accompanied by local perturbations 
of the membranes at the fusion site through the exerted mechanical force.[10,14] The 
velocity of leaflet mixing of reconstitution experiments (8.0 ms) is far away from physi-
ological neurotransmitter release after electrical stimulation (< 0.5 ms) and it is sug-
gested that other proteins than the above mentioned accelerate the merger of mem-
branes.[57,77] Moreover, the process of native membrane fusion is temporal and spatial 
controlled. Thus, control mechanisms for fusion priming, targeted trigger and fast re-
lease of neurotransmitter are present in natural systems. 
The starting point of the SNARE mediated fusion process might be the binding of the 
cytosolic Sec/Munc (SM) protein Munc18-1 to the closed conformation of Sx1A (N-ter-
minal Habc domain interacts with the SNARE motif of Sx1A) and inhibits the formation 
of the Sx1A/SNAP 25 acceptor complex (Figure 2.5.4-1, A). Sx1A forms clusters with 
acidic lipids like PIP2 or PIP3 under the contribution of calcium ions. Thereby, proteins 
enrich at the fusion site (spatial control).[58,78] Munc13, another cytosolic SM protein, 
mediates the transition of the closed conformation of Sx1A to the open conformation. 
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At that point, SNAP 25 might bind to Sx1A forming the acceptor complex (Fig-
ure 2.5.4-1, B). Afterwards, both SM proteins support the formation of the partial zip-
pered SNARE complex under contribution of Syb2.[79] For instance, it is known that 
Munc18-1 interacts with the membrane proximal region of Syb2 and thus supports the 
SNARE complex assembly. Cytosolic complexin (Cpx) binds to the Sx1A/SNAP 25 
complex (or partial zippered SNARE complex).[80,81] The N-terminal accessory helix 
might serve as a placeholder for the C-terminal part of Syb2 and inhibit C-terminal 
complexation when Syb2 binds.[81] Consequently, it has a clamping function and holds 
the tethered SV in a fusion-ready (primed) state. The connection between the SV and 
the plasma membrane is also supported by the calcium sensor synaptotagmin (Syt) 
which resides in the SV membrane and binds to the plasma membrane (Figure 2.5.4-1, 
C). Upon influx of calcium (temporal control), the C2 domains of Syt interact stronger 
with negatively charged lipids of the plasma membrane and induce membrane curva-
ture as well as closer intermembrane contact.[82,83] Furthermore, Cpx is released by 
the calcium influx (Figure 2.5.4-1, D). Now, zippering proceeds into the LRs and TMDs 
of Syb2 and Sx1A. Mechanical force is exerted on the membranes which induces the 
lipidic fusion process.[84] Zippering into the C-terminal regions of Syb2 and Sx1A is 
accompanied by TMD motions pulling the membranes together. Thereby, the C-termini 
of both proteins remain initially attached to the membrane surfaces. When the tilting 
forces become too strong, C-termini detach from polar headgroups and migrate into 
the hydrophobic core of the membranes causing a rearrangement of lipids. As a con-
sequence of lipid rearrangement the fusion pore opens.[14] Initial fusion pores flicker 
rapidly (4000 Hz) between opened and closed stage before permanently close or 
open.[52] Stabilisation of the open pore is achieved by its expansion. Membrane tension 
might be a crucial factor for pore extension and it is known that dynamin in cooperation 
with cytoskeletal components induces such tension.[62,63] Recently, it was suggested 
that the fusion pore is neither lipidic nor proteinous but is mainly lined by lipids and to 
some degree by the C-termini of Syb2 and Sx1A (Figure 2.5.4-1, E).[85]  
 
 
 
 
Membranes and Their Fusion 
 
21 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.4-1 Supposed fusion mechanism mediated by the key SNARE proteins Syb2, Sx1A and 
SNAP 25. Regulatory proteins Munc18-1, Munc13, Cpx and Syt are involved in spatial and temporal 
control of the fusion process beside other proteins (not shown) (based on ref. 79 and 84). 
 
In conclusion, seven proteins crucial for neuronal exocytosis were presented. The rep-
resented interplay of these proteins during SNARE mediated fusion is partly specula-
tive, because several – sometimes contradictory – interactions for one protein are de-
scribed in literature. Thus, one protein might act at different stages of the fusion pro-
cess or in a combined synergetic manner with other proteins. It is obvious that the 
process is highly complex. Moreover, it is conceivable that there is not the one and 
only mechanism of fusion but several mechanisms might lead to membrane merger. 
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2.6) Model Systems for Membrane Fusion 
Due to the importance of biological membranes for life and their complexity concerning 
organisation and function, model systems were introduced. The overall goal of model 
systems is the reduction of complexity and thus the facilitation for scientists to assess 
the individual roles of membrane components. Through model membranes, it is possi-
ble to investigate physical properties like phase behaviour, lateral mobility and flip-flop 
mobility (asymmetric membranes) of lipids. Furthermore, membranes can be exam-
ined concerning their dynamics like protein clustering within the membrane and protein 
recognition between membranes as a crucial factor for membrane fusion.[86] Fusion is 
defined as merging of two distinct membranes into one continuous membrane accom-
panied by the leakage-free formation of aqueous connections (fusion pores) between 
membrane encapsulated interiors. This directed process is mediated by fusogenes, 
i.e. substances which interact with membranes to fuse them. The exchange of lipids 
between merged membranes, the exchange of contents between the membrane en-
capsulated interiors and the alteration in membrane size (in regard to liposomes) are 
crucial features of membrane fusion which are exploited for its detection.[56] However, 
leaflet mixing is also conceivable without fusion in the form described in Section 2.4, 
e.g. through the diffusion of lipids.[87] Leakage during the fusion process can falsify the 
results of content mixing assays and the detection of increased particle sizes by indi-
rect physical methods (e.g. DLS) after fusion is not necessarily the result of membrane 
fusion, because liposome aggregation lead to size increase as well.[56] In order to eval-
uate a study concerning membrane fusion, it is very important to understand how the 
fusion process is observed and how the observation is interpreted. For the detection 
of membrane features and fusion processes many methods like nuclear magnetic res-
onance (NMR) spectroscopy, electron paramagnetic resonance (EPR), mass spec-
trometry (e.g. NanoSIMS), differential calorimetry scanning (DSC), electron and fluo-
rescence microscopy as experimental approaches are available. Additionally, com-
puter simulations like full-atomistic and coarse-grained models serve as theoretical ap-
proaches.[21,86] 
The combination of model membrane, fusogene and detection method is the actual 
model system which is used to elaborate membrane related topics. Within the following 
sections the three pillares for studying membrane fusion are presented. 
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2.6.1) Model Membranes 
Over the last decades several model membranes have been developed. They differ 
concerning the arrangement of the membrane. Liposomes are spherical particles 
which diffuse in bulk suspension or are immobilised through tethering at solid sup-
ports.[86] Other model membrane systems are presented by free-standing black lipid or 
planar supported membranes which correspond more to the planar geometry of 
plasma membranes than to native vesicles. A combination of the latter bilayer systems 
constitute pore spanning membranes.[88] In this section, four model membranes are 
presented concerning their structure, preparation and application (Figure 
2.6.1-1, A-D). 
 
 
 
 
 
 
 
 
Figure 2.6.1-1 Selection of model membranes: A) Cross section of a liposome, B) black lipid membrane, 
C) planar supported membrane (freely supported) and D) pore-spanning membrane (based on ref. 21 
and 88). 
 
Liposomes: In 1966 PAPADADJOPOULOS and BANGHAM observed that temperature and 
divalent cations like calcium ions influence the permeability for univalent ions (e.g. so-
dium) of liquid crystals composed of phosphatidylserine (PS) and phosphatidylcholine 
(PC) lipids, respectively. Liquid crystals were prepared by sonication of aqueous lipid 
dispersions and it is mentioned that the crystals were able to capture ions.[89] Although 
it is not directly mentioned, this was one of the first studies using liposome-like struc-
tures as model system for biological membranes. Depending on the preparation tech-
nique different structured and sized liposomes can be created: Multilamellar vesicles 
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(MLVs) are onion shaped liposomes with several bilayers formed by hydration of lipid 
films stuck to glass walls. The films are prepared by evaporation of organic solvents 
containing the dissolved lipids. The hydration time influences the liposome size and 
the amount of entrapped aqueous content. MLV formation requires mechanical agita-
tion of the hydrated films.[32,90] Small unilamellar vesicles (SUVs) with a diameter of 30 
to 50 nm are mainly prepared by ultrasound sonication of MLVs dispersions, whereas 
liposome size homogeneity depends on time of treatment and used lipid composition. 
Another preparation technique is the French press.[91] The strong curvature of SUVs 
may lead to asymmetric membranes with an appropriate mixture of lipids. Furthermore, 
SUVs are relatively unstable due to bending stress which leads to spontaneous fusion 
events.[21,32] Large unilamellar vesicles (LUVs) have mean diameters between 100 and 
400 nm and are usually formed by extrusion techniques.[92,93] Giant unilamellar vesi-
cles (GUVs) with diameters of 15 µm or more are obtained by electroformation.[94] In 
general, liposome preparations are rapidly performed without much effort. Liposomes 
are mostly stable structures which can be stored at least over several days. However, 
oxidation processes lead to scission of the acyl chains of lipids at double bonds. Hy-
drolysis processes cleave acyl chains at the ester boundary. Such chemical modifica-
tions lead to changes of bilayer permeability, phase transition temperature and lipo-
some size. Therefore, protective measures must be considered, like degassed water 
for buffer solutions, avoidance of strong irradiation, usage of inert gases and low tem-
peratures for lipid/liposome storage. Further, the avoidance of strong acidic or basic 
pH values in liposome suspensions is important.[90] Examples for the application of 
liposomes are the examination of membrane fusion with reconstituted native SNARE 
proteins or the transfer of encapsulated cargos (e.g. DNA) to living cells as a potential 
drug delivery system.[19,95] 
Black lipid membranes (BLMs, Figure 2.6.1-1, B) are prepared by spreading lipids dis-
solved in an organic solvent over a small hole (e.g. ~1 mm in diameter) in the separat-
ing wall of a container filled with an aqueous solution. The lipids form a bilayer which 
spans the hole.[96] BLMs are fragile structures which tend to rupture and the reconsti-
tution of native proteins might be problematic because of organic solvents which are 
involved in the membrane preparation procedure.[88] However, BLMs enable unlike lip-
osomes easy access to both sides of the bilayer. Single ion channels can be examined 
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by conductance measurements. Furthermore, fusion events and effects of proteins ad-
sorbed to the membrane surface can be investigated using fluorescence microscopy 
techniques.[97]  
Planar supported membranes (Figure 2.6.1-1, C) are fixed lipid bilayers (covalently or 
through ion bridges) via the inner leaflet to substrates like silicon, glass or gold and are 
named integrated bilayers. The fixation of the inner leaflet restricts the lateral mobility 
of lipids and reconstituted proteins, whereby bigger molecules are stronger restricted. 
The introduction of a super-thin water layer (10 Å) between substrate and bilayer cre-
ates freely supported bilayer which allows lipids and proteins to move laterally. The 
introduction of a polymer cushion into the interspace of membrane and substrate in-
creases additionally the distance between substrate and membrane and facilitates lat-
eral mobility.[21,98] Bilayers are deposited by liposome spreading on pure quartz slides 
or on lipid monolayers which are transferred to slides from the water-air interface of a 
LANGMUIR-BLODGETT trough. If liposomes with integrated proteins (proteoliposomes) are 
used, protein containing supported membranes are created. Moreover, the preparation 
method for planar lipid bilayers using liposomes and preformed monolayers allows the 
generation of asymmetric membranes.[99] Planar supported bilayers are suitable for the 
determination of fusion intermediates and kinetics of single fusion events by fluores-
cence microscopy.[77] 
Pore-spanning membranes (Figure 2.6.1-1, D): A combination of BLMs and planar 
supported membranes are pore-spanning membranes. Silicon-nitride grids are cov-
ered with layers of titanium and gold. Latter is treated with an amphiphilic thiol making 
the surface prone for vesicle spreading. GUVs are spread on the porous surface cre-
ating a planar membrane which covers pores of 5 µm in diameter and rims of the 
grid.[100] Pore-spanning membranes combine the advantages of BLM (accessibility of 
both membrane sides) and planar supported membranes (high stability, avoidance of 
organic solvents during preparation). By laser scanning confocal microscopy it is pos-
sible to observe single fusion events and to distinguish between docking, hemifusion 
and full fusion during the fusion event.[88]  
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2.6.2) Fusogenes 
In the 1970’s calcium ions were used to investigate membrane fusion of SUVs. It was 
suggested that calcium ions interact with the polar headgroups of PS and reduce re-
pulsive forces between membranes. Thus, liposomes can approach each other. The 
formation of a nearly water-free trans-complexes by polar headgroups of the apposed 
membranes and the calcium ions reduces the inter-membrane spacing further (Fig-
ure 2.6.2-1, A). Moreover, calcium ions induce phase transition of the outer leaflets 
(fluid → crystalline) resulting in an unstable state making membranes susceptible to 
fusion supported by the local release of heat due to phase transition.[101,102] However, 
the product of fusion was not necessarily a bigger intact liposome. Other lipidic struc-
tures like flattened bilayer dices were observed.[101] Additionally, liposomes can just be 
deformed or ruptured by calcium ions and membrane interactions are nonspecific. 
Consequently, the calcium-liposome system is confined concerning the investigation 
of natural membrane fusion processes.[103] Therefore, other fusogenes were created 
which mimic the ability of integral fusion proteins to fuse membranes.  
 
 
 
 
 
 
 
 
Figure 2.6.2-1 Illustration of docked liposomes mediated by different fusogenes (red): A) Calcium ions 
form a tethering complex with the lipid headgroups. B) Headgroups of lipids are linked to DNA recogni-
tion motifs. C) Integral membrane proteins are linked to recognition motifs like PNA or coiled-coil forming 
peptides (based on ref. 56). 
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For instance, a construct consisting of a lipid anchor and a DNA based recognition 
motif was synthesised to mimic the minimal fusion machinery of SNARE proteins (Fig-
ure 2.6.2-1, B). Dioctadecyl-glycerol anchored complementary DNA sequences of 24 
nucleobases or partially hybridised DNA sequences of 27 bp anchored by two choles-
terol anchors (12 membrane proximal base pairs to ensure double cholesterol anchor-
ing and 15 free nucleobases) fuse SUVs and LUVs. By the induction of non-comple-
mentary DNA sequences close to the lipid anchor, it is possible to vary the inter-mem-
brane distance between the liposomes and thus to investigate the role of distances 
concerning fusion efficiency. In general, long DNA spacer increases docking rates and 
reduces fusion efficiency. This is in agreement with the requirement of close proximity 
for membrane fusion (Section 2.4).[104–107] Another artificial fusion system also bases 
on lipid anchors. However, in this case the anchors are linked via flexible polyeth-
ylenglycol (PEG) spacers to peptidic coiled-coil forming recognition units. This con-
struct resembles the minimal SNARE machinery concerning the coiled-coil forming 
recognition units of three heptads as the shortest known hetero coiled coil and fuse 
liposomes of different sizes without leakage. The application of LUVs and pore-span-
ning membranes for these model peptides leads only to docking.[88,108] This is under-
standable, because the lipid anchor does not span the whole membrane and does not 
affect membrane continuity significantly. The force of molecular recognition might not 
be sufficiently transferred to the membranes via the lipid anchors to induce fusion of 
membranes with less curvature stress. Lipids presenting three melamine and three 
cyanuric acid residues in opposing membrane lead to liposome docking through hy-
drogen bonds but not to fusion. Latter is induced by addition of antimicrobial membrane 
surface-active magainin.[109] This amphiphilic peptide forms an α-helix with a hydro-
phobic and a positively charged surface on opposite sides. Magainin binds to nega-
tively charged lipid headgroups and disrupts membrane continuity.[110] Concerning the 
SNARE proteins Syb2 and Sx1A it is suggested that the TMDs do not only function as 
membrane anchors but have further functions like the perturbation of lipid continuity or 
the induction of bending stress making membranes prone to fuse.[11,111] Especially, in 
the late stages of the fusion process (fusion pore opening) TMDs are probably crucial 
factors.[14] To shed more light on the functions of TMDs during the fusion process, 
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fusogenes were developed which are combined constructs of natural LR/TMD se-
quences of Syb2 or Sx1A and artificial recognition motifs based on peptide nucleic 
acids (PNA) or coiled-coil forming peptides (Figure 2.6.2-1, C).[15,16] 
 
2.6.2.1) PNA-LR/TMD Peptide Hybrids as SNARE Mimetics 
The linkage of the LRs/TMDs of Syb2 and Sx1A (SybLR/TMD and SxLR/TMD) as na-
tive membrane anchors and aminoethylglycine peptide nucleic acid (aeg-PNA) 
decamers yielding SNARE mimetics which combine natural features of SNARE pro-
teins with well controllable artificial recognition motifs. Unlike lipid based membrane 
anchors, TMDs are thought to play an active role during membrane fusion. After dock-
ing of the membranes is induced by molecular recognition, N-terminal regions including 
the LRs might perturb membrane packing and lead to the first hydrophobic contact of 
the opposing membranes through splayed lipids (Section 2.4). Furthermore, TMDs 
might induce electrostatic condensation of lipids and thus create a suitable lipidic en-
vironment for membrane fusion. Through C-terminal zippering mechanical force is 
transferred to the membrane allowing the formation of a fusion pore. Afterwards, TMDs 
reduce membrane curvature stress and thereby stabilising the pore.[12,67] The aeg-PNA 
consists of a polyamide backbone of N-(2-aminoethyl)glycine (aeg) units and nucleo-
bases which are attached through methylenecarbonyl linkers to the backbone.[112] The 
sequences for PNA decamers are chosen concerning hybridisation (WATSON-CRICK 
base pairing) in parallel and antiparallel orientation (Figure 2.6.2.1-1). The PNA 
strands form thermally very stable helical duplexes with melting temperatures of 46 °C 
for parallel (PNA1/PNA3) and 66 °C for antiparallel (PNA1/PNA2, released energy 
upon association is 31 kBT) duplexes. The hybridisation is independent of the prevail-
ing salt concentration.[15,113–115] The aeg-backbone is neutral and has no negative 
charges like RNA and DNA backbones. Furthermore, it is achiral and thus synthesis 
problems of PNA monomers concerning enantiomeric purity is avoided. PNA is highly 
biostable, i.e. it is not degraded by nucleases or proteases.[116] In vitro experiments 
demonstrated that 4-5 % of the SNARE complexes exhibit an antiparallel orienta-
tion.[117] In addition to the ternary Syb2/Sx1A/SNAP 25 complex several other weakly 
interacting binary complexes like a Syb2/Sx1A-complex were identified.[7] The PNA 
recognition system provides the possibility to investigate the relationship between 
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recognition orientation and membrane fusion. Another important aspect of 
PNA-LR/TMD peptide hybrids is the transition region between the PNA recognition 
units and the LRs of Syb2 and Sx1A. The LRs are probably random-coils which adapt 
α-helical structures not before the zippering interactions reach these regions.[76] It is 
doubtful, if PNA recognition is convenient to induce C-terminal zippering because the 
topology of the PNA helix is different compared to the coiled-coil four-helix bundle of 
the native SNARE motifs (compare Figure 2.6.2.1-1 with Figure 2.6.2.2-1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6.2.1-1 SNARE analogues based on the LRs/TMDs of Syb2 and Sx1A. The SNARE motifs are 
exchanged by decamers of aeg-PNA: A) Crystal structure of an antiparallel double helix of hexameric 
PNA strands. Green, red and blue sticks represent carbon, oxygen and nitrogen atoms, respectively. 
Letters N and C mark C- and N-termini of the single strands. The distances between the terminal Cα-at-
oms are 14.7 Å (yellow dashed lines). The insert represents the basic structure of an aeg-PNA monomer 
(nb: nucleobase). B) Sequences of the used PNA-LR/TMD peptide hybrids: The LR/TMD of Syb2 (light 
and dark blue) is linked to the PNA1 sequence (light green). The LR/TMD of Sx1A is connected to the 
PNA1 (non-complementary, control), the PNA2 (cyan, antiparallel recognition) or the PNA3 sequence 
(dark blue, parallel recognition). Red X and Y mark the C-terminal aa positions of Syb2 and Sx1A which 
were systematically mutated in the present study. The crystal structure is taken from ref. 113 (PDB code: 
1pup) and was processed by using the PyMOL 0.99rc6 software. 
 
For instance, the distance between the backbones of the PNA double helix is ~15 Å 
(Figure 2.6.2.1-1, A). The diameter of the Syb2/Sx1A-coil of the SNARE complex is 
~6 Å in the transition region of the SNARE motifs and LRs (distance of the last C-ter-
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minal Cα-atoms of the Syb2 and Sx1A motifs, Figure 2.6.2.2-1, B).[118] Thus, the dis-
tance between the C-terminal aas of the Syb2 and Sx1A motifs is significantly smaller 
than the distance between the C-terminal PNA monomers of the artificial PNA recog-
nition system. Moreover, the rotation per bp (20°) within the PNA-double helix differs 
from the twist of the Syb2 and Sx1A helices per aa within the Syb2/Sx1A-coil (2.9°, for 
calculation see Section 5.8).[119] These structural differences of the PNA recognition 
system lead to a different positioning of the N-terminal aas in the LRs of Syb2 and 
Sx1A. Consequently, the artificial PNA recognition units might impair C-terminal zip-
pering interactions within the LRs and TMDs. Nevertheless, PNA-LR/TMD peptide hy-
brids are able to bring membranes in spatial proximity and to induce fusion.[15] In the 
case of lacking C-terminal zippering, the transfer of mechanical force to the TMDs like 
in the case of native SNARE recognition is probably reduced, because the LRs of Syb2 
and Sx1A do not form stiff α-helices. Thus, the flexibility of the unstructured LRs impair 
effective force transfer and membrane fusion.[13] The transferred force might nonethe-
less perturb membrane continuity by a motion of polar C-terminal ends of the TMDs 
from the membrane-water interface into the hydrophobic centre of the membrane and 
open a fusion pore.[14] Thus, the required energy for this motion might be a crucial 
factor and depends on the C-terminal charges of the TMDs of Syb2 and Sx1A.[17] The 
usage of native LR/TMD sequences offers the possibility to modify the LRs/TMDs of 
Syb2 and Sx1A: Mutation studies exchanging particular aas like in this work or a batch 
of aas can be performed as well as the introduction of tags and chemical modified aas 
as further possible applications. The advantage of these fusogenes is that modifica-
tions – whatever they look like – are in the natural peptidic environment. Thus, conclu-
sions of studies using PNA-LR/TMD peptide hybrids are suitable to clarify the role of 
specific regions of the natural SNARE-TMDs right up to single atoms (precision de-
pends also on the applied detection method). 
 
2.6.2.2) E3/K3-LR/TMD Peptide Hybrids as SNARE Mimetics 
MEYENBERG et al. developed artificial fusogenes which are similar to the already pre-
sented PNA-LR/TMD peptide hybrids. Again, the LR/TMD sequences of Syb2 and 
Sx1A are used, but they are coupled to coiled-coil forming peptides (E3 and K3) in-
stead of PNA.[16] α-helical coiled coils are well studied quaternary protein structures of 
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right-handed α-helices which form left-handed superstructures.[120] The relationship 
between the aa sequence and the resulting quaternary structures like dimers, trimers 
or tetramers is well understood. Empirically found sequence-to-structure rules are used 
to create new artificial supermolecular structures (de novo design). Coiled coils are 
built up by heptad repeats with a typical pattern of hydrophobic (h) and polar (p) aa 
residues (hpphppp, usually denoted as abcdefg). Consequently, a coiled-coil se-
quence presents its hydrophobic residues (3.5-residue spacing) nearly concerted with 
one helical turn (3.6 residues per turn), i.e. the hydrophobic aa residues are on the 
same side of the α-helix. However, the result of the slight difference in aa arrangement 
is the typical superhelical structure of coiled coils. Positions a and d are located at the 
interface of the coiled-coil strands and connect the monomers by hydrophobic interac-
tions (knob-into-holes (KIH) interactions).[121] These aas are important for the stability, 
oligomeric state and the orientation (parallel or antiparallel) of the coiled coils. For in-
stance, if in positions a and d an isoleucine and a leucine residue are present, respec-
tively, a parallel dimer is the preferred superstructure. The dimer formation can be sup-
ported by the introduction of asparagine in position a (accompanied by reduced stabil-
ity).[122] If the positions of isoleucine and leucine are exchanged against each other, a 
tetramer is preferred.[123] Positions e and g harbour typically charged aas like lysine, 
glutamate, aspartate or arginine and contribute to the stability and specificity of the 
coiled-coil structure beside the hydrophobic core interactions. The usage of oppositely 
charged aas in different peptide sequences for the positions e and g induces comple-
mentary and supports the formation of heterodimers. Amino acids in position b, c and 
f are suitable to improve the water solubility of coiled-coil structures because of their 
peripheral location within the complex. However, these positions influence also the 
formation of higher oligomers (> trimers), if they are occupied by small hydrophobic 
aas (e.g. alanine). Furthermore, helix favouring aas like alanine are more frequent at 
these positions of coiled-coil sequences than helix breakers like glycine or proline, be-
cause helicity is the basic requirement of coiled-coil formation. In general, positions b, 
c, e, f and g are more permissive than positions a and d for modifications.[124,125] Fol-
lowing these relationships between sequence and structure, HODGE et al. developed a 
short and stable coiled-coil recognition system (Figure 2.6.2.2-1, C-E). The sequences 
E3 ((EIAALEK)3) and K3 ((KIAALKE)3) form heterodimeric parallel coiled coils. Posi-
tions a and d are occupied by isoleucine and leucine which support dimerisation. In 
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the case of isoleucine, the hydrophobicity at the interaction site and therefore dimer 
stability is increased. In positions b and c two alanines reside which enhance helicity. 
Oppositely charged aas are localised in e and g (glutamate in E3 and lysine in K3), 
which improves heterodimerisation. Three heptad repeats are sufficient to form stable 
duplexes with a Kd value of 70 nM (released energy upon association is 16 kBT).[126] 
Due to the coiled-coil structure, the E3/K3 recognition system corresponds more to the 
native SNARE recognition than the PNA system. The diameter of the E3/K3-coiled coil 
is ~1.4 nm (14 Å) and match the SNARE complex diameter.[118] However, the diameter 
of the Syb2/Sx1A-coil is with ~0.6 nm (6 Å) much smaller (Figure 2.6.2.2-1, B-C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6.2.2-1 Comparison of structural features of the natural SNARE complex and the E3/K3 com-
plex: A) Lateral view on the SNARE complex with the four α-helices of Syb2 (Sybmotif, green), Sx1A 
(Sxmotif, cyan) and the two SNAP 25 domains (Sn1, magenta and Sn2, yellow). N- and C-terminus of 
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the complex are tagged by the letters N and C, respectively. B) Frontal view on the C-terminal end of 
the SNARE complex. (colour code as in A). The distance between the last C-terminal Cα-atoms is 5.9 Å 
(yellow dashed line). C) Frontal view on the C-terminal end of the E3/K3 complex (E3, green and K3, 
cyan). The distance between the last C-terminal Cα-atoms is 14.0 Å (yellow dashed line). D) Lateral 
view on the E3/K3 complex (colour code as in C). E) Amino acid sequences of the used SNARE ana-
logues: The LR/TMD (light and dark blue) of Syb2 is connected to the E3 recognition unit (green). In the 
case of the inverted E3 peptide (iE3), the aa sequence is reverse. The LR/TMD (light and dark orange) 
of Sx1A is connected to the K3 recognition unit (cyan). Red X and Y mark C-terminal aa positions of the 
TMDs which were systematically mutated in the present study: Crystal and NMR solution structures are 
taken from ref. [127] (SNARE complex, PDB code: 1n7s) and ref. 120 (E3/K3 complex, PDB code: 1u0i). 
Structures were processed by the PyMOL 0.99rc6 software. 
 
The twists per aa of the E3/K3 and Syb2/Sx1A coiled coils coincide (both 2.9°, for 
calculation see Section 5.8). Therefore, the structural features of E3/K3-LR/TMD pep-
tide hybrids match those of native Syb2 and Sx1A better compared to the 
PNA-LR/TMD peptide hybrids and the situation for C-terminal zippering is more con-
venient. However, a direct evidence (e.g. due to crystal structures) for zippering up to 
the C-termini is lacking. In addition, differences in the heptad register are also present. 
The C-terminal heptads of Syb2 and Sx1A reach into the LRs and this is not the case 
for the artificial E3/K3 based model peptides. C-terminal zippering requires spatial 
proximity of the aas in the LRs/TMDs which depends on the aa arrangement induced 
by the recognition units (see the Appendix, Comparison of Native and Artificial Se-
quences, Figure A-8). Modifications of the C-termini of E3-SybLR/TMD and 
K3-SxLR/TMD model peptides are identical to those of the PNA-LR/TMD peptide hy-
brids (for a more detailed description of modifications see Section 2.7). 
 
 
 
 
 
 
Membranes and Their Fusion 
 
34 
 
2.6.3) Detection Methods for Membrane Characteristics 
The following section describes detection techniques for the determination of mem-
brane characteristics. The focus is on the detection of membrane adhesion (docking), 
the mixing of lipids between membranes (fusion of membrane leaflets), the exchange 
of contents between membrane encapsulated compartments through an aqueous con-
nection (fusion pore) and the increase of membrane size. These are the key charac-
teristics for membrane fusion.[108] Beside the key characteristics of fusion, there are 
other important membrane features which should be known for the evaluation of mem-
brane fusion. For instance, the lamellarity of liposomes, the orientation of proteins 
within the membrane, the lateral mobility of membrane components and the phase 
behaviour of the membrane are important features with regard to membrane fusion. 
 
 
 
 
 
 
 
 
Figure 2.6.3-1 Overview of the variety of methods applied to determine membrane characteristics. Elec-
tron paramagnetic resonance (EPR): Orientation of spin-labelled proteins within a membrane; phase 
separation of membranes.[128,129] Nuclear magnetic resonance spectroscopy (31P-, 2H-NMR): Lamellarity 
of liposomes; phospholipid ratio between inner and outer leaflet; orientation of cholesterol within a phos-
pholipid bilayer.[130,131] X-ray diffraction: Structural rearrangements of lipids during phase transition; de-
tection of membrane fusion intermediates.[45,132] Differential scanning calorimetry (DSC): Influence of 
lipids on membrane phase transition.[133] Fourier transform infrared spectroscopy (FTIR): Conformations 
in acyl chains of lipids in different phases (lipid packing).[134] The present collection of methods does not 
claim completeness. Furthermore, it is not possible to differentiate methods clearly from each other, 
because they are often applied in combination. 
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2.6.3.1) Electron Microscopy  
Electron microscopy (EM) is a very useful detection tool, because it delivers images of 
liposomes. EM images deliver important structural information within the nanometer 
range regarding size and membrane integrity. Moreover, it is possible to observe di-
rectly membrane fusion intermediates. Two examples are freeze fracture EM (ffEM) 
which yields three-dimensional images of liposomes and cryogenic transmission EM 
(cryoTEM) by which a through-vision-perspective is obtained.[21,135,136] However, a se-
rious drawback of ffEM concerning heterogeneous liposome populations is that frac-
ture planes pass through randomly distributed liposomes. Thus, the planes do not rep-
resent the midplane of liposomes in any case. Consequently, diameters obtained by 
ffEM are partly smaller than the actual diameters.[32] The drawback can be overcome 
by using cryoTEM. In this method, a liquid film of ~300 nm thickness is frozen and 
irradiated in its entirety. Liposomes within the film can be recorded. Due to ice crystal 
formation and elevated osmotic pressure in both EM methods, morphological shifts are 
conceivable. Therefore, the application of cryoprotectants like DMSO are important.[136] 
 
2.6.3.2) Microfluorimetry  
Microfluorimetry (MF) represents an important tool for the detection of membrane char-
acteristics in the sub-micron range. This detection method relies on confocal micros-
copy and its technical advancement confocal laser scanning microscopy (CLSM). In 
both techniques small areas of fluorophore labelled membranes are excited. The emis-
sion signal is observed via an optical microscope supported by a photomultiplier.[137] 
Total internal reflection fluorescence (TIRF) microscopy is one widely used MF tech-
nique. When a laser beam illuminates the interface of two layers with different refrac-
tive indices (glass and water), total reflection occurs. However, some of the light energy 
permeates the interface of the two layers and creates an electric field parallel to the 
layers (evanescent wave). This field is capable of exciting fluorophores which are close 
to the layer with the higher refractive index (glass). Consequently, only fluorescent 
molecules within distances of 100 nm to the surface are excited. The emission is de-
tected in good spatial and temporal resolution by a microscope equipped with a CCD 
camera.[138] For instance, it is possible to discern individual labelled lipids during the 
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fusion process and to distinguish between different intermediates of single fusion 
events.[52] In general, by using TIRF one can obtain kinetic binding curves or binding 
isotherms of membrane-protein interactions.[77] For fluorescence recovery after photo-
bleaching (FRAP) microscopy, the membrane is labelled with a fluorophore and a de-
fined area of the membrane is irradiated by a laser beam which induces photobleach-
ing of the fluorophores. After bleaching, the recovery of the fluorescence in the irradi-
ated region is monitored. FRAP enables the determination of lateral diffusion coeffi-
cients of lipids and proteins within the membrane.[139] Single particle tracking (SPT) is 
also used to detect diffusion processes. Using this method, labelled molecules are not 
bleached but tracked by cameras with suitable resolution. Fluorescence interference 
contrast (FLIC) microscopy exploits the interference of direct and reflected light from 
fluorophores in front of a mirror. It is possible to determine protein orientation within 
lipid bilayers with a resolution of 1-2 nm, if different positions of the protein are la-
belled.[77]  
 
2.6.3.3) Spectrofluorimetry 
Spectrofluorimetry (SF) is closely related to MF. Instead of images or videos, fluores-
cence spectra are recorded and analysed. Fluorescence correlation spectroscopy 
(FCS) is a method for the detection of molecular binding events and lateral diffusion. 
Through the usage of two dyes of a FRET (Förster resonance energy transfer) pair it 
is possible to discriminate between docking and fusion of two liposomes with temporal 
resolution in the millisecond range (fluorescence cross correlation spectroscopy 
(FCCS)). Two populations of liposomes labelled with different dyes diffuse freely in a 
confocal microscope. If liposomes interact with each other, equal intensive fluores-
cence signals are temporal correlated but no FRET effect is observed. When leaflet 
mixing between the two differently labelled liposomes occurs, the intensity of one sig-
nal is enhanced (acceptor fluorophore) and the other signal (donor fluorophore) de-
creases.[140–142] The effect of fluorescence anisotropy is exploited to detect binding 
events between proteins, e.g. between membrane bound and cytosolic proteins or be-
tween proteins which tend to aggregate at membranes.[9,143] Fluorophores are attached 
to one binding partner. The fluorophores are excited by polarised light and the gener-
ated emission depends on the rotational time of the protein bound fluorophore. The 
Membranes and Their Fusion 
 
37 
 
rotational time is slowed down by binding partners and this causes less depolarisation 
of the emitted light compared to the polarisation of the exciting light. The reduction of 
depolarisation indicates binding events.[144] 
Spectrofluorimetry in bulk assays based on FRET: The detection and analyses of 
FRET between headgroup labelled lipids in membranes is exploited to determine leaf-
let mixing between separated membranes which is induced by membrane fusion (Fig-
ure 2.6.3.3-1, B). FRET is a physical process of electronic energy transfer between a 
donor and an acceptor fluorophore. The donor is excited by light irradiation. Thereby, 
it transfers energy to the acceptor, which emits light at another wavelength. At the 
same time emission of the donor is inhibited. FRET is independent of direct contact or 
emitted light of the donor. Rather the transfer requires dipol-dipol interactions of the 
fluorophores and depends strongly on the distance between the donor and acceptor 
fluorophore (Figure 2.6.3.3-1, A).[145,146] Typical Förster radii (distance between donor 
and acceptor with a FRET efficiency of 50 %) are in the range of 1.5 – 6.0 nm.[147] 
 
 
 
 
 
 
 
Figure 2.6.3.3-1 FRET based leaflet mixing assays: A) FRET effect illustrated by a Jablonski diagram 
(taken from ref.146). B) Total leaflet mixing (TLM, top) and inner leaflet mixing (ILM, bottom) after treat-
ment of labelled liposomes (NBD as donor (yellow) and Rh as acceptor (red)) with sodium dithionite 
(DT).  
 
There are two methods for detecting leaflet mixing: One membrane is labelled with a 
FRET pair (e.g. nitrobenzoxadiazol (NBD) as donor and lissamine rhodamine B (Rh) 
as acceptor). If these membranes are in contact with unlabelled membranes, leaflet 
mixing might occur, i.e. leaflets of apposed membranes merge. Thus, labelled lipids 
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migrate into the unlabelled region of the newly formed membrane and vice versa. Con-
sequently, labelled lipids are diluted and thus the FRET efficiency is reduced. Usually 
while exciting the donor fluorophore, the emission of the donor fluorophore is detected 
and increases when the FRET efficiency is reduced by dilution of labelled lipids 
(dequenching of donor).[148] By treating liposomes with dithionite ions (membrane im-
permeable substance), NBD of the outer leaflets is deactivated. As result, the reduction 
of the FRET effect by dilution of labelled lipids during membrane fusion is restricted to 
the inner leaflets (Figure 2.6.3.3-1, B). In conclusion, hemifusion (merger of outer leaf-
lets) and full fusion (merger of both leaflets) is distinguishable by total and inner leaflet 
mixing assays exploiting the increase of NBD fluorescence due to FRET reduction 
(Figure 2.6.3.3-2).[149,150] 
 
 
 
 
 
 
 
 
Figure 2.6.3.3-2 Fluorescence spectra of a typical leaflet mixing experiment with FRET fluorophores in 
one liposome population. Fusion with unlabelled liposomes results in an increase of the donor emission 
(NBD at 535 nm, indicated by the arrow below the red curve) and in a decrease of the acceptor emission 
(Rh at 585 nm, indicated by the arrow below the blue curve). 
 
The second FRET based assay for the detection of leaflet mixing relies on the labelling 
of both membranes with only one fluorophore, respectively. (e.g. Texas Red and Ore-
gon Green). If leaflet mixing takes place, both dyes approach each other and an in-
crease of the FRET effect is observed (not depicted).[151] Through this experimental 
arrangement failed results due to liposome rupture processes are avoided, because 
FRET occurs only when the membranes merge. In the case of two fluorophores in one 
liposome population (Figure 2.6.3.3-1, B), the rupture of liposomes leads to FRET pair 
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dilution, i.e. the detected reduction of FRET efficiency is not necessarily related to 
membrane fusion. 
Spectrofluorimetry in bulk assays based on self-quenching and fluorescent complexes: 
Further indication for full fusion is gained by content mixing assays. Water-soluble 
self-quenching fluorophores (e.g. sulforhodamine B (SRB) or calcein) or fluorescent 
complex forming substances (terbium cations and dipicolinic acid (DPA)) are used for 
this purpose.[152–154] When liposomes loaded with SRB in self-quenching concentra-
tions are mixed with liposomes without SRB, the concentration of the dye is reduced 
and an increase in emission is detected. This implies an aqueous connection between 
the liposomes. However, an increase in emission can also occur due to leakage pro-
cesses.[155] Therefore, a control experiment must be performed using liposomes which 
are filled with a content dye, but do not carry fusogenes in their membranes. In another 
experimental setup, one liposome population carries terbium ions and the other popu-
lation DPA. Upon aqueous contact between both populations, a fluorescent complex 
is formed and its emission can be detected. Leakage during the process of fusion is 
also a problematic issue for this content mixing assay and must be reviewed by an 
control experiment. If the membrane-impermeable strong chelator ethylendiaminetet-
raacetate (EDTA) is added to liposomes after starting the fusion reaction with sufficient 
time delay, terbium ions are chelated by EDTA and a decrease in emission is detected 
when leakage occurs.[154]  
 
2.6.3.4) Colloidal Probe Microscopy 
Membrane-membrane interactions can be investigated by modified atomic force mi-
croscopy (AFM). The standard tip of a cantilever has a sharp pyramidal shape inap-
propriate for the coverage with a lipid bilayer. Therefore, in colloidal probe microscopy 
(CPM) the cantilever is equipped with a colloidal probe made of borosilicate glass with 
diameters of 1-20 µm. The spherical probe is covered by a lipid bilayer with integral 
peptides. An opposing solid supported membrane on a silicon wafer is also doped with 
peptides. The integrity of membranes on the sphere and the solid support is controlled 
by means of fluorescence microscopy. Homogeneous coverage and lateral mobility of 
the membrane are ascertained by CLSM based FRAP experiments. The cantilever 
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with the spherical probe approaches the solid supported membrane. Through deflec-
tions of the cantilever acting forces are recorded. The approach curve contains infor-
mation about breakthrough and fusion events. Afterwards, the cantilever is pulled away 
from the solid supported membrane. The resulting retraction curve gives information 
about adhesion forces induced by interacting peptides and merged leaflets of the mem-
branes (Figure 2.6.3.4-1).  
 
 
 
 
 
 
Figure 2.6.3.4-1 Illustration of a CPM experiment: A) Colloidal probe covered by a membrane ap-
proaches a solid supported membrane. B) Spherical probe retracts from the solid supported membrane. 
Interactions between membrane bound components (e.g. integral peptides) and membrane fusion can 
be detected (only hemifusion is depicted) (based on ref. 156). 
 
The area of contact between both membranes can be estimated by the applied exter-
nal force during the approach, the size of the probe and YOUNG’S modulus E of the 
corresponding materials. With knowledge of the cross sectional area of lipids it is pos-
sible to calculate how many lipids are in close contact.[156] The estimation of the number 
of interacting peptides is more sophisticated because of possible peptide clustering. 
However, if one assumes a homogeneous distribution of peptides with known cross 
sectional area and molar peptide to lipid ratio, it is in principle possible to estimate the 
number of potentially interacting peptides. Thus, forces delivered by CPM can be as-
signed to single molecules.  
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2.7) Applied Membrane Fusion System 
In the present study SNARE mimetics consisting of natural LR/TMD sequences of the 
SNARE actors Syb2 and Sx1A are used. The native recognition motifs are replaced 
by artificial recognition units based on aeg-PNA or coiled-coil forming peptides (E3 and 
K3) (Sections 2.6.2.1 and 2.6.2.2). The peptides are synthesised by means of standard 
solid phase peptide synthesis (SPPS) using the base labile Fmoc-protecting group for 
N-terminal amino groups and acid labile groups for the aa residues and the nucleo-
bases of the PNA recognition units (Figure 2.7-1).[157,158] The synthesis principle is 
identical for all synthesised peptides, but differs slightly concerning the used reagents 
for the PNA-LR/TMD and E3/K3-LR/TMD peptide hybrids. 
 
 
 
 
 
 
 
 
 
Figure 2.7-1 General synthesis scheme of Fmoc based SPPS: Framed structures emphasise the usage 
of different resins for C-terminal carboxy acid or amide groups, respectively. Deprotection of the N-ter-
minal Fmoc group is performed under basic conditions. For the formation of an amide bond (coupling) 
the introduced aa is activated through an active ester. By N-terminal acetylation (capping) of unreacted 
peptides, the misincorporation of aas during subsequent SPPS is avoided. Cleavage of the ester or 
amide bond between the peptide and resin is performed under acidic conditions releasing the respective 
C-terminal group and the aa side chains. Detailed presentations of deprotection, active ester formation, 
acetylation, cleavage with scavengers, aspartimide formation and racemisation reactions are available 
in the Appendix, Solid Phase Peptide Synthesis. Abbreviations: R: resin, Raa: aa residue and Act: active 
ester (based on ref. 159 and 160). 
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The LR/TMD of Syb2 is throughout linked to PNA1 in the case of PNA-LR/TMD peptide 
hybrids and to iE3 or E3 sequences in regard to E3/K3-LR/TMD peptide hybrids. On 
the other side, the LR/TMD of Sx1A is connected to the sequences PNA1, PNA2 or 
PNA3 concerning PNA-LR/TMD peptide hybrids and to K3 in the case of 
E3/K3-LR/TMD peptide hybrids (Figures 2.6.2.1-1 and 2.6.2.2-1). Interactions be-
tween PNA1-SybLR/TMD and PNA2-SxLR/TMD leads to antiparallel PNA duplex for-
mation (C- and N-termini are positioned at opposite sides of the duplex). Parallel recog-
nition (C- and N-termini are positioned on the same side of the duplex) is achieved by 
PNA1-SybLR/TMD and PNA3-SxLR/TMD and the combination of PNA1-SybLR/TMD 
and PNA1-SxLR/TMD serves as control with non-complementary recognition units. If 
E3-SybLR/TMD is combined with K3-SxLR/TMD parallel coiled-coil formation is ex-
pected. For mixtures of iE3-SybLR/TMD and K3-SxLR/TMD antiparallel interactions 
are assumed.[161] The native C-terminal aas of SybLR/TMD and SxLR/TMD are threo-
nine and glycine, respectively. These aas are exchanged for glutamate or lysine as 
carboxylic acids or amides (Table 2.7-1). The mutations result in different charges at 
the C-termini. The charges are suggested to influence the fusion behaviour with regard 
to membrane perturbation through the immersion of the C-terminal regions of the 
SybTMD and SxTMD into the hydrophobic core of the membrane. It is assumed that 
immersion of the C-terminal parts occurs during the recognition process of native 
SNARE proteins.[17,18,67] Herein applied model peptides are used to gain a closer in-
sight on this process. 
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Table 2.7-1 Molecular structures of aas used for C-terminal modifications of the SybTMDs and SxTMDs. 
Inserted tables indicate charges (Q) at the C-termini and applied abbreviations of C-terminally modified 
SNARE TMDs. 
 
In addition to C-terminal charges, the orientation (parallel or antiparallel) of the SNARE 
mimetics during recognition plays a crucial role, because only the parallel orientation 
leads to C-terminal zippering.[15] Molecular simulations suggested a thinning-widening 
mechanism for native SNARE proteins during the stalk-pore transition. C-terminal at-
tractive forces between the TMDs of Syb2 and Sx1A as well as interactions between 
the LRs of the same peptides and membrane surfaces might combine thinning with 
widening motions of the stalk intermediate driven by C-terminal zippering. Those inter-
actions might also inhibit the propagation of a metastable hemifusion diaphragm inter-
mediate by clamping the stalk intermediate (Figure 2.7-2).[12,13]  
 
C-terminal aas of SybTMD (X) C-terminal aas of SxTMD (Y) 
 
 
  
  
Qacid = -2 SybE 
Qamide = -1 SybEa 
 
Qacid = -/+ SybK 
Qamide = +1 SybKa 
 
Qacid = -1 SybT 
Qamide = 0 SybTa 
 
Qacid = -1 SxG 
Qamide = 0 SxGa 
 
Qacid = -2 SxE 
Qamide = -1 SxEa 
 
Qacid = -/+ SxK 
Qamide = +1 SxKa 
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Figure 2.7-2 Illustration of the applied membrane fusion system with supposed fusion pathways: A) 
Parallel recognition between PNA1-SybLR/TMD and PNA3-SxLR/TMD or E3-SybLR/TMD and 
K3-SxLR/TMD corresponds to the native recognition orientation. Through C-terminal attractive forces 
between the duplexes (bent magenta arrows) and interactions between the LRs and membranes (ma-
genta circles), the stalk intermediate thins down and widens simultaneously (magenta arrows). Thereby, 
fusion pore formation is achieved. Red X and Y indicate the positions of aa exchanges (Table 2.7-1). B) 
Antiparallel recognition between PNA1-SybLR/TMD and PNA2-Sx/LR/TMD or iE3Syb-LR/TMD and 
K3-SxLR/TMD leads to docking, but neither C-terminal zippering nor a thinning-widening mechanism is 
conceivable. The stalk intermediate might transit a diaphragm intermediate or emerge directly into a 
fusion pore.  
 
Described SNARE mimetics are incorporated into LUVs, which are prepared by the 
extrusion technique.[93] Thereby, peptide/lipid films are prepared from organic solu-
tions. The films are hydrated before extrusion. The loss of lipid material during lipo-
some preparation is controlled by determination of the amount of phosphate. There-
fore, the lipids must be digested. The released phosphate is treated with molybdate 
under reductive conditions. The concentration of the resulting phosphatemolybdate 
complex is determined photometrically.[162,163] Another easier and faster possibility to 
determine the lipid loss is to measure the decrease of fluorescence of labelled lipids 
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before and after liposome preparation. However, this can only be performed for la-
belled liposomes. The insertion of peptides is controlled by a density-gradient centrif-
ugation based assay. Thereby, the liposomes with peptides (proteoliposomes) are ul-
tra-centrifuged using a density gradient. The equilibrium of gravity force and Brownian 
motion leads to separation of particles with high density (peptides) and those with low 
density (proteoliposomes). The separation is controlled by sodium dodecyl sulfate pol-
yacrylamide gel electrophoresis (SDS-PAGE) and silver staining. The fusion behaviour 
of liposomes, which carry SNARE mimetics is examined by recording the course of 
FRET efficiency. For that, one proteoliposome population is labelled with the FRET 
pair NBD/Rh. If the labelled lipids are present in sufficient concentrations, FRET occurs 
due to close contact between the dyes. Leaflet mixing with unlabelled proteoliposomes 
lead to reduction of the FRET efficiency indicating for membrane fusion (Section 
2.6.3.3). Moreover, SNARE mimetics were incorporated into pore spanning and solid 
supported membranes to investigate the fusion behaviour by CLSM and CPM (Sec-
tions 2.6.1 and 2.6.3.4). For experimental details see the experimental part (Chap-
ter 5). 
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3) Results and Discussion 
 
3.1) Influence of the Recognition Units of SNARE Mi-
metics on Leaflet Mixing 
Both PNA-LR/TMD and E3/K3-LR/TMD peptide hybrids with modified C-termini were 
tested by FRET based bulk leaflet mixing assays regarding their ability to induce mem-
brane fusion. Independent of the C-terminal modifications, E3/K3-LR/TMD peptide hy-
brids exhibit consistently stronger leaflet mixing than the corresponding PNA based 
model peptides (Figure 3.1-1, A-B).  
 
 
 
 
 
 
 
 
Figure 3.1-1 Total leaflet mixing assays of liposomes decorated with SNARE mimetics carrying carbox-
ylic acid termini (SybX- and SxY-TMDs). The increase of donor emission (NBD) occurs due to mixing of 
lipids of the outer and inner leaflets: Parallel oriented recognition of A) the PNA1/PNA3 duplex and B) 
the E3/K3 coiled-coil formation. Native C-terminal threonine of the SybT-TMD and glycine of the SxG-
TMD were exchanged either by lysines (SybK- and SxK-TMDs), by glutamates (SybE- and SxE-TMDs) 
or by glutamates for the SybT-TMD and lysines for the SxG-TMD (SybE- and SxK-TMDs). Symbols in 
brackets indicate the charges of C-terminal aas at pH = 7.4. 
 
The general reason for higher fusion efficiencies of the E3/K3-LR/TMD peptide hybrids 
compared to PNA-LR/TMD peptide hybrids are the recognition motifs. E3/K3 
coiled coils bring the LRs/TMDs of Syb2 and Sx1A in closer contact than the 
PNA1/PNA3 duplexes (Figures 2.6.2.1-1 and 2.6.2.2-1). Therefore, the mechanical 
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force exerted on membranes and accompanied perturbations caused by TMD immer-
sion are stronger for E3/K3 based model peptides. Moreover, the thermal stability for 
E3/K3 coiled coils (Tmelt = 57 °C) is higher than for PNA1/PNA3 duplexes 
(Tmelt = 46 °C) and thus, higher amounts of energy are released during coiled-coil for-
mation. This might enhance the process of membrane fusion.[15,164] Higher inner leaflet 
mixing rates due to full fusion underlines the stronger fusion efficiency of 
E3/K3-LR/TMD peptide hybrids (Figure 3.1-2, A-B).  
 
 
 
 
 
 
 
 
Figure 3.1-2 Inner leaflet mixing of liposomes decorated with SNARE mimetics carrying carboxylic acid 
termini (SybX- and SxY-TMDs). The increase of donor emission (NBD) occurs due to dilution of labelled 
lipids of the inner leaflets. Emission intensities are normalised by using the 100 % intensity value after 
Triton X treatment with fluorescent NBD in outer and inner leaflets (same 100 % value as for the nor-
malisation of TLM measurements): Parallel oriented recognition of A) PNA1/PNA3 duplex and B) E3/K3 
coiled-coil formation. Native C-terminal threonine of the SybT-TMD and glycine of the SxG-TMD were 
exchanged either by lysines (SybK- and SxK-TMDs), by glutamates (SybE- and SxE-TMDs) or by glu-
tamates for the SybT-TMD and lysines for the SxG-TMD (SybE- and SxK-TMDs). Symbols in brackets 
indicate charges of C-terminal aas at pH = 7.4.  
 
During ILM measurements of proteoliposomes with PNA based model peptides, only 
the combination PNA1/SybE + PNA3/SxK exhibits a significant increase of NBD emis-
sion (~3 %) indicative for the merger of inner leaflets. For the E3/K3-LR/TMD peptide 
hybrids, all C-terminally modified peptides exhibit certain degrees of inner leaflet mix-
ing. This observation supports the assumption that C-terminal zippering is especially 
important for the transition of hemifusion intermediates (stalk and/or diaphragm inter-
mediates, Figure 2.7-1) to full fusion.[14] E3/K3 recognition corresponds rather to native 
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SNARE complex formation than PNA1/PNA3 interactions, because the twists of the 
E3/K3-coiled coil and the Syb2/Sx1A-coil coincide with 2.9°/aa. In the case of a PNA 
helix, the twist per bp is 20°. This difference might result in an unfavourable positioning 
of the N-terminal aas of the LRs of Syb2 and Sx1A for interactions which might be 
important for C-terminal zippering.[10] However, the distance of 1.4 nm between the 
facing helices in the C-terminal region of the E3/K3-coiled coil corresponds to the di-
ameter of an aeg-PNA helix. The distance in the C-terminal region of the 
Syb2/Sx1A-coil is with 0.6 nm much smaller. Concerning these structural features both 
E3/K3 and PNA based recognition are inappropriate to mimic native SNARE recogni-
tion (Sections 2.6.2.1 and 2.6.2.2). Furthermore, aas allocated to the coiled-coil for-
mation of the native SNARE motif reach into the LRs of Syb2 and Sx1A.[127] However, 
this does not correspond to the coiled-coil register of the used E3/K3 model peptides 
(Appendix, Comparison of Native and Artificial Sequences). Consequences of these 
mismatches are discussed later (Section 3.4.6.2). 
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3.1.1) Recognition Orientation of PNA-LR/TMD Peptide Hy-
brids 
Parallel interactions of SNARE mimetics with PNA recognition units lead mainly to 
stronger leaflet mixing than those with antiparallel recognition (Figures 3.1.1-1 and 
3.1.1-3). This observation is in line with the prevailing parallel mode of recognition of 
native SNARE proteins and underlines the assumption that parallel interacting model 
peptides can exert more force on the membranes during the process of recognition via 
their TMDs (Figure 2.7-2).[3] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.1-1 Total leaflet mixing of liposomes decorated with SNARE mimetics carrying carboxylic 
acid (SybX- and SxY-TMDs, A-B) and amide termini (SybXa-and SxYa-TMDs, C-D). The increase of 
donor emission (NBD) occurs due to the mixing of lipids of the outer and inner leaflets. Peptide combi-
nations presented in A) and C) follow the parallel recognition mode. Combinations in B) and D) follow 
the antiparallel recognition mode. Native C-terminal threonines of the SybT(a)-TMDs and glycines of the 
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SxG(a)-TMDs were exchanged either by lysines (SybK(a)- and SxK(a)-TMDs), by glutamates (SybE(a)- 
and SxE(a)-TMDs) or by glutamates for the SybT(a)-TMDs and lysines for the SxG(a)-TMDs 
(SybE(a)- and SxK(a)-TMDs). Symbols in brackets indicate charges of C-terminal aas at pH = 7.4. 
 
Interestingly, the drop of fusion efficiency in TLM assays due to antiparallel recognition 
is more distinct for PNA-LR/TMD peptide hybrids with C-terminal amides (Fig-
ure 3.1.1-1, C-D) than for model peptides with carboxylic acids (Figure 3.1.1-1, A-B). 
Amide like C-termini are less charged and therefore their immersion into the mem-
branes during parallel recognition and accompanied membrane perturbation is fa-
voured due to a lower energy barrier for TMD motions compared to C-terminal carbox-
ylic acids, which are stronger charged (Section 3.2). If model peptides interact in the 
antiparallel mode, immersion of the C-termini into the membranes is not possible due 
to an inappropriate arrangement of the TMDs (Figure 2.7-2, A-B). In conclusion, less 
membrane perturbation through the C-termini during antiparallel recognition has 
stronger effects on leaflet mixing of liposomes with model peptides carrying C-terminal 
amides than on liposomes with peptides carrying carboxylic acids, because the mem-
brane perturbation is less distinct for stronger charged C-termini during parallel recog-
nition. Nevertheless, TLM measurements using antiparallel interacting model peptides 
with C-terminal carboxylic acids and amides – even when slight – was detected (Fig-
ure 3.1.1-1, B and D). Thus, the antiparallel recognition of PNA-LR/TMD peptide hy-
brids probably act in form of peptidic bridges between the membranes bringing them 
in spatial proximity.[165] The length of the antiparallel PNA duplex with 0.32 nm rise/bp 
and the LRs of Syb2 and Sx1A as stretched α-helices with 0.15 nm rise/aa is estimated 
to be ~6 nm.[113] At a distance of 6 nm, no membrane fusion is conceivable. Therefore, 
other reasons might play a role. Leaflet mixing induced by antiparallel interacting 
PNA-LR/TMD peptide hybrids with C-terminal carboxylic acids is weak except for the 
combinations PNA1/SybE + PNA2/SxK and PNA1/SybK + PNA2/SxK which exhibit 
strong TLM (Figure 3.1.1-1, B). The C-terminal lysines of these model peptide combi-
nations might enhance membrane perturbation through electrostatic interactions of the 
positively charged amino groups of the side chains with the headgroups of the phos-
pholipids and hydrophobic interactions of the residual hydrocarbon chains with the lipid 
tails (snorkelling interactions).[166] The combination of peptidic connection and mem-
brane perturbation through C-terminal lysines seem to be sufficient to induce TLM. For 
the combination PNA1/SybE + PNA2/SxK, lysines support leaflet mixing only through 
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the lysine modified SxTMDs. However, the combinations of PNA1/SybE + PNA3/SxK 
(parallel) and PNA1/SybE + PNA2/SxK (antiparallel) exhibit similar extents of leaflet 
mixing (Figure 3.1.1-2). The increase in NBD emission is even higher in the first 450 s 
of the measurement of antiparallel recognition. Furthermore, C-terminal lysines as am-
ides should have similar perturbing effects like lysines as carboxylic acids, but for the 
combination PNA1/SybKa + PNA2/SxKa (Figure 3.1.1-1, D) only an emission increase 
of ~5 % (corresponding carboxylic acid combination: 13 %) is detected. These contra-
dictory results are rather explainable by the instability of proteoliposomes, differences 
in added amounts of liposomes during measurements and/or by differences in the de-
gree of peptide insertion than by C-terminal modifications and the mode of recognition. 
These aspects are discussed in more detail in Sections 3.4.2, 3.4.3 and 3.4.4. 
 
 
 
 
 
 
 
Figure 3.1.1-2 Total leaflet mixing of liposome populations with following peptide combinations: 
PNA1/SybE + PNA3/SxK (parallel recognition, black graph), PNA1/SybE + PNA2/SxK (antiparallel 
recognition, orange graph) and PNA1/SybK + PNA1/SxK (control, magenta graph). Symbols in brackets 
indicate charges of C-terminal aas at pH = 7.4. 
 
ILM assays for the antiparallel recognition between SNARE mimetics with C-terminal 
carboxylic acids have mainly the same tendencies compared to the results of TLM 
assays, i.e. combinations PNA1/SybT + PNA2/SxG and PNA1/SybE + PNA2/SxE ex-
hibit only slight hemifusion because of slight TLM rates (< 5 %, Figure 3.1.1-1, B) and 
no significant ILM rates (Figure 3.1.1-3, B). However, concerning the combination 
PNA1/SybE + PNA2/SxK significant leaflet mixing was also observed in ILM assays 
(Figure 3.1.1-3, B). The observation of leaflet mixing in TLM and ILM assays indicates 
full fusion. Strong TLM is usually accompanied by relative strong ILM. One exception 
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herein is the combination PNA1/SybK + PNA2/SxK. For this mixture, an increase in 
NBD emission of ~15 % during TLM assays was detected (Figure 3.1.1-1, B), but in 
ILM assays no significant increase was observed (Figure 3.1.1-3, B). Thus, lysine mod-
ified PNA-LR/TMD peptide hybrids induce only strong hemifusion, if they interact in 
antiparallel orientation. SNARE mimetics with C-terminal amides show only a slight 
increase in NBD emission for both TLM (< 10 %, Figure 3.1.1-1, D) and ILM (< 1 %, 
Figure 3.1.1-3, D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.1-3 Inner leaflet mixing of PNA-LR/TMD peptide hybrids with carboxylic acid (SybX- and 
SxY-TMDs) and amide termini (SybXa- and SxYa-TMDs). The increase of donor emission (NBD) occurs 
due to mixing of the inner leaflets. Emission intensities are normalised by using the 100 % intensity 
value after Triton X treatment with fluorescent NBD in outer and inner leaflet (the same 100 % value as 
for the normalisation of the TLM assays). A) and C) Parallel interacting PNA1 and PNA3 recognition 
motifs. B) and D) PNA1 and PNA2 sequences interact in antiparallel orientation (N- and C-termini are 
at different sides of the duplex). 
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Consequently, antiparallel recognition between peptides with C-terminal amides lead 
only to weak hemifusion. Although it was expected that at least the combinations with 
C-terminal lysines as amides would induce stronger membrane fusion. Like mentioned 
for TLM assays, these contradictory results might be rather explainable by experi-
mental aspects like proteoliposome instability, added amounts of proteoliposomes for 
the leaflet mixing assays and/or by different degrees of peptide insertion than by struc-
tural features of the model peptides. For ILM assays, the same contradictory results in 
regard to parallel and antiparallel recognition between SybE- and SxK-TMDs were ob-
tained (Figure 3.1.1-4). All other combinations of the PNA-LR/TMD peptide hybrids in 
parallel orientation were superior compared to antiparallel oriented hybrids concerning 
inner leaflet mixing assays. The reason for it might not be found in the mode of recog-
nition but again rather in experimental uncertainties. For instance, it is conceivable that 
the loss of lipid material during liposome preparation was higher for liposomes deco-
rated with PNA3/SxK than for liposomes carrying PNA2/SxK (Section 3.4.3).  
 
 
 
 
 
 
 
 
Figure 3.1.1-4 Inner leaflet mixing of liposome populations with following peptide combinations: 
PNA1/SybE + PNA3/SxK (parallel recognition, black graph), PNA1/SybE + PNA2/SxK (antiparallel 
recognition, orange graph) and PNA1/SybK + PNA1/SxK (magenta graph). 
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3.1.2) Recognition Orientation of E3/K3-LR/TMD Peptide 
Hybrids 
For the induction of antiparallel recognition, the E3 sequence was inverted yielding the 
iE3 sequence (Figure 2.6.2.2-1, E). However, through the sequence inversion the hy-
drophobic core of the coiled coil is altered. Polar glutamate and alanine at positions a 
and d change knob into hole (KIH)-interactions dramatically. Another state of oligomer-
isation is required to ensure preferred hydrophobic packing. ZHENG et al. demonstrated 
that the inversion of the E3 sequence changes the orientation and oligomerisation of 
the coiled coil from a parallel dimeric to an antiparallel tetrameric assembly.[164] In this 
study, paramagnetic NMR spectroscopy, FRET based measurements and 
coarse-grained molecular dynamics (CGMD) simulations demonstrated that assem-
blies of iE3 and K3 peptides (without the LRs/TMDs of Syb2 and Sx1A) are antiparallel 
oriented.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.2-1 Comparison of parallel and antiparallel coiled-coil forming SNARE mimetics: A) TLM. B) 
ILM. C) Illustration of the parallel (left) and the antiparallel (right) recognition mode of the 
(i)E3/K3-LR/TMD peptide hybrids. For parallel recognition, one SybTMD (dark blue) and one SxTMD 
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(dark orange) per coiled coil are involved, respectively (dimer formation). For antiparallel recognition, 
two SybTMDs and two SxTMDs participate per coiled coil, respectively (tetramer formation). 
 
A Job-plot indicates a 1:1 binding stoichiometry and analytical ultracentrifugation as 
well as CGMD simulations suggest tetrameric coiled coils with two iE3 and K3 pep-
tides, respectively. Within the tetramer iE3 and K3 peptides are antiparallel to each 
other, whereby identical peptides are parallel oriented. This change in oligomerisation 
must be considered, when parallel and antiparallel recognition of coiled-coil SNARE 
mimetics are compared (Figure 3.1.2-1, C). TLM and ILM assays demonstrated that 
the parallel and antiparallel recognition between the SNARE mimetics with native 
C-terminal ends induce leaflet mixing (hemifusion and partial full fusion). Parallel inter-
actions led to slightly stronger leaflet mixing (Figure 3.1.2-1, A-B). This is an agreement 
with native SNARE proteins which follow mainly the parallel recognition mode. Com-
pared to PNA induced antiparallel recognition between SybTMDs and SxTMDs with 
native C-terminal aas (PNA1/SybT + PNA2/SxG, ~5 % emission increase, Fig-
ure 3.1.1-1, B), the antiparallel tetrameric coiled coil evokes much stronger TLM 
(iE3/SybT + K3/SxG, ~17 % emission increase, Figure 3.1.2-1, A). ILM assays confirm 
TLM assays with an increase of emission of ~2 % (Figure 3.1.2-1, B). For the cognate 
PNA-LR/TMD peptide hybrids, no ILM was detected (Figure 3.1.1-3, B). In this case, 
the stronger increase is not explainable by C-terminal zippering, because these inter-
actions are not possible for iE3/K3 recognition. Antiparallel tetramer formation con-
nects the apposed membranes. The length of the tetramer (21 aas) and the LRs of 
Syb2 and Sx1A (10 aas, respectively) is estimated to be ~6 nm, if one assumes 
stretched α-helices with a rise of 0.15 nm per aa. However, a distance of 6 nm is not 
sufficient to induce membrane fusion. It is supposed that K3 peptides interact with the 
headgroups of phospholipids and thereby shaping the membranes. This results in pos-
itively curved protrusions. In addition, DOPE (negative curvature supporting stalk for-
mation) and cholesterol (stabilisation of the fusion pore) accumulate in the vicinity of 
K3.[52] Furthermore, K3 binds not only to the membrane where it is inserted via its 
SxTMD, but also to the opposing membrane.[167] These peptide-membrane interac-
tions facilitate the fusion of docked membranes. For aeg-PNA, no membrane interac-
tions are reported. Membrane activity of K3 is logically also crucial for parallel 
coiled-coil mediated membrane fusion. The K3 based model peptides – although ini-
tially not expected and desired – do not only mimic the SNARE motif of Sx1A, but also 
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membrane shaping activities which are known to be involved in natural fusion pro-
cesses (Section 2.4.2). However, the exact extent of fusion supporting interactions be-
tween K3 and the membranes is not known. 
 
3.2) Influence of C-Terminal Carboxylic Acids and Am-
ides of SNARE Mimetics on Leaflet Mixing 
The tendency of higher fusion efficiency for E3/K3-LR/TMD peptide hybrids compared 
to PNA based model peptides with C-terminal carboxylic acids is also observed for the 
SNARE mimetics with amides as C-termini. However, the differences in TLM are even 
higher than for carboxylic acid-like C-termini (Figure 3.2-1, A-B and C-D). This differ-
ence is explainable by the release of more energy during E3/K3 recognition than during 
PNA1/PNA3 interactions. Furthermore, E3/K3-LR/TMD peptide hybrids mimic native 
SNARE complex formation better concerning the transition between recognition units 
and LRs (Sections 2.6.2.2 and 3.1). Therefore, E3/K3-LR/TMD peptide hybrids exert 
probably more force on membranes through its C-termini during recognition than 
PNA-LR/TMD peptide hybrids. In the case of C-terminal amides, the negative charges 
of the carboxylic acid groups are missing. Therefore, the energy-barrier for the transi-
tion of the amide C-termini into the hydrophobic core of the membrane is lower than 
for the carboxylic acid C-termini. Membrane fusion supported by the perturbation of 
lipid continuity through the immersion of C-termini is thought to be more efficient for 
C-terminal amides.[14,17] Increased fusion efficiencies of C-terminal amides were ob-
served for all combinations in the group of E3/K3 based model peptides (compare B 
and D, Figure 3.2-1).  
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Figure 3.2-1 Total leaflet mixing of liposomes decorated with SNARE mimetics carrying amide (SybXa- 
and SxYa-TMDs, A-B) and carboxylic acid termini (SybX-and SxY-TMDs, C-D). Increase of donor emis-
sion (NBD) occurs due to labelled lipids of the outer and inner leaflets. All combinations follow the par-
allel recognition mode. The exchange of aas for peptides with amide termini is the same as for peptides 
with carboxylic acid termini. 
 
Within the PNA based peptide group, only combinations of natural aas and glutamate 
as C-terminal amides (PNA1/SybTa + PNA3/SxGa and PNA1/SybEa + PNA3/SxEa) 
fuse with higher efficiency than the same combinations as carboxylic acids 
(PNA1/SybT + PNA3/SxG and PNA1/SybE + PNA3/SxE) (Figure 3.2-2, A). However, 
in the case of PNA-LR/TMD peptide hybrids with lysines or glutamates and lysines, 
carboxylic acids (PNA1/SybK + PNA3/SxK and PNA1/SybE + PNA3/SxK) fuse more 
efficiently than amides (PNA1/SybKa + PNA3/SxKa and PNA1/SybEa + PNA3/SxKa) 
(Figure 3.2-2, B). 
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Figure 3.2-2 Selections of PNA-LR/TMD peptide hybrids which differ in TLM efficiency due to its C-ter-
mini: A) Peptides with amide C-termini exhibit stronger fusion than those with C-terminal carboxylic 
acids. B) Peptides with carboxylic acid C-termini show stronger fusion than those with amide C-termini. 
 
This is contradictory, because the charge is also reduced in the case of C-terminal 
lysines for the SybTMD and SxTMD or glutamates for the SybTMD and lysines for the 
SxTMD as amides. Different degrees of peptide insertion during liposome preparation 
might again be one reason for the above mentioned contrary fusion behaviour (Section 
3.4.4). Another reason for stronger leaflet mixing of the combinations 
PNA1/SybE + PNA3/SxK and PNA1/SybK + PNA3/SxK compared to the same combi-
nations with C-terminal amides might be the low stability of proteoliposomes carrying 
PNA-LR/TMD peptide hybrids with C-terminal lysines. Both as carboxylic acids and as 
amides, these peptides seem to destabilise membranes stronger than peptides with 
native aas or glutamates. For instance, for all PNA based model peptides with C-ter-
minal lysines, visible aggregation processes were observed within 30-60 min after lip-
osome preparation (Tables 3.4.2-2 and 3.4.2-3). Native aas or glutamates induced 
sometimes fast aggregation as well, especially as amides, but with less propensity. In 
general, proteoliposomes with PNA1/SybEa and PNA1/SybKa are less stable than 
those with the cognate SNARE mimetics PNA1/SybE and PNA1/SybK. The instability 
of proeteoliposomes might be another reason for the contradictory results mentioned 
above, because the detection of leaflet mixing is influenced by the accompanied ag-
gregation processes (Section 3.4.2).  
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3.3) Significant Differences in Leaflet Mixing Due to 
C-Terminal Modifications 
It is supposed that the charges of the C-termini of Syb2 and Sx1A are crucial for the 
transition of hemifusion intermediates to full fusion because of C-terminal zippering 
accompanied immersion of the C-terminal ends into the membranes. The caused dis-
continuity might lead to a rearrangement of lipids which results in fusion pores.[14,17] 
The application of modified SNARE mimetics in leaflet mixing assays should help to 
clarify this assumption. All proteoliposome combinations were measured three times. 
However, the individual measurements differ partially considerable from each other 
concerning the detected increases of NBD emission. These variations are explicable 
by experimental uncertainties (Section 3.4). In the following sections, only significant 
differences between total leaflet mixing measurements with regard to C-terminal mod-
ifications of the SNARE mimetics are discussed. 
 
3.3.1) PNA-LR/TMD Peptide Hybrids with C-Terminal Car-
boxylic Acids 
For parallel PNA recognition, the combination PNA1/SybE + PNA3/SxK (fluorescence 
increase of ~24 % after 20 min detection time) can be clearly distinguished from the 
combinations PNA1/SybT + PNA3/SxG (~8 %) and PNA1/SybE + PNA3/SxE (~3 %) 
in TLM assays (Figure 3.3.1-1, A). However, a clear distinction between ILM curves is 
not possible (Figure 3.3.1-1, B). C-terminal threonine and glycine for the SybTMD and 
SxTMD (PNA1/SybT + PNA3/SxG), respectively, represent the native C-terminal aas 
and effective fusion was expected. However, only slight hemifusion was observed for 
this combination, because of the relative slight fluorescence increase in TLM assays 
(~8 %, Figure 3.3.1-1, A) and negligible low increase in ILM assays (< 1 %, Fig-
ure 3.3.1-1, B). 
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Figure 3.3.1-1 Leaflet mixing measurements with (significant) differences in the increase of NBD fluo-
rescence: A) TLM and B) ILM results of parallel interacting PNA-LR/TMD peptide hybrids with C-terminal 
glutamates and threonines for the SybTMDs as well as lysines, glycines and glutamates for SxTMDs 
(all C-terminal aas as carboxylic acids). 
 
Parallel PNA recognition is not sufficient to exert enough force on the TMDs to rear-
range lipids for full fusion by immersing C-terminal ends because of the relative high 
energy barriers for the transition of negative charges of the carboxylic acid groups of 
SybT- and SxG-TMDs from the water/membrane interface into the headgroup re-
gion/hydrophobic core of the membranes. Furthermore, additional energy through 
C-terminal zippering of the LRs/TMDs of Syb2 and Sx1A is unlikely due to topological 
differences between the PNA duplexes and LRs/TMDs of the SNARE mimetics (Sec-
tions 2.6.2.1 and 3.5.2). C-terminal glutamates for the SybTMDs and SxTMDs 
(PNA1/SybE + PNA3/SxE) hinder efficient fusion more distinctly. During TLM a fluo-
rescence increase of < 3 % within 20 min was detected which is in the range of the 
control experiment (Figure 3.3.1-1, A). This weak fluorescence increase might indicate 
docking with a slight unspecific exchange of lipids of the outer leaflets of the 
PNA1/SybE and PNA3/SxE liposomes, but lipid mixing of the inner leaflets is excluded, 
because ILM assays exhibit no fluorescence increase at all (Figure 3.3.1-1, B). The 
double negative charge of the C-terminal glutamates raises the energy barrier for the 
transition of C-termini into the membranes (Section 3.5.2). Therefore, no rearrange-
ment of the lipids through TMD immersion and membrane fusion occur.[14,17] Intri-
guingly, the combination of glutamates for the SybTMDs and lysines for the SxTMDs 
(PNA1/SybE + PNA3/SxK) exhibit the strongest leaflet mixing rates (24 % for TLM and 
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3 % for ILM, Figure 3.3.1-1) of PNA based model peptides with C-terminal carboxylic 
acids in the parallel recognition mode. This is partially contradictory, because gluta-
mate modifications of the SybTMDs have hindering effects on fusion as well. However, 
C-terminal lysines of SxTMDs have destabilising effects on the membrane continuity 
and support leaflet mixing. Nevertheless, C-terminal lysines for both SybTMD and 
SxTMD exhibit less leaflet mixing (~18 %) than C-terminal glutamates and lysines (not 
significant), respectively (Figure 3.2-1, C). It is conceivable, that the low stability of the 
PNA1/SybK liposomes influence experimental outcomings because of aggregation 
processes which hamper the detection of membrane fusion. The combination 
PNA1/SybK + PNA3/SxK induces more efficient leaflet mixing (~18 %) than the com-
binations of native C-termini (~8 %) and C-terminal glutamates for both C-termini 
(~3 %) with regard to TLM assays (Figure 3.3.1-2, A). However, no significant distinc-
tion regarding ILM assays was possible (Figure 3.3.1-2, B). Membrane perturbing ef-
fects of C-terminal zwitterionic lysines for the SybTMDs and SxTMDs support the fu-
sion of PNA based SNARE mimetics more effectively than negative charges of the 
native TMDs or TMDs modified with glutamates. Leaflet mixing would probably be even 
stronger, if labelled PNA1/SybK liposomes were more stable, because the instability 
of labelled proteoliposomes affect the detection of membrane fusion by spectrofluorim-
etry (Section 3.4.2). 
 
 
 
 
 
 
 
Figure 3.3.1-2 Total and inner leaflet mixing measurements with (significant) differences in the increase 
of NBD fluorescence: A) TLM and B) ILM results of parallel interacting PNA-LR/TMD peptide hybrids 
with C-terminal lysines, threonines and glutamates for the SybTMDs as well as lysines, glycines and 
glutamates for the SxTMDs (all C-terminal aas as carboxylic acids). 
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Another fusion supporting feature of the lysine combination might be the supposed 
C-terminal attractions between the C-termini of SybK- and SxK-TMDs, respectively, 
due to opposing charges (Figure 2.7-2).[13] However, the antiparallel combination of 
lysine modified SNARE mimetics (PNA1/SybK + PNA2/SxK (~15 %)) was also more 
efficient concerning membrane fusion (TLM) than the antiparallel recognition of native 
and glutamate modified TMDs (PNA1/SybT + PNA2/SxG (~5 %) and 
PNA1/SybE + PNA2/SxE, (~3 %)). If attractive forces between the C-termini of SNARE 
mimetics are important, it is expected that the lysine combination tends to less leaflet 
mixing in the antiparallel recognition mode, e.g. in the range of native TMDs, because 
no C-terminal interactions are conceivable due to the orientation of the TMDs to each 
other, but this was not the case. Membrane perturbing effects of C-terminal lysines 
support fusion during both parallel and antiparallel recognition. Thus, it is not possible 
to control the assumption of fusion supporting C-terminal attractions by the usage of 
C-terminal lysines. Rather, it is necessary to compare mixtures of SNARE mimetics 
with opposing C-terminal charges for one proteoliposome population, e.g. 
PNA1/SybKa and PNA1/SybEa for labelled liposomes as well as PNA3/SxKa and 
PNA3/SxEa (PNA2/SxKa and PNA2/SxEa) for unlabelled liposomes. Except of the ly-
sine combination (PNA1/SybK + PNA2/SxK), fluorescence increases for antiparallel 
recognising model peptides with C-terminal carboxylic acids were always < 5 % in TLM 
assays (Figure 3.3.1-3, A). These slight increases might be merely evoked by unspe-
cific leaflet mixing due to spatial proximity induced by docking. All ILM assays of anti-
parallel interacting PNA-LR/TMD peptide hybrids were below 1 % after 20 min of de-
tection (Figure 3.3.1-3, B) and significant differentiations between the ILM measure-
ments concerning C-terminal modifications are not possible. Thus, most antiparallel 
recognising PNA-LR/TMD peptide hybrids led to docking. For the antiparallel mode, 
only the lysine combination (PNA1/SybK + PNA2/SxK) induced hemifusion, because 
the fluorescence increase in TLM assays is high (~15 %, Figure 3.3.1-3, A) and no 
significant emission increase concerning the ILM measurements was detected (Fig-
ure 3.3.1-3, B). Lysine induced membrane perturbations might support the transition 
from docked to hemifused proteoliposomes.  
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Figure 3.3.1-3 Total and inner leaflet mixing measurements with (significant) differences in the increase 
of NBD fluorescence: A) TLM and B) ILM results of antiparallel interacting PNA-LR/TMD peptide hybrids 
with C-terminal lysines, threonines and glutamates for the SybTMDs as well as lysines, glycines and 
glutamates for the SxTMDs (all C-terminal aas as carboxylic acids). 
 
The higher leaflet mixing efficiency of the combination PNA1/SybE + PNA2/SxK com-
pared to the combination PNA1/SybK + PNA2/SxK is contradictory, because no mem-
brane perturbing effects of the SybE-TMDs are expected (Figure 3.3.1-4, A-B). The 
higher stability of PNA1/SybE liposomes compared to PNA1/SybK liposomes might be 
a reason for these results (Section 3.4.2). The fast aggregation of proteoliposomes 
induced by PNA1/SybK peptides might hamper molecular recognition between labelled 
and unlabelled proteoliposomes. Furthermore, fast aggregation of labelled PNA1/SybK 
liposomes led to high losses of lipid material during proteoliposome preparation for ILM 
assays (Section 3.4.1). The absence of a fluorescence increase for the combination 
PNA1/SybK + PNA2/SxK in ILM assays is probably a result of the loss of lipid material 
during size exclusion chromatography (Figure 3.3.1-4, B). 
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Figure 3.3.1-4 Total and inner leaflet mixing measurements with significant differences in the increase 
of NBD fluorescence: A) TLM and B) ILM results of antiparallel interacting PNA-LR/TMD peptide hybrids 
with C-terminal lysines and glutamates for the SybTMDs as well as lysines for the SxTMDs (all C-termi-
nal aas as carboxylic acids). 
 
3.3.2) PNA-LR/TMD Peptide Hybrids with C-Terminal Am-
ides 
For PNA based model peptides with C-terminal amides in the parallel recognition 
mode, significant distinctions are similar compared to C-terminal carboxylic acids. The 
combination PNA1/SybEa + PNA3/SxKa (~20 %) is again the most fusogenic in this 
group and is clearly distinguishable from the combinations PNA1/SybKa + PNA3/SxKa 
(~8 %) and PNA1/SybEa + PNA3/SxEa (~5 %) in TLM assays (Figure 3.3.2-1, A). Lip-
osomes carrying SNARE mimetics with C-terminal amides are in general less stable 
than carboxylic acids. Especially the model peptides with lysines as amides destabi-
lised applied membranes (Section 3.4.2). The combination PNA1/SybKa + PNA3/SxKa 
(~8 %) exhibit less leaflet mixing compared to its carboxylic acid cognate 
PNA1/SybK + PNA3/SxK (~18 %) due to stronger aggregation processes of the la-
belled proteoliposomes. The negative charge of the side chain of C-terminal gluta-
mates as amides seems to counteract destabilising effects of C-terminal amides and 
fusion hampering aggregation is less pronounced. Therefore, the combination 
PNA1/SybEa + PNA3/SxKa combines stabilising effects owing to C-terminal gluta-
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mates, which are advantageous for the detection of leaflet mixing assays through spec-
trofluorimetry, and destabilising effects of C-terminal lysines concerning unlabelled 
proteoliposomes, which are advantageous for leaflet mixing itself due to membrane 
perturbing effects. In the case of PNA1/SybEa + PNA3/SxEa destabilising effects of 
C-terminal lysines are missing and fusion efficiency is relative low. 
 
 
 
 
 
 
 
 
Figure 3.3.2-1 Total and inner leaflet mixing measurements with (significant) differences in the increase 
of NBD fluorescence: A) TLM and B) ILM results of parallel interacting PNA-LR/TMD peptide hybrids 
with C-terminal glutamates and lysines for the SybTMDs as well as lysines and glutamates for the 
SxTMDs (all C-terminal aas as amides). 
 
Native C-terminal aas as amides (PNA1/SybTa + PNA3/SxGa (~14 %)) have no C-ter-
minal charges. Therefore, the immersion of C-terminal ends into the membranes is 
facilitated. In addition, the lack of charges might lead to flawed insertion of SNARE 
mimetics destabilising membranes by enhanced surface interactions through the not 
inserted peptides. This might be another reason for the clear distinction concerning the 
combination PNA1/SybKa + PNA3/SxKa (~8 %, Figure 3.3.2-2, A). However, the main 
reason is again the high tendency of PNA1/SybKa liposomes to aggregate. This ten-
dency is also given for PNA1/SybTa and PNA3/SxGa liposomes, but the velocity of 
aggregation was less rapid (Section 3.4.2). Due to the low fluorescence increase in 
ILM (< 0.5 %, Figure 3.3.2-2, B), the combination PNA1/SybTa + PNA3/SxGa seems 
to induce only hemifusion, but it is known that this combination can also lead to full 
fusion.[18] The purity of 15 % of the PNA3/SxGa sample (Appendix, Chromatography 
Results of PNA-LR/TMD Peptide Hybrids) was relative low compared to other peptides 
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of this group (for all peptides ~30 % of purity). Thus, hemifusion might be rather a result 
of low purity than of structural features of the peptide. In general, variations between 
the individual ILM measurements of the SNARE mimetics with C-terminal amides were 
especially high and no distinction between the combinations is possible at all (Fig-
ures 3.3.2-1, B and 3.3.2-2, B). Again, the low stability of proteoliposomes with SNARE 
mimetics as amides and accompanied high losses of lipid material during liposome 
preparation for ILM assays led to weak fluorescence signals during detection. The sig-
nal weakness exacerbated the resolution of the ILM measurements.  
 
 
 
 
 
 
 
 
Figure 3.3.2-2 Total and inner leaflet mixing measurements with (significant) differences in the increase 
of NBD fluorescence: A) TLM and B) ILM results of parallel interacting PNA-LR/TMD peptide hybrids 
with C-terminal threonines and lysines for the SybTMDs as well as glycines and lysines for the SxTMDs 
(all C-terminal aas as amides). 
 
PNA-LR/TMD peptide hybrids as amides in the antiparallel recognition mode were the 
weakest fusogenes tested in the present study. In TLM assays, all combinations ex-
hibited fluorescence increases smaller than 7 % after 20 min of detection. In ILM meas-
urements, increases were smaller than 1 % (Figure 3.3.2-3, A-B). A significant differ-
entiation was neither in TLM nor in ILM assays possible. It is obvious that these com-
binations lead only to docking and accompanied unspecific leaflet mixing. Lower de-
grees of peptide insertion due to missing C-terminal negative charges might reduce 
docking events which is in line with the results of PSM experiments with parallel inter-
acting PNA-LR/TMD peptide hybrids as amides (Section 3.4.6.2). Furthermore, mem-
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brane destabilising effects of not inserted model peptides with C-terminal amides (in-
teractions with membrane surfaces) and accompanied liposome aggregation have a 
negative impact on leaflet mixing itself and its detection through FRET reduction (Sec-
tions 3.4.1 and 3.4.2). 
 
 
 
 
 
 
 
 
Figure 3.3.2-3 Total and inner leaflet mixing measurements of amide modified PNA-LR/TMD peptide 
hybrids: A) TLM and B) ILM results of antiparallel interacting model peptides with C-terminal amides. 
For both assays, a significant differentiation between the single combinations is not possible. 
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3.3.3) E3/K3-LR/TMD Peptide Hybrids with C-Terminal Car-
boxylic Acids 
Like in the case of PNA-LR/TMD peptide hybrids with C-terminal carboxylic acids, 
E3/K3 based model peptides with glutamates and lysines for the SybTMDs and 
SxTMDs, respectively, induced strongest leaflet mixing (~40 % fluorescence increase 
over 20 min detection time). This combination is clearly distinguishable from the com-
binations E3/SybT + K3/SxG (~25 %) and E3/SybE + K3/SxE (~15 %) in TLM and ILM 
assays (Figure 3.3.3-1, A-B). 
 
 
 
 
 
 
 
 
Figure 3.3.3-1 Total and inner leaflet mixing measurements of E3/K3 based SNARE mimetics with (sig-
nificant) differences in the increase of NBD fluorescence: A) TLM and B) ILM results of parallel interact-
ing E3/K3-LR/TMD peptide hybrids with C-terminal glutamates and threonines for the SybTMDs as well 
as lysines, glycines and glutamates for the SxTMDs (all C-terminal aas as carboxylic acids). 
 
The model peptide E3/SybE did not induce aggregation of proteoliposomes and thus 
it is assumed that the C-terminal negative charge of the aa residue is less destabilising 
than the residual positive charge of lysine (K3/SxK), which induces aggregation (Sec-
tion 3.4.2). The high stability of labelled E3/SybE liposomes and the membrane per-
turbating effects of K3/SxK are probably the main reasons for the high fusogenity of 
the combination E3/SybE + K3/SxK. The fluorescence increase in ILM assays of this 
combination was also high (~8 %) indicative for full fusion. Native C-terminal ends in-
duces full fusion as well, but with a lower tendency (~3 % fluorescence increase in ILM 
assays). C-terminal glutamates lead rather to hemifusion, because the emission in-
crease in ILM assays is with ~2 % even lower. Nevertheless, a distinct differentiation 
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between the combinations of E3/SybT + K3/SxG and E3/SybE + K3/SxE in ILM assays 
was not possible (Figure 3.3.3-1, B). Whereas the combination E3/SybK + K3/SxK 
(~30 % increase) is clearly distinguishable from the combination E3/SybE + K3/SxE 
(~15 % increase) in TLM assays (Figure 3.3.3-2, A). The membrane destabilising ef-
fects of C-terminal lysines might be one reason for the higher fusogenity of the lysine 
combination like in the case of the corresponding PNA-LR/TMD peptide hybrids. An-
other reason might be attractive forces between the C-termini which are supposed to 
support a thinning-widening mechanism of the fusion process (Section 2.7). However, 
leaflet mixing measurements with PNA based model peptides refute this assumption 
(Section 3.3.1). The degree of purity of the used peptide samples is probably another 
reason for the high fusogenity of the lysine combination: E3/SybE and K3/SxE peptides 
have purities of ~43 % and ~31 %, respectively. The lysine modified model peptides 
have corresponding values of ~18 % and 22 % (Appendix, Chromatography Results 
of E3/K3-LR/TMD Peptide Hybrids). The higher degree of impurities concerning the 
lysine combination might induce more points of distortion at the membrane surfaces 
and therefore supports leaflet mixing processes (Section 3.4.5). 
 
 
 
 
 
 
 
 
Figure 3.3.3-2 Total and inner leaflet mixing measurements of E3/K3 based SNARE mimetics with (sig-
nificant) differences in the increase of NBD fluorescence: A) TLM and B) ILM results of parallel interact-
ing E3/K3-LR/TMD peptide hybrids with C-terminal lysines and glutamates for the SybTMDs and 
SxTMDs (all C-terminal aas as carboxylic acids). 
 
A clear distinction between the lysine and glutamate combinations with regard to ILM 
measurements is not possible due to the strong variations between the individual 
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measurements (Figure 3.3.3-2, B). However, it can be assumed that the lysine combi-
nation has the higher tendency for full fusion (~5 % increase in ILM assays) compared 
to the glutamate combination (~2 % increase). In conclusion, the E3/K3 recognition 
system is sufficient to induce full fusion by using native SybT- and SxG-TMDs. In-
creased negative charges at the C-termini as for glutamate modified model peptides 
(SybE- and SxE-TMDs) reduce the fusion efficiency because of a higher energy barrier 
for the immersion of the C-termini into the membranes. C-terminal lysines (SybK- and 
SxK-TMDs) seem to rescue and even enhance fusion because of their destabilising 
effects on membranes. 
 
3.3.4) E3/K3-LR/TMD Peptide Hybrids with C-Terminal Am-
ides 
E3/K3 based model peptides with C-terminal amides in the parallel recognition mode 
are the most efficient fusogenes of the present study. Again, the combination of C-ter-
minal glutamates with C-terminal lysines exhibited the strongest leaflet mixing rates 
(fluorescence increase of ~45 %). This combination is clearly distinguishable from the 
combinations E3/SybTa + K3/SxGa (~30 %) and E3/SybEa + K3/SxEa (~27 %, Figure 
3.3.4-1, A). Explanations for the observed fusion behaviour are in line with those of 
other applied SNARE mimetic groups: Model peptides with C-terminal glutamates do 
not destabilise liposomes due to their residual negative charges. On the other hand, 
C-terminal lysines destabilise membranes –  especially as amides (Section 3.4.2). Sta-
ble labelled proteoliposomes are more suitable for the detection of leaflet mixing and 
destabilised unlabelled proteoliposomes support leaflet mixing processes. The combi-
nation E3/SybEa + K3/SxKa combines these features. The reduced fusion efficiency 
of the combination E3/SybTa + K3/SxGa is explainable by the lower stability of the 
E3/SybTa liposomes compared to the E3/SybEa liposomes. Moreover, glycines of the 
K3/SxGa peptides have not the same membrane destabilising effects as lysines of the 
K3/SxKa peptides. However, native C-terminal aas as amides have no charges and 
this might lead to flawed insertion. Not inserted peptides might additionally destabilise 
proteoliposomes through interactions with the membrane surface and explain the 
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slightly higher leaflet mixing rates of this combination compared to the glutamate com-
bination (not significant). In corresponding ILM assays, the mentioned combinations 
are not distinguishable from each other due to strong variations between the individual 
measurements (Figure 3.3.4-1, B). 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.4-1 Total and inner leaflet mixing measurements of E3/K3 based SNARE mimetics with (sig-
nificant) differences in the increase of NBD fluorescence: A) TLM and B) ILM results of parallel interact-
ing E3/K3-LR/TMD peptide hybrids with C-terminal glutamates and threonines for the SybTMDs as well 
as lysines, glycines and glutamates for the SxTMDs (all C-terminal aas as amides). 
 
In ILM assays for the combination E3/SybEa + K3/SxKa an increase of the fluores-
cence of ~6 % indicative for full fusion was observed. Other combinations have lower 
tendencies for full fusion: The fluorescence increases of the combinations 
E3/SybTa + K3/SxKa and E3/SybEa + K3/SxEa are ~3 % and ~4 %, respectively. The 
exchange of the detected fluorescence increases concerning TLM and ILM assays of 
these combinations (Figure 3.3.4-1, compare A and B) is probably explainable by 
higher losses of lipid material during the preparation of E3/SybTa liposomes (Section 
3.4.3). Moreover, the lysine combination (~40 %) can be differentiated from the gluta-
mate combination (~27 %) in TLM assays (Figure 3.3.4-2, A). Otherwise, the same 
combinations are not distinguishable in ILM assays (Figure 3.3.4-2, B). 
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Figure 3.3.4-2 Total and inner leaflet mixing measurements of E3/K3 based SNARE mimetics with (sig-
nificant) differences in the increase of NBD fluorescence: A) TLM and B) ILM results of parallel interact-
ing E3/K3-LR/TMD peptide hybrids with C-terminal lysines and glutamates as amides for the SybTMDs 
and SxTMDs (all C-terminal aas as amides). 
 
The destabilising effects on membranes of the lysines are one reason for the higher 
fusogenity of the combination of peptides with C-terminal lysines compared to the glu-
tamate combination. The fact that the tendencies of TLM assays are not reflected in 
ILM assays is rather explainable by high losses of lipid material during the E3/SybKa 
liposome preparation for ILM assays (E3/SybKa liposomes aggregate rapidly) than by 
C-terminal structural features of these SNARE mimetics. 
 
3.3.5) Conclusion of the Results Concerning C-Terminal 
Modifications 
In conclusion, SNARE mimetics with C-terminal negative charges yields stable prote-
oliposomes, but low rates of leaflet mixing. No or positive charges at the C-termini of 
SNARE mimetics result in unstable proteoliposomes, but high rates of leaflet mixing. 
No charges might result in flawed insertion of the peptides. Partially or not inserted 
peptides interact with the surfaces of membranes resulting in unstable proteolipo-
somes. C-terminal lysines interact through their residual positive charges and relative 
long hydrocarbon chains with the phosphate groups and acyl chains of the lipids. 
These interactions perturb the membrane continuity more than glutamates and native 
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aas at the C-termini of the model peptides. The instability of proteoliposomes appears 
as aggregation, which hampers molecular recognition between the membrane bound 
model peptides and influences the detection of leaflet mixing by spectrofluorimetry. 
Negatively charged aas might interact with positively charged headgroup residues like 
choline or ethanolamine, but did not permeate into the membrane in the extent of pos-
itively charged C-terminal lysines. Thus, aggregation is less prone for SNARE mimetics 
with C-terminal negative charges. ILM assays are especially influenced by unstable 
labelled proteoliposomes. The aggregation of unstable proteoliposomes leads to a high 
loss of lipid material during proteoliposome preparation for ILM assays and weak fluo-
rescence signals which reduce the resolution of ILM measurements. Lysines with their 
positive charges at the amino groups of the side chains and their relatively long resid-
ual hydrocarbon chain perturbs membranes as carboxylic acids and as amides, but 
destabilising effects seem to be stronger when amides are used. In this case, the neg-
ative charges of the native carboxylic acid groups are missing and the C-terminal ends 
permeate deeper into the membrane than lysines as carboxylic acids. Furthermore, it 
is conceivable that C-terminal lysines as carboxylic acids (zwitterionic) induce C-termi-
nal attractive forces between SybTMDs and SxTMDs, respectively. However, high leaf-
let mixing rates are also explicable by membrane destabilisation through lysine resi-
dues. For instance, PNA-LR/TMD peptide hybrids with C-terminal lysines as carboxylic 
acids, which interact in the antiparallel mode, tend to high leaflet mixing rates as well. 
Therefore, it is not possible to assign the high fusion rates to attractive forces between 
the C-termini. Beside structural properties of the model peptides other factors like un-
expected stoichiometry due to loss of lipid material during extrusion and size exclusion 
chromatography, different degrees of peptide insertion and different grades of impuri-
ties of the peptide samples influence the experimental outcomings. 
 
3.4) Evaluation of Leaflet Mixing Assays 
In the following sections, problematic issues concerning the applied FRET based leaf-
let mixing assays are discussed: Crucial points are ILM assays, proteoliposome stabil-
ity, loss of lipid material during extrusion and size exclusion chromatography, degrees 
of peptide insertion and the purity of peptide probes. 
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3.4.1) Evaluation of Inner Leaflet Mixing Assays 
For the inner leaflet mixing (ILM) assays, labelled proteoliposomes were treated with 
sodium dithionite (DT). The reduction of the NBD fluorophores and accompanied loss 
of fluorescence was determined by means of spectrofluorimetry. The typical decrease 
of fluorescence was in the range of 60 %, whereby it must be noted that ~10 % were 
induced by dilution due to the addition of DT solution to the proteoliposome suspension 
(Figure 3.4.1-1, A). After DT treatment, the excess of DT was removed by size exclu-
sion chromatography. However, many of the labelled proteoliposome samples tend to 
visible aggregation within 30-60 min after extrusion. In the case of PNA-LR/TMD pep-
tide hybrids, proteoliposomes with PNA1/SybK, PNA1/SybKa and PNA1/SybTa pep-
tides were unstable. For E3/K3 based model peptides, proteoliposomes with E3/SybKa 
and E3/SybTa peptides exhibited high instability (for 100 % of the samples fast visible 
aggregation was observed). Due to fast aggregation, the loss of lipid material during 
size exclusion chromatography and therefore the loss of fluorescent probes was espe-
cially distinct for these samples. For instance, if one compares the decrease of Rh 
fluorescence before and after size exclusion chromatography of stable PNA1/SybT 
and unstable PNA1/SybKa liposomes, it is obvious that the loss of fluorescence is 
much higher for the unstable proteoliposomes (Figure 3.4.1-1, B). For stable 
PNA1/SybT liposomes, the decrease of fluorescence through size exclusion chroma-
tography at 585 nm was ~60 % and for unstable PNA1/SybKa liposomes ~95 %. 
 
 
 
 
 
 
 
 
Figure 3.4.1-1 A) Detection of NBD fluorescence during DT treatment. The typical decrease of fluores-
cence was ~50 %. B) Loss of Rh-labelled DOPE during size exclusion chromatography: Fluorescence 
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spectra of labelled PNA1/SybT liposomes (stable) before (solid, dark blue) and after (solid, light blue) 
as well as of labelled PNA1/SybKa liposomes (unstable) before (dashed, dark red) and after (dashed, 
light red) size exclusion chromatography.  
 
Size exclusion chromatography of other proteoliposome samples led to similar results 
with regard to aggregation tendencies. Beside the detection of fluorescence of labelled 
lipids, the loss of lipid material was also evaluated by the determination of the amounts 
of inorganic phosphate of the phospholipids before and after size exclusion chroma-
tography.[163] Both measurements are in good agreement with each other (Ta-
ble 3.4.1-1). Further results are presented in the Appendix: Loss of Lipid Material Dur-
ing Proteoliposome Preparation and Size Exclusion Chromatography, Tables A-3 and 
A-5. 
 
Table 3.4.1-1 Loss of lipids during size exclusion chromatography determined by phosphate tests and 
Rh-fluorescence. 
Remarks: a) Loss of lipid material calculated by using determined masses of phosphorus before and 
after size exclusion chromatography and b) by exploiting the fluorescence intensity at 585 nm of 
Rh-DOPE before and after size exclusion chromatography. PNA1/SybE liposomes are tendentially sta-
ble, PNA1/SybEa and PNA1/SybTa liposomes are unstable. 
 
The performance of ILM assays for unstable proteoliposomes was problematic, be-
cause of the resulting weak fluorescence signals. The detected fluorescence increases 
of the leaflet mixing curves are in a small range and a differentiation between them is 
problematic. However, the ILM measurements can be normalised in two different ways: 
If for normalisation the fluorescence before DT treatment is used, i.e. fluorescence 
originates from both leaflets, the resolution of the detected emission is low (Fig-
ure 3.4.1-2, A) compared to the detection of fluorescence after DT treatment, i.e. fluo-
rescence of NBD originates solely from the inner leaflets. In the latter case, fusion 
curves can be better distinguished from each other (Figure 3.4.1-2, B). 
 
sample 
loss determined by PO4 test 
[%]a 
loss determined by Rh-fl.  
[%]b 
PNA1/SybE 55.2 55.6 
PNA1/SybEa 89.7 64.8 
PNA1/SybTa 86.7 81.0 
PNA1/SybTa 73.5 73.8 
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Figure 3.4.1-2 Comparison of two normalisation approaches for ILM assays (same proteoliposome 
probes were used): Normalisation of the fluorescence increase by using Fmax values of labelled prote-
oliposomes A) before DT induced NBD inactivation of the outer leaflets and B) after NBD inactivation. 
 
However, herein presented results of ILM assays were evaluated by using the first 
mentioned approach, because of better comparability with TLM assays. Percental val-
ues at the y-axis are directly related to the corresponding TLM assays. An emission 
increase of 10 % means that 10 % of both leaflets are mixed. For the second approach, 
percental values are restricted to inner leaflets, i.e. that an increase of 10 % of emis-
sion indicates 10 % of inner leaflet mixing (100 % corresponds to the total abolition of 
FRET by micellisation of the proteoliposomes through detergent treatment). 
 
3.4.2) Evaluation of Liposome Stability 
In the previous sections, it has already been mentioned that several proteoliposome 
samples were unstable, i.e. they tend to aggregate. Turbidity of the proteoliposome 
suspensions is a visible sign for aggregation. This can be detected by measuring the-
optical density of the samples at 550 nm (not performed).[102] Another possibility to an-
alyse membrane stability is restricted to labelled liposomes. This test can be performed 
before visible turbidity evolves. NBD/Rh-labelled proteoliposomes were treated with 
sodium dithionite (DT). This reducing reagent is charged and does not cross the hy-
drophobic core of membranes, if it is added in appropriate concentrations to the prote-
oliposome suspensions.[149] The addition induces a drop of fluorescence, because the 
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nitro group of NBD-labelled lipids of the outer leaflets is reduced and thereby NBD 
loses its fluorescent features. Subsequently, the fluorescence reaches a plateau and 
no further decrease is detected. However, if the proteoliposomes are unstable, a slow 
and continual decrease of the fluorescence was observed due to membrane defects 
and/or rupture processes enabling DT to reach NBD-DOPE of the inner leaflets (Fig-
ure 3.4.2-1, A-B). It must be noted that flip-flop motions of lipids might be another rea-
son for the decrease of NBD emission after DT treatment, but this process is actually 
slow. Nevertheless, SNARE-TMDs are known to accelerate lipid translocation and 
therefore a slight fluorescence decrease after DT treatment might also originates from 
the inserted model peptides .[34,168,169] All labelled proteoliposomes were tested con-
cerning its membrane stability through DT treatment. In Table 3.4.2-1 averaged values 
(out of three measurements) of fluorescence curves like in Figure 3.4.2-1 are pre-
sented. Slopes before DT addition (Sbefore) are closer to zero than afterwards because 
of the absence of the reducing DT. Additionally, values are rather positive, probably 
due to slight rupture processes and an accompanied decrease of FRET between NBD- 
and Rh-labelled DOPE. 
 
 
 
 
 
 
 
 
Figure 3.4.2-1 Evaluation of proteoliposome stability through DT treatment: Detection of NBD emission 
of NBD/Rh-labelled proteoliposomes carrying A) PNA-LR/TMD peptide hybrids and B) E3/K3 based 
model peptides. Areas limited by black lines were used for slope determination (for calculation see Sec-
tion 5.7.7.5).  
 
Exceptions from that are liposomes carrying PNA1/SybK and PNA1/SybKa peptides 
with relative high positive Sbefore (0.097 a.u./s and 0.044 a.u./s, respectively) as well as 
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liposomes with E3/SybE and E3/SybEa with relatively high negative Sbefore 
(−0.028 a.u./s and −0.026 a.u./s). High positive Sbefore might be explainable by stronger 
rupture processes due to the destabilising effects of C-terminal lysines which interact 
stronger with the membrane surfaces than the other applied aas. The high negative 
Sbefore of the E3/SybE and E3/SybEa samples might be explicable by proteoliposomes 
which adhere to the walls of the cuvette. Proteoliposomes, which stick to glass walls 
outside the area of detection are not available for further detection. However, this is 
not a consequence of the peptides E3/SybE and E3/SybE, because PNA1/SybE and 
PNA1/SybEa (no consequence of the TMDs) as well as other E3 based model peptides 
(no consequence of the recognition unit E3) did not exhibit this experimental outcom-
ings. Thus, this result is rather a consequence of inherent features of the individual 
samples than of the model peptide features.  
 
Table 3.4.2-1 Slopes of fluorescence curves before and after DT treatment: Sbefore is the slope within 
the first 30 s of the measurement and Safter is the slope within 120-150 s after the addition of DT.  
liposomes with: Sbefore [a.u./s] Safter [a.u./s] 
PNA1/SybT 0.004 -0.046 
PNA1/SybE 0.005 -0.024 
PNA1/SybK 0.097 -0.041 
PNA1/SybTa 0.013 -0.182 
PNA1/SybEa 0.013 -0.068 
PNA1/SybKa 0.044 -0.060 
E3/SybT -0.001 -0.074 
iE3/SybT 0.005 -0.031 
E3/SybE -0.028 -0.034 
E3/SybK 0.008 -0.054 
E3/SybTa 0.001 -0.201 
E3/SybEa -0.026 -0.114 
E3/SybKa -0.013 -0.172 
Pure liposomes 0.003 -0.017 
 
Slopes after DT addition (Safter) are mainly in line with fast visible aggregation, i.e. la-
belled liposomes with slopes smaller than −0.040 a.u./s after DT treatment tend to ag-
gregate within 30-60 min after extrusion (compare Table 3.4.2-1 with Table 3.4.2-2). 
Safter for PNA1/SybEa, E3/SybT, E3/SybK and E3/SybEa are smaller than 
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−0.040 a.u./s, i.e. proteoliposomes are partly permeable for DT ions, but exhibit no 
visible aggregation directly after extrusion. However, long-termed aggregation, i.e. vis-
ible aggregation several days or weeks after proeteoliposome preparation, was ob-
served. 
 
Table 3.4.2-2 Visible aggregation of labelled liposomes within 30-60 min after preparation: ntotal is the 
total number of tested liposome probes, nstable is the number of liposome probes without aggregation, 
nunstable is the number of liposome probes with aggregation and punstable is the percental amount of unsta-
ble liposome probes. 
 
Taking DT measurements and visible aggregation into account, it is possible to subdi-
vide the SNARE mimetics into three classes concerning their destabilising effects on 
the liposomes:  
1) SNARE mimetics with strong destabilising effects exhibit fast aggregation within 
30-60min after proteoliposome preparation and negative slopes slighter than 
−0.040 a.u./s after DT treatment: PNA1/SybK, PNA1/SybKa, PNA1/SybTa, 
E3/SybTa and E3/SybKa. 
2) SNARE mimetics with inter-destabilising effects show no fast aggregation after 
proteoliposome preparation, but slighter slopes than −0.040 a.u./s after DT 
treatment: PNA1/SybEa, E3/SybT, E3/SybK and E3/SybEa. 
liposomes with ntotal  nstable nunstable punstable [%] 
PNA1/SybT 4 3 1a 25 
PNA1/SybE 3 3 0 0 
PNA1/SybK 6 0 6 100 
PNA1/SybTa 9 0 9 100 
PNA1/SybEa 5 5 0 0 
PNA1/SybKa 4 0 4 100 
E3/SybT 4 4 0 0 
iE3/SybT 4 4 0 0 
E3/SybE 7 7 0 0 
E3/SybK 7 7 0 0 
E3/SybTa 6 0 6 100 
E3/SybEa 5 5 0 0 
E3/SybKa 5 0 5 100 
pure liposomes 4 4 0 0 
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3) SNARE mimetics with no destabilising effects do not cause aggregation several 
months after preparation and slopes are higher than −0.040 a.u./s after DT 
treatment: PNA1/SybE, E3/SybE and iE3/SybT. 
It must be noted that this classification is not exclusively attributed to structural features 
of the SNARE mimetics but also to aspects like different degrees of purity (Section 
3.4.5 and the Appendix, Chromatography Results) of the peptide probes and probably 
incomplete peptide insertion (Section 3.4.4) concerning some proteoliposome probes. 
It was observed, that the addition of E3/SybT peptides and the LR/TMD of Syb2 to 
stable liposome suspensions lead to fast visible aggregation indicative for the destabi-
lising effects of the LR/TMD of Syb2 probably due to interactions with the membrane 
surface. The same effects are conceivable for peptides which are not correctly recon-
stituted during proteoliposome preparation.  
For unlabelled proteoliposomes with SxLR/TMD based model peptides, the stability 
was solely evaluated by means of fast visible aggregation (Table 3.4.2-3).  
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Table 3.4.2-3 Visible aggregation of unlabelled liposomes within 30-60 min after preparation: ntotal is the 
total number of the tested liposome probes, nstable is the number of liposome probes without aggregation, 
nunstable is the number of liposome probes with aggregation and punstable is the percental amount of unsta-
ble liposome probes. 
 
PNA-LR/TMD peptide hybrids with C-terminal carboxylic acids are stable except for 
peptides with C-terminal lysines (PNA1/SxK, PNA2/SxK and PNA3/SxK). PNA based 
SNARE mimetics with C-terminal amides are rather unstable. However, peptides with 
C-terminal glutamates as amides (PNA2/SxEa and PNA3/SxEa) are stable. PNA se-
quences have obviously no influence on aggregation processes, because SNARE mi-
metics with the same LRs/TMDs but different PNA sequences affect liposomes in the 
same extent. Concerning C-terminal modifications, E3/K3-LR/TMD peptide hybrids 
have the same effects as PNA based model peptides, i.e. C-terminal lysines and/or 
amides are destabilising and glutamates and/or carboxylic acids are not destabilising. 
Intriguingly, all K3-peptide hybrids are unstable independent on their C-termini. In con-
clusion, instabilities of all applied proteoliposomes are justifiable by following aspects: 
liposomes with ntotal  nstable nunstable punstable [%] 
PNA2/SxG 4 4 0 0 
PNA2/SxE 3 3 0 0 
PNA2/SxK 8 0 8 100 
PNA2/SxGa 3 0 3 100 
PNA2/SxEa 3 3 0 0 
PNA2/SxKa 9 2 7 78 
PNA3/SxG 4 3 1a 25 
PNA3/SxE 3 3 0 0 
PNA3/SxK 9 0 9 100 
PNA3/SxGa 9 0 9 100 
PNA3/SxEa 3 3 0 0 
PNA3/SxKa 8 0 8 100 
PNA1/SxK 4 0 4 100 
K3/SxG 5 0 5 100 
K3/SxE 6 2 4 67 
K3/SxK 4 0 4 100 
K3/SxGa 6 0 6 100 
K3/SxEa 4 0 4 100 
K3/SxKa 9 0 9 100 
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1) C-terminal lysines and lysines of the K3 recognition units interact with the hy-
drophilic headgroups and hydrophobic tails of the phospholipids (snorkelling in-
teractions). These interactions might shape and thereby perturb membrane con-
tinuity.[166,167] 
2) C-terminal amides delete the C-terminal negative charges of carboxylic acid 
groups. In native LR/TMD sequences of Syb2 and Sx1A (SybT and SxG) these 
charges might help to position TMDs within membranes, because they prefer 
the hydrophilic environment at the surface of membranes and the negative 
charges are obviously not tolerated in the hydrophobic core of the membranes. 
Thus, carboxylic acid groups might act as a C-terminal TMD positioner together 
with the charged aa of the LRs as N-terminal TMD positioner (C-terminal aa of 
the LRs of Syb2 and Sx1A is lysine). The lack of C-terminal charges might result 
in flawed insertion of the TMDs, i.e. the C-termini might be rather located within 
the hydrophobic core than at the surface of the membranes or peptides are in 
no sense inserted. Thereby, TMDs perturb membranes through stronger sur-
face interactions resulting in a membrane collapse. Aggregation processes 
seem to be enhanced by C-terminal lysines which interact strongly with phos-
pholipids. C-terminal glutamate as amide offers a negative charge through its 
side chain, which replaces the function of the negative charge of the native car-
boxylic acid group as a C-terminal TMD positioner. In this way, SNARE mimet-
ics with C-terminal glutamate destabilise membranes less than lysine, threonine 
or glycine as C-terminal amides. 
3) For all fusion assays, not purified peptides were used. The concentration deter-
mination of peptide stock solutions used for proteoliposome preparation were 
performed by UV-spectroscopy. However, calculated concentrations using the 
LAMBERT-BEER law might be misleading, because impurities absorb UV light at 
chosen wavelengths as well as completely synthesised peptides. Thus, two 
probes with identical determined concentrations might include different amounts 
of entirely synthesised peptides and amounts of impurities, which are added 
during the proteoliposome preparation. For the applied model peptides, impuri-
ties probably consist mainly of LR/TMDs of Syb2 and Sx1A with parts of the 
recognition units, because the possibility for deleted sequences during SPPS 
increases with increasing peptide chain lengths (synthesis starts at C-terminal 
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TMDs). In the case of PNA-LR/TMD peptide hybrids, nucleobases and trypto-
phan contribute mainly to the detected absorption at 260 nm. For instance, if 
one limits the absorption of the PNA1 sequence to thymine nucleobases and 
ignore other nucleobases, three TMDs with one thymine instead of one com-
pletely synthesised PNA1-SybLR/TMD peptide will be added during the prepa-
ration of proteoliposomes, because the PNA1 sequence includes three thy-
mines (Figure 2.6.2.1-1). In the case of E3/K3 based model peptides, circum-
stances are slightly different, because the concentrations of these peptides are 
determined by using the absorption of tryptophan, tyrosine and cysteine at 
280 nm. Therefore, the absorption used for concentration determinations has 
its origin exclusively in the LRs/TMDs with regard to (i)E3-SybLR/TMD peptides. 
For these peptides, indeed rather supposed amounts of TMDs are added during 
liposome preparation, but the TMDs carry probably no or incomplete recognition 
motifs. For K3-SxLR/TMD peptides, the situation is comparable to those of PNA 
based model peptides, because the absorption originates mainly from N-termi-
nal tryptophans (Figure 2.6.2.2-1). In conclusion, for crude PNA-LR/TMD pep-
tide hybrids probably more LRs/TMDs are added than supposed. These peptide 
fragments might additionally destabilise membranes. In the case of 
(i)E3-SybLR/TMD peptides, the supposed amounts of LRs/TMDs are probably 
added, but with less recognition units as supposed. However, K3-SxLR/TMD 
peptides are rather added with amounts of impurities like for PNA based model 
peptides. Therefore, liposomes with (i)E3-SybLR/TMD peptides are tendentially 
more stable than PNA and K3 based model peptides. 
Pure liposomes are the most stable probes, because of the lack of membrane desta-
bilising peptides. There were no hints for visible aggregation processes even after 
months (for DLS measurements see Figure 3.4.6.1-2, A).  
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3.4.3) Loss of Lipid Material During Proteoliposome Prep-
aration  
The supposed ratio of 1 to 4 of labelled to unlabelled liposomes is optimal for lipid 
mixing assays, i.e. applying this ratio lead to the highest increase of donor emission 
(NBD) during the leaflet mixing assays with the same peptide combination.[170] How-
ever, it is not sufficient to limit the determination of the liposome ratio to the used vol-
umes of liposome suspensions for the performance of leaflet mixing assays, because 
during the preparation of proteoliposomes different amounts of lipid material are re-
strained by the extrusion apparatus. Rather, it is necessary to determine the mass of 
phosphorus of the suspensions. This value is proportional to the amounts of phospho-
lipids and to the number of size-homogeneous proteoliposomes. The determination of 
phosphorus amounts of iE3/SybT and K3/SxG liposome suspensions revealed that 
10 µL of the iE3/SybT liposome suspension contain 0.99 µg of phosphorus. The 
K3/SxG suspension contained less phosphorus (0.77 µg phosphorus/10 µL). Thus, 
10 µL of the labelled iE/SybT liposome suspension combined with 160 µL of the unla-
belled K3/SxG liposome suspension (K3/SxG liposome suspension was diluted in the 
ratio 1 to 3 due to better storage conditions concerning proteoliposome stability) did 
not reflect the supposed liposome ratio of 1 to 4 (Appendix, Loss of Lipid Material Dur-
ing Proteoliposome Preparation and Size Exclusion Chromatography, Table A-5).  
 
 
 
 
 
 
 
 
Figure 3.4.3-1 Total leaflet mixing of liposomes decorated with iE3/SybT and K3/SxG peptides: Dark 
brown curve represents the 1:4 ratio limited to the added volumes of labelled and unlabelled proteolipo-
somes. The light brown curve represents the adjusted lipid ratio. To reduce lipid aggregation processes 
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and gain time for phosphate tests, the K3/SxG liposome probe was diluted with fusion buffer (1:3). 
Measurements were performed ca. 24 h after extrusion of iE3/SybT and K3/SxG liposomes. 
 
In this experiment, the actual ratio was 1 to 3.1. By increasing the added volume of the 
K3/SxG liposome suspension from 160 µL to 205 µL the supposed ratio of 1 to 4 was 
achieved. For the adjusted liposome ratio, the increase of NBD emission was 3 % 
higher than for the not adjusted ratio (Figure 3.4.3-1). These results underline that it is 
necessary to determine the mass of phosphorus for each proteoliposome suspension 
to ensure that the actual liposome ratio match the supposed ratio.  
Like mentioned before, for ILM assays it is necessary to delete the amount of NBD 
fluorescence originating from the outer leaflets of the membrane by sodium dithionite 
(DT). The excess of DT must be removed before starting the ILM assays. By size ex-
clusion chromatography, DT is separated from the proteoliposomes. However, also 
small proteoliposomes and micelles, which are formed during the proteoliposome prep-
aration or subsequently formed voluminous lipid aggregates are restrained. The result 
is a reduced lipid concentration, which influences the supposed lipid ratio for ILM as-
says of 1 to 4. Therefore, it is necessary to adjust the lipid ratio by using the results of 
phosphate determination assays. Additionally, it is possible to determine the loss of 
lipids via the loss of the fluorescent probe Rh-DOPE by spectrofluorimetry (Fig-
ure 3.4.1-1, B and Table 3.4.1-1).  
 
 
 
 
 
 
 
 
Figure 3.4.3-2 ILM of liposomes decorated with E3/SybK and K3/SxK peptides: Dark red curve repre-
sents the 1:4 ratio limited to the added volumes of labelled and unlabelled proteoliposomes. Light red 
curve represents the adjusted lipid ratio considering solely the E3/SybK liposome sample. Both meas-
urements were performed 1 d after the preparation of proteoliposomes.  
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In Figure 3.4.3-2 the increases of NBD fluorescence indicative for inner leaflet mixing 
are presented: The merging proteoliposomes were decorated with E3/SybK (labelled 
proteoliposomes) and K3/SxK (unlabelled proteoliposomes) peptides. In one case, the 
supposed ratio was solely adjusted by the added volumes of proteoliposome suspen-
sions. In the other case, the added volume of the E3/SybK liposome suspension was 
adjusted by means of phosphorus determination. Through the adjustment, a higher 
increase of NBD emission was observed, though solely the added amounts of the 
E3/SybK liposome suspension was considered. It is expected that the additional con-
sideration of unlabelled K3/SxK liposomes would lead to even stronger leaflet mixing.  
 
3.4.4) Evaluation of the Insertion Degree of SNARE Mimet-
ics in Model Membranes 
It is doubtful that all used SNARE mimetics are inserted to the same levels in the model 
membranes and are arranged correctly as integral peptides. For instance, SNARE mi-
metics without C-terminal charges (SybTa- and SxGa-TMDs) might insert partially, i.e. 
span the membrane only partially, or they inserted in no sense. Therefore, it is crucial 
to examine the degree of peptide insertion. Density-gradient centrifugation and fluo-
rescent probes were used to search into this crucial point of experiments concerning 
membrane fusion.  
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3.4.4.1) Evaluation by Density-Gradient Centrifugation  
Density-gradient centrifugation and subsequent SDS-PAGE was applied to examine 
whether the SNARE mimetics are inserted in the liposome membranes. Proteolipo-
somes were ultra-centrifuged in a medium of layered units of different density. During 
the centrifugation, liposomes accumulate in layers of low density. Whereas not inserted 
peptides accumulate in layers of high density (Figure 3.4.4.1-1).  
 
 
 
 
 
 
 
Figure 3.4.4.1-1 Illustration of density-gradient centrifugation: Nycodenz is used to establish different 
layers of density when dissolved in buffer. Black circles and red bars illustrate liposomes and model 
peptides, respectively. 
 
The content of the test tubes was fractionated after centrifugation and SDS-PAGE was 
performed. It is assumed that the detection of peptides via silver-staining in fractions 
of low density (pure buffer) is an evidence for the insertion of peptides in the liposome 
membranes. However, it is also possible that peptides adsorb at the surface of the 
liposome membranes or that they are only partially inserted. Beside the examination 
of proteoliposomes prepared through standard procedures (Section 5.5.1), proteolipo-
somes with the threefold amounts of peptide (n = 37.5 nmol) were prepared to provoke 
failed insertion. Furthermore, peptides dissolved in TFE were subsequently added to 
pure liposomes to test if peptides are adsorbed at the surface of the liposomes. It is 
known that low concentrations of TFE in liposome suspensions (< 30 %, v/v) have no 
effect on the bilayer structure.[171] For standardly prepared proteoliposomes, the pres-
ence of peptides was indeed proved only for fractions of low density indicative for pep-
tide insertion (Figure 3.4.4.1-2, A). However, liposome samples with an excess of pep-
tides and subsequently added peptides exhibit similar patterns, i.e. peptides were also 
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detected in fractions of low density (Figure 3.4.4.1-2, B-C). Therefore, this experiment 
was not suitable to examine correct peptide insertion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.4.1-2 Images of SDS-PA gels: A) Standardly prepared E3/SybT liposomes. B) Standardly 
prepared E3/SybT liposomes with the threefold amounts of E3/SybT peptides. C) Pure liposomes with 
E3/SybT peptides added after liposome preparation. Visualisation of peptides was achieved via sil-
ver-staining. Smearing of the peptide bands in B) and C) occurred probably due to overloading and high 
lipid contents (formation of peptide/lipid aggregates). 
A 
B C 
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One possible method to overcome the problem concerning peptides adsorbed at the 
surface of membranes is the application of sodium carbonate. By treatment with car-
bonate, liposomes are converted into membrane sheets. During this process, periph-
erally associated peptides are released, whereby integrally associated peptides remain 
within the membrane sheets. Through centrifugation the peripheral peptides are sep-
arated from integral peptides.[172] 
 
3.4.4.2) Evaluation by Fluorescent Probes 
Another approach for the determination of peptide insertion is the usage of fluores-
cently labelled recognition motifs which bind to membrane bound peptides. After the 
removal of unbound fluorescent probes via dialysis, it might be possible to determine 
a relative exact amount of SNARE mimetics which are available for molecular recog-
nition. In a first attempt, the K3 recognition motif was labelled with NBD (NBD-K3) at 
its N-terminal end. Furthermore, E3/SybT liposomes were prepared. In buffer dissolved 
NBD-K3 was added (nNBD-K3 = 2.5 nmol) to standardly prepared E3/SybT liposomes 
(nE3/SybT = 2.5 nmol). It was assumed that 60 % of the membrane bound peptides are 
directed towards the exterior of the proteoliposomes and thus are available for molec-
ular recognition (nav E3/SybT = 1.5 nmol).[170] After sufficient time for the binding of 
NBD-K3 to the E3 recognition units, it was attempted to remove the excess of unbound 
NBD-K3 by dialysis (Figure 3.4.4.2-1).  
 
 
 
 
 
 
Figure 3.4.4.2-1 Illustration of the peptide insertion test based on fluorescently labelled K3 recognition 
motifs: A) Molecular recognition between NBD-K3 and available E3/SybT peptides as well as the ad-
sorption of NBD-K3 at the membrane surface. B) Removal of unbound NBD-K3 peptides through dialy-
sis. Colour code: SybT-LR/TMD (blue), E3 recognition unit (light green), K3 recognition unit (turquoise), 
NBD (yellow star), N-and C-termini (red letters N and C). 
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It must be noted that during liposome preparation (extrusion) and dialysis 47 % and 
27 % of the lipid material were lost, respectively (determined by phosphate tests). It 
was assumed, that the loss of lipid material is proportional to the loss of E3/SybT pep-
tides. Thus, theoretically only 0.58 nmol of the E3/SybT peptides were available after 
dialysis. For fluorescence measurements, 9.1 % of the dialysis formulation was used 
(nused = 0,053 nmol). By the establishment of calibration curves, it was attempted to 
determine the amount of NBD-K3 which binds to the available E3/SybT peptides of the 
proteoliposomes. It was calculated, that 0.008 nmol NBD-K3 bound to E3/SybT pep-
tides, i.e. 15.1 % of the membrane bound peptides directed to the exterior were avail-
able for molecular recognition. However, through control experiments it was also as-
certained that the dialysis procedure removed only ~50 % of the NBD-K3 peptides (di-
alysis without liposomes). Furthermore, it is known that K3 peptides interact strongly 
with membranes, i.e. membranes compete with E3 recognition units for binding of 
NBD-K3 (Figure 3.4.4.2-1).[167] Another problematic issue is the increase of NBD fluo-
rescence due to elevated hydrophobicity of the environment.[173] Therefore, the amount 
of membrane bound NBD-K3 exhibit probably stronger fluorescence than E3/SybT 
bound fluorescent peptides and its contribution to total fluorescence is higher. A valid 
relationship between fluorescence and the concentration of E3 bound NBD-K3 was 
therefore not possible.a No membrane interacting recognition motifs like PNA oligo-
mers, the usage of a fluorophore which is less influenced by the hydrophobicity of 
membranes and the application of a more effective technique to remove fluorescent 
probes (e.g. centrifugal concentrators) might help to overcome the drawbacks of the 
presented experimental setup for the determination of the degree of peptide inser-
tion.[174] 
 
                                                          
a Insertion tests based on fluorescent probes were performed by NINA SCHMIDT in the context of her 
Bachelor thesis. 
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3.4.5) Influence of Peptide Purity on Leaflet Mixing Experi-
ments 
By analytical UPLC, purities of the used peptide samples were determined. For 
PNA-LR/TMD peptide hybrids as raw products, purity degrees of 15-40 % were deter-
mined by the integration of chromatograms. For E3/K3 based model peptides, the de-
termined purity degrees were only slightly higher (20-40 %, Appendix, Chromatog-
raphy Results, Tables A-1 and A-2). It is assumed that impurities of the model peptide 
samples affect experimental outcomings of the performed leaflet mixing assays due to 
peptide fragments which associate with the model membranes and thereby inducing 
membrane destabilisation. As a first attempt to examine this assumption, E3/SybK and 
K3/SxE peptides were purified by HPLC. Collected probes had yields of 61 % (not 
purified E3/SybK: 18 %) and 45 % (not purified K3/SxE: 31 %). In TLM assays using 
raw products and peptides purified by HPLC, slightly different rates of leaflet mixing 
were observed (Figure 3.4.5-1). Admittedly, for both measurements of the combination 
E3/SybK + K3/SxE the increase of NBD emission due to leaflet mixing was relative low 
compared to other presented combinations, probably because of a low degree of pep-
tide insertion, deviations from the optimal ratio of labelled and unlabelled liposomes of 
1 to 4 (determination of lipid amounts of proteoliposome samples was not performed) 
and/or unstable labelled proteoliposomes. Nevertheless, raw products exhibited a 
higher increase of NBD emission after 20 min of detection time than the purified pep-
tides. 
 
 
 
 
 
 
 
Figure 3.4.5-1 TLM experiments of labelled and unlabelled liposomes decorated with E3/SybK and 
K3/SxE peptides, respectively: Grey curve represents leaflet mixing of one TLM assay with not purified 
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E3/SybK and K3/SxE peptides. Black curve represents leaflet mixing of one TLM assay with purified 
peptides. Magenta curve represents leaflet mixing of labelled E3/SybK liposomes with unlabelled lipo-
somes and serves as control.  
 
Strong fluorescence increases of both measurements within the first 75 s happened 
probably because of molecular recognition and accompanied leaflet mixing between 
the proteoliposome populations. Moreover, the increased hydrophobicity of the envi-
ronment through the addition of unlabelled proteoliposomes support the initial fast flu-
orescence increase as well, because the emission of NBD is sensitive with regard to 
its environment.[173] However, the subsequent slight increase for proteoliposomes with 
not purified peptides (grey curve in Figure 3.4.5-1) took probably place because of 
unspecific leaflet mixing and rupture processes of the labelled proteoliposomes which 
might be induced by higher degrees of impurity of the unpurified peptide samples. It 
must be noted that these comparing measurements concerning the influence of pep-
tide purity on leaflet mixing assays were performed only once. Measurements with 
other peptide combinations exhibiting higher leaflet mixing rates and adjusted prote-
oliposome ratios as well as the control of peptide insertion must be performed to get a 
more exact view on the influence of sample impurities.  
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3.4.6) Size of Proteoliposomes and Its Influence on Fusion  
3.4.6.1) Determination of Proteoliposome Size 
Since the 1970’s, dynamic light scattering (DLS) is used to determine the size of lipo-
somes.[175] The sample is illuminated by laser light which is scattered by particles. Scat-
tered light signals are detected in right angle (90°) or back angle (~175°) position and 
depend on the Brownian motion of particles (Figure 3.4.6.1-1).  
 
 
 
 
 
 
 
 
Figure 3.4.6.1-1 Experimental setup of dynamic light scattering measurements: Two common positions 
for the detector are possible, either 90° or ~175° with respect to the sample (depends on device type). 
Laser (1), sample-cell (2), detectors (3), attenuator (4), correlator (5) and computer (6), (taken from ref. 
176).  
 
The usage of a back angle has several advantages: The laser beam does not travel 
through the entire sample and therefore less multiple scattering (additional scattering 
of already scattered light) occurs. Because of this, it is possible to measure sample at 
higher concentrations and the error resulting from dust particles is reduced (big dust 
particles tend to scatter in the forward direction). The 90° arrangement reduces the 
detectable size range of particles due to a longer pathway through the sample cell. In 
both experimental setups scatter signals are interpreted as an autocorrelation function, 
which decay over time, if the signal at t = 0 µs is balanced with the following signals of 
the measurement (correlation graphs in Figures 3.4.6.1-2 and 3.4.6.1-3). The decay 
constant is proportional to the translational diffusion coefficient Dt. Through the 
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STOKES-EINSTEIN equation, Dt is related to the hydrodynamic diameter Dh of the particles 
within a dispersion: 
𝐷h =  
𝑘B𝑇
3𝜋𝜂𝐷t
 
Thereby, kB is the Boltzmann constant, T the absolute temperature in Kelvin and η the 
dynamic viscosity of the dispersion medium. In general, it can be noted that smaller 
particles move faster than bigger ones. For the validity of DLS measurements it is as-
sumed that the particles are spheric.[90] Advantages of this kind of liposome size de-
termination are the non-invasive nature of measurements and the fast performance. A 
disadvantage is the detection of large ensembles of particles which results in relative 
imprecise intensity-weighted averages (z-averages) and lacking information about the 
liposome structure. For example, it is not possible to distinguish between uni- and mu-
tilamellar liposomes.[176,177] A basic feature of liposomes prepared by extrusion con-
cerning their size, defined as diameter of a spheric particle, is: there is no distinct size. 
Liposome suspensions rather exhibit a size distribution which covers several tens of 
nanometers. However, sizes are not distributed homogeneously, but as a Gaussian 
distribution with a predominated centre of size (main size). In the present study, extru-
sion was performed using polycarbonate membranes with a nominal pore size of 
100 nm. Determined size distributions (detection by back angle) typically include sizes 
bigger than 100 nm, but also sizes smaller than 100 nm. During extrusion, liposome 
tubes are formed which pinch off yielding liposomes of different sizes due to pore depth 
and lipid composition.[93] In Figures 3.4.6.1-2 and 3.4.6.1-3 selections of DLS meas-
urements of liposomes carrying PNA and E3/K3 based model peptides are presented. 
The measurements were performed several months after extrusion. Due to aggrega-
tion processes during storage, the determined sizes (weighted average) were bigger 
than 150 nm for pure liposomes (Figure 3.4.6.1-2, A) and liposomes carrying K3/SxE 
and E3/SybE peptides (Figure 3.4.6.1-3, B-C).  
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Figure 3.4.6.1-2 Selection of size distribution histograms with corresponding correlation curves of 
A) pure liposomes and liposomes decorated with B) PNA1/SybT, C) PNA3/SxG and D) PNA3/SxEa: All 
liposome populations were several months old when DLS measurements were performed. For each 
measurement two diameter values for the (proteo)-liposomes are given: the weighted average of size 
distribution and the main size at the top of highest bin of each histogram. The polydispersity index (PdI) 
indicates the degree of polydispersity of the suspension (see text). 
 
For proteoliposomes carrying PNA3/SxG and PNA3/SxEa, diameters were even big-
ger than 200 nm concerning the weighted average of size (Figure 3.4.6.1-2, C-D). 
PNA1/SybT liposomes with a size of 190 nm were only slightly smaller than 200 nm 
(Figure 3.4.6.1-2, B). E3/SybK liposomes with 137 nm were an exception (Fig-
ure 3.4.6.1-3, A). The smaller diameter is probably explainable by a shorter time range 
between proteoliposome preparation and DLS measurements (17 d). However, 
K3/SxE liposomes were stored over the same time before DLS measurements and 
exhibited a significant bigger diameter of 158 nm (Figure 3.4.6.1-3, B). It is known, that 
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the K3 recognition motif interacts strongly via its lysine residues with membranes and 
thus might induce accumulation processes between proteoliposomes and therefore 
detection of bigger particles.[167] In general, freshly prepared liposomes exhibit sizes 
closer to 100 nm. In Tables A-6 and A-7 (Appendix, Determination of Proteoliposome 
Size) the sizes of additional samples are listed, determined by DLS and NTA measure-
ments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.6.1-3 Selection of size distribution histograms with corresponding correlation curves of lipo-
somes decorated with A) E3/SybK, B) K3/SxE and C) E3/SybE: For liposomes with E3/SybK and 
K3/SxE peptides DLS measurements were performed 17 d after preparation, whereas liposomes with 
E3/SybE were prepared 4 months before DLS measurements. For each measurement two values for 
the liposome diameter are given: the weighted average of size distribution and the main size in top of 
highest bin of each histogram. The polydispersity index (PdI) indicates the degree of polydispersity of 
the suspension (see text). 
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The proteoliposome samples, which were measured at the day of liposome preparation 
(designated by the term “few hours” in the Appendix) tend to have sizes below 150 nm. 
LYGINA determined similar sizes for freshly prepared liposomes carrying PNA-LR/TMD 
peptide hybrids (111 nm for PNA1/SybT with a peptide/lipid ratio of 1:200).[170] How-
ever, MEYENBERG determined sizes of liposomes carrying E3/SybT (104 nm) and 
K3/SxG (79 nm) peptides which were smaller than the diameters determined in the 
present study. Reasons for it might be the smaller time range between preparation and 
DLS measurements as well as the lower peptide/lipid ratio of 1:1000.[178]  
A further feature concerning the quality/stability of proteoliposome samples is the 
grade of dispersity expressed by the polydispersity index (PdI): Suspensions exhibiting 
a PdI smaller than 0.20 are defined as monodisperse.[178] Nearly all proteoliposome 
populations (Figures 3.4.6.1-2 and 3.4.6.1-3) show values below 0.20 and therefore 
are considered to be monodisperse. Even a long interval between preparation and 
DLS measurements does not necessarily result in much higher polydispersity values 
of the suspensions (e.g. Figure 3.4.6.1-3, C), but in most cases a long-running storage 
is correlated to higher PdI values. Pure liposomes exhibited the lowest measured PdI 
of 0.077 in this study indicating a highly monodisperse suspension. Thus, the size dis-
tribution is relatively small compared to proteoliposome samples of similar age (Fig-
ure 3.4.6.1-2, A). On the other hand, liposomes decorated with PNA3/SxEa peptides 
have a PdI of 0.287 indicative for a polydisperse suspension. The range of size distri-
bution is broader than for the PNA3/SxG peptide carrying liposomes of similar age 
(Figure 3.4.6.1-2, C-D). In the case of PNA3/SxE liposomes, amounts of bigger lipo-
somes exceed the amounts of smaller liposomes concerning the main fraction of the 
distribution. This result might be interpreted by stronger uncontrolled accumulation pro-
cesses and indicates for a low quality/stability of this proteoliposome sample.  
Another technique for size determination of liposomes is the nanoparticle track-
ing analysis (NTA) which is also based on the STOKES-EINSTEIN equation. However, 
here the light scattering signal is not analysed directly. Rather, light scattering is used 
to visualise liposomes. With the aid of a microscope, videos of several seconds are 
captured by a CCD camera. Subsequently, the video is analysed concerning the mean 
squared displacement of illuminated particles (Figure 3.4.6.1-4).  
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Figure 3.4.6.1-4 Experimental setup of the nanoparticle tracking analysis (left side) and an image of a 
typical particle track (right side), (taken from ref. 179). 
 
The particle displacement is used to determine the translational diffusion coefficient 
and therefore the mean size (diameter) of the proteoliposomes. An advantage of NTA 
measurements compared to DLS, is the analysis of single particles. It is possible to 
estimate the concentrations of particles with certain diameters in the sample. Further-
more, it is possible to observe slow aggregation processes in real time. However, the 
concentration determination depends on the scattering volume which is on the other 
hand very small. Therefore, it is important to set the initial dilution in a range in which 
enough particles for a statistically significant analysis are present. An inappropriate 
high amount of particles leads to crossing particle trajectories (failed assignment of the 
particle to its trajectory) or to failures in particle distinction. Both affect the analysis of 
the diffusion coefficients of particles and thus the estimation of their number and 
size.[179] Diameters of liposomes carrying E3/K3 based model peptides determined by 
NTA measurements are presented in the Appendix (Determination of Proteoliposome 
Size, Table A-7). 
 
3.4.6.2) Influence of Proteoliposome Size on Membrane Fusion 
It is obvious that suspensions contain proteoliposomes of different sizes, even if they 
are freshly prepared. Proteoliposomes of different sizes have different tendencies to 
fuse. Smaller proteoliposomes have a stronger tendency to fuse because of a higher 
bending stress of their membranes. This stress is relaxed by membrane fusion forming 
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bigger proteoliposomes with less bending stress.[90] Leaflet mixing assays applying the 
combinations E3/SybK + K3/SxK or E3/SybTa + K3/SxGa with different sized lipo-
somes revealed that coiled-coil based SNARE mimetics induce fusion when SUVsb for 
both peptides were used. No fusion was observed when GUVs for K3-SxLR/TMD pep-
tides and LUVs for E3-SybLR/TMD peptides were used. Considering the leaflet mixing 
assays with LUVs presented in Sections 3.1 and 3.2, it is concluded that 
E3/K3-LR/TMD peptide hybrids are capable to fuse liposomes with sizes in the range 
of 30-150 nm (SUVs and LUVs, respectively), but no LUVs (~240 nm) with GUVs 
(> 1000 nm).  
Furthermore, it was tested if LUVs carrying E3-SybLR/TMD peptides (E3/SybK and 
E3/SybTa) fuse with pore-spanning membranes (PSM) doped with K3 based model 
peptides (K3/SxK and K3/SxGa). In these experiments, only docking was observed.c 
E4 and K4 recogntion units connected by PEG12 linkers and cholesterol anchors to 
LUVs and PSM, respectively, exhibit exclusively docking. However, native SNARE pro-
teins (minimal fusion machinery) reconstituted in LUVs and PSM lead to membrane 
fusion.[19,88] One possible reason for these observations might be C-terminal zippering 
of native SNARE proteins into the LRs/TMDs which is probably crucial to fuse relative 
stable membranes (i.e. membranes with little curvature). The tendency of liposomes 
carrying E4 or E3 recognition units anchored by cholesterol or native TMDs to dock at 
PSMs doped with K4 or K3 recognition units anchored also by cholesterol or native 
TMDs is probably explicable by the absence of C-terminal zippering. Thus, the herein 
used artificial coiled-coil recognition system might not induce further interactions be-
tween LRs and TMDs of Syb2 and Sx1A because of topological differences between 
both parts of the model peptides (Section 2.6.2.2 and the Appendix, Comparison of 
Native and Artificial Sequences).  
Another interesting aspect of leaflet mixing assays using LUVs and PSMs was the rate 
of docking: SNARE mimetics with C-terminal lysines as carboxylic acids (E3/SybK and 
K3/SxK, zwitterionic C-termini) led to more docked LUVs than the corresponding pep-
tides with native aas as amides (E3/SybTa and K3/SxGa, uncharged C-termini). This 
                                                          
b Prepared by the detergent removal method, peptide/lipid ratio of 1:250 and lipid composition of 
POPE/POPS/DOPC/cholesterol/lab. PE (19:10:50:20:1, n/n/n/n/n). 
c Leaflet mixing and PSM assays were performed by RAPHAEL HUBRICH, Institute of Organic and Bio-
molecular Chemistry, Georg-August University Göttingen. 
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observation supports the assumption that C-terminal charges are crucial for the correct 
insertion of TMDs within the membrane (Section 3.4.2).  
 
3.5) Results of Atomic Force Microscopy 
3.5.1) Detection of Membrane Fusion by Colloidal Probe 
Microscopy 
For colloidal probe microscopy (CPM) measurements, the LRs and TMDs of Syb2 and 
Sx1A were used, which carry glutamates (SybE and SxE) or the amides of threonine 
and glycine (SybTa and SxGa) as C-terminal aas. As recognition units, PNA1 and 
PNA3 decamers (parallel recognition) are linked to the mentioned LRs/TMDs. The-
following combinations were tested: PNA1/SybE + PNA3/SxE and PNA1/SybTa + 
PNA3/SxGa. In general, CPM measurements confirmed interactions between the PNA 
recognition units, because the detected adhesion forces were roughly ten times higher 
in the presence of PNA-LR/TMD peptide hybrids than in the absence. The adhesion 
forces fA were determined by retraction curves (Figure 3.5.1-2). In addition, for model 
peptides with C-terminal glutamates and amide modified threonine/glycine, 2 and 7 
fusion events (hemifusion and/or full fusion) out of 600 measurements were detected, 
respectively. Potential (hemi)-fusion was detected by breakthrough events in the ap-
proach curves (Figure 3.5.1-1). Both results are statistically not relevant to conclude 
for efficient fusion. Two events (2 out of 600, 0.3 %) determined for peptides with glu-
tamate C-termini (PNA1/SybE + PNA3/SxE) are consistent with the FRET based bulk 
leaflet mixing measurements which exhibit no significant increase of donor emission 
(Figure 3.3.1-1). In contrast, for peptides with amide modified native aas (threonine 
and glycine), breakthrough events were also hardly observed by CPM (7 out of 600, 
1.2 %), although leaflet mixing assays indicate at least hemifusion.d 
 
                                                          
d CPM measurements were performed by HANNES WITT, Institute of Physical Chemistry, Georg-August 
University Göttingen. 
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Figure 3.5.1-1 Exemplary approach curve (PNA1/SybTa + PNA3/SxGa) with the illustration of a break-
through event. Window highlights the kink of a breakthrough event which is indicative for a (hemi-)fusion 
event (dwell time: 1 s, trigger point: 1.0 nN), (illustration based on ref. 156).  
 
Native SNARE proteins Syb2, Sx1A and SNAP 25 which were examined by OELKERS 
et al. under similar conditions (dwell time: 10 s, trigger point: 0.2 nN) lead to consider-
able more fusion events (hemifusion: 16.2 %, full fusion: 7.6 %) which is explainable 
by the higher energy barrier for (hemi)-fusion of membranes at colloidal probes and 
solid supports. These membranes are less curved and thus less capable for membrane 
merger than SUVs or LUVs. The result is in line with pore spanning membrane (PSM) 
based measurements, in which also slightly curved membranes were applied (Section 
3.4.6.2).[88,180] The minimal SNARE fusion machinery is obviously more fusogenic than 
the PNA based model peptides. Due to experimental noise, the direct detection of 
(hemi)-fusion events through approach curves is not possible.  
However, the formation of force plateaus during retraction is an additional indirect in-
dicator for fusion events, because plateaus can be indicative for the formation of lipidic 
connections between the membranes of the spherical probe and the solid support (Fig-
ure 3.5.1-2). The simultaneous observation of breakthrough events in the attraction 
curve and force plateaus in the retraction curve might be a good indicator for fusion 
events. Nevertheless, due to low statistics of the performed CPM measurements it was 
not possible to observe both events simultaneously. 
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Figure 3.5.1-2 Exemplary retraction curve (PNA1/SybTa + PNA3/SxGa) with illustration of two possible 
connections between the membranes: a) Connection through the recognition motifs of the SNARE mi-
metics. The force plateau evolves due to detaching of the membrane from the colloidal probe. b) Con-
nection through hemifused membranes. The force plateau evolves due to the separation of the mem-
brane from the solid support. (right). Arrows highlight force plateaus of the exemplary retraction curve, 
which are indicative for peptidic or lipidic connections. The adhesion force fA of the presented curve is 
~510 pN, the tether length lt is ~200 nm and the tether force ft is ~45 pN (illustration based on ref. 156). 
 
Furthermore, it must be noted that the force plateaus of the retraction curves can also 
evolve due to molecular connection between the SNARE mimetics without membrane 
fusion. However, retraction curves include additional information concerning mem-
brane interactions and tether features: For instance, the adhesion force fA can be used 
to determine the number of bonds in the contact zone. The tether length lt is directly 
observable through the retraction curves and the tether force ft can be used for the 
determination of the tether radii.[156,181] In conclusion, a valid comparison between 
FRET based leaflet mixing results of Section 3.3 and the results of the CPM measure-
ments is not possible because of the low statistics of the CPM measurements as well 
as the experimental uncertainties of the leaflet mixing results (influencing factors de-
scribed in Section 3.4). However, possible reasons for the differences of the results 
determined by FRET based bulk leaflet mixing and CPM measurements might be al-
legeable by the prevalent curvature stress of the model membranes in both experi-
mental setups: In bulk measurements, LUVs were used which are much stronger 
curved than the solid supported membranes of the CPM measurements. Moreover, for 
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CPM measurements it is conceivable, that the solid support hinders membrane fusion 
because of a restricted mobility of the SNARE mimetics and interactions of the C-ter-
mini with the surface of the solid supports.[98] 
 
3.5.2) Energy Barrier for C-Terminal Peptide Immersion 
into Membranes 
The last step of SNARE mediated membrane fusion, i.e. pore formation, depends prob-
ably on the immersion of C-terminal ends of the TMDs of Syb2 and Sx1A into the 
membranes (Section 3.3). The movement of C-terminal ends into the headgroup re-
gion (bilayer interface) and hydrophobic core of the membranes might induce pertur-
bation of the lipid continuity and thus the rearrangement of lipids ending in the open-
ness of a fusion pore.[14] WIMLEY et al. determined free energies for the transfer of pro-
teinogenic aas from the bilayer interface to water by means of equilibrium dialysis and 
reverse-phase HPLC (determination via partition coefficients).[182]  
 
Table 3.5.2-1 Free energy transfer from bilayer interface to water determined by WIMLEY et al. (values 
include side chain and backbone contribution), (taken from ref. 182). 
Remarks: Experiments were performed at a) pH = 8 and b) pH = 2. Thus, C-terminal carboxylic acid 
groups of the model peptide Ac-WL-X-LL-OH (X represents the position of examined aas) were either 
negatively charged (deprotonated state) or not charged (protonated state). 
 
Table 3.5.2-1 presents the energy values for the C-terminal aas applied in the present 
study. The energy barrier for the transfer of glutamate at pH = 8 from water to the bi-
layer interface was the highest of the WIMELY study (2.02 kcal/mol) due to repulsive 
forces between the negative charges of the lipidic phosphodiester groups and the neg-
ative charges of the two carboxylic acid groups of glutamates. Therefore, it is assumed 
that C-terminal glutamates in model peptides induce a high energy barrier for the tran-
amino acid (X) ΔGx [kcal/mol] a ΔGx [kcal/mol] b 
threonine -0.14 ± 0.06  not given 
glycine -0.01 ± 0.05  not given 
lysine -0.44  -0.99 ± 0.11 
glutamate -2.02 ± 0.11  0.01 ± 0.05 
Results and Discussion 
 
104 
 
sition of the C-termini of SNARE mimetics into the membranes. Indeed, SNARE mi-
metics with C-terminal glutamates as carboxylic acids induce no (as PNA-LR/TMD 
peptide hybrids) or only slight (as E3/K3-LR/TMD peptide hybrids) leaflet mixing in 
FRET based bulk measurments. However, energy values determined by WIMELY et al. 
do not represent the conditions applied in leaflet mixing experiments of the present 
study. For instance, LUVs were exclusively prepared by POPC. Moreover, pentapep-
tides were used and the examined aas were positioned in the middle of these peptides 
surrounded by leucines. This is not the peptidic environment of the applied C-terminal 
aas of the SNARE mimetics and experimental outcomings of the leaflet mixing experi-
ments are not throughoutly explainable by the energy values given in Table 3.5.2-1. 
For example, C-terminal lysines have a higher energy barrier (0.44 kcal/mol) than the 
native aas threonine (0.14 kcal/mol and glycine (0.01 kcal/mol), but the lysine combi-
nations in the parallel recognition mode were the stronger fusogenes in FRET based 
leaflet mixing assays.  
AFM measurements can be used to determine forces required for the detachment of 
lipids and TMDs from the membranes.[183,184] For this approach, thiol functionalised 
peptides embedded in solid supported membranes were bound to cantilever tips cov-
ered by gold.[185] When the cantilever was pulled away from the solid supported mem-
brane, kinks in force-distance curves indicative for membrane-peptide interactions 
were detected (Figure 3.5.2-1). These events could be used to calculate forces re-
quired for the movement of the TMDs through the membrane. In a first attempt, 
E3/SybT peptides were extended by N-terminal cysteines yielding Cys-E3/SybT pep-
tides. AFM measurements with Cys-E3/SybT peptides revealed several force events. 
In Figure 3.5.2-1, B one detected force event is exemplary presented. 
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Figure 3.5.2-1 A) Illustration of AFM pulling experiment with E3/SybT-peptides. B) Exemplary force-dis-
tance curve. Three further types of force events were detected (not shown). Inlet: 40 events were rec-
orded with a cantilever velocity of 1 µm/s. Predominant force events were detected at ~34 pN.  
 
Concerning this kind of event, forces in the range of 30-40 pN were detected (45 % of 
all events) and might corresponds to the removal of the model peptide from the bilayer. 
The removal depends among other factors (e.g. unfolding of the TMD helices) on the 
forces required for the detachment of the C-terminal end of the Syb2-TMD from the 
bilayer interface and the subsequent shift into the hydrophobic core of the mem-
brane.[184] However, more than the half of detected forces events were not in the range 
of 30-40 pN and the broad distribution of force values prevent the application of a 
mathematic model (Figure 3.5.2-1, inlet of B). For valid results, it is necessary to per-
form more measurements with changing cantilever velocities. This might yield valid 
insights into force event characteristics and might allow the application of a suitable 
model (for instance, the BELL-EVANS model).[186,187] If it is feasible, it would be possible 
to determine forces and related energies concerning the interactions between the 
C-terminal parts of integral SNARE mimetics and model membranes.e  
 
                                                          
e AFM measurements were performed by MARIAN VACHE, Institute of Physical Chemistry, Georg-August 
University of Göttingen. 
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3.6) Trigger for Peptide Mediated Membrane Fusion  
ZHENG et al. proposed that the inversion of E3 sequences (iE3 sequences) in the E3/K3 
coiled-coil system leads to changes in the orientation and the oligomeric state of the 
coiled-coils. Instead of parallel dimers, antiparallel tetramers are formed (Section 
3.1.2).[164] Within the scope of this thesis, it was attempted to trigger molecular recog-
nition and accompanied fusion of liposomes with iE3/SybT or K3/SxG peptides by the 
addition of dissolved K3 or iE3 peptides. (Figure 3.6-1).  
 
 
 
 
 
 
 
 
 
Figure 3.6-1 Illustration of the assumed mode of liposome docking induced by the addition of soluble 
components (K3, iE3) to liposomes carrying iE3/SybT or K3/SxG peptides. Subsequent membrane fu-
sion is not shown: A) Liposomes are decorated with iE3/SybT peptides and K3 recognition units are 
added as dissolved components. B) Liposomes are decorated with K3/SxG SNARE mimetics and iE3 
peptides are added as dissolved components. 
 
However, when dissolved K3 peptides were added to membrane anchored iE3/SybT 
SNARE mimetics, no significant increase of donor emission was detected. Admittedly, 
a slight increase of NBD emission was observed, when unlabelled iE3/SybT liposomes 
were added to labelled iE3/SybT liposomes. The increased hydrophobicity of the me-
dium through the addition of unlabelled proteoliposomes might amplify NBD emission 
within the first 120 seconds.[173] After stabilisation of the NBD signal, different amounts 
of dissolved K3 peptides were added, but the additions did not lead to enhanced leaflet 
mixing and thus not to membrane fusion. Drops of emission during the measurements 
Results and Discussion 
 
107 
 
with 30 nmol and 60 nmol are consequences of the increased volumes resulting from 
the added K3 peptide solutions (Figure 3.6-2, A). The suggested tetramer formation 
seems to be hindered by the raised restriction of membrane anchored iE3 recognition 
units compared to the tetramer formation of iE3 and K3 peptides in solution without 
TMDs. Furthermore, iE3-K3 interactions compete with membrane-K3 and K3-K3 inter-
actions. Therefore, it is conceivable that K3 peptides bind to membranes or other 
dissolved K3 units and are excluded from tetramer formation.[167,188]  
 
 
 
 
 
 
 
 
Figure 3.6-2 Total leaflet mixing assays of labelled and unlabelled proteoliposomes doped with 
1.25 nmol of A) iE3/SybT or B) K3/SxG model peptides. In both experiments no membrane fusion was 
observed due to the addition of A) dissolved K3 or B) iE3 recognition units. 
 
When dissolved iE3 peptides were added to membrane anchored K3/SxG SNARE mi-
metics, also no leaflet mixing amplifying effects of the dissolved components were de-
tected (Figure 3.6-2, B). However, after the addition of unlabelled K3/SxG liposomes, 
continuous increases of NBD emission indicative for leaflet mixing were observed. This 
is explicable by the homodimerisation of K3/SxG SNARE mimetics which reside in op-
posing membranes. Additionally, the high affinity of anchored K3 recognition units to 
membranes might induce membrane destabilisation and intermembrane contacts 
through binding events to apposed membranes. Both kinds of interactions might sup-
port leaflet mixing.[167,188] The addition of dissolved iE3 peptides did not amplify the 
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increase of NBD emission. Thus, it is assumed that no fusion triggering tetramer for-
mation occurs.f 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
f Experiments for the examination of membrane fusion triggering effects of dissolved peptidic compo-
nents were performed by NINA SCHMIDT in the context of her Bachelor thesis at the Institute of Organic 
and Biomolecular Chemistry, Georg-August University Göttingen. 
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4) Conclusion and Outlook 
In general, parallel recognising SNARE mimetics are more fusogenic than mimetics in 
the antiparallel recognition mode. This is in line with the known predominant parallel 
recognition of the native SNARE proteins.[3] It is obvious that parallel interacting model 
peptides are able to exert more force via their TMDs on membranes than in the anti-
parallel binding mode (Figure 2.7-2). Antiparallel recognition leads rather to docking 
than to hemifusion or full fusion. However, antiparallel interacting iE3/SybT and 
K3/SxG peptides induce hemifusion and partially full fusion. This is intriguingly, be-
cause the distance between the membranes connected by an antiparallel tetrameric 
coiled coil is estimated to be ~6 nm, but membrane fusion is induced at an intermem-
brane distance of 0.9 nm (Section 3.1.2).[45,164] Therefore, other membrane fusion sup-
porting factors must be present in this system. It is known that K3 peptides interact 
strongly with membranes via their lysine residues.[166] Thereby, the membranes are 
shaped and probably destabilised.[167] Furthermore, it is conceivable that the LRs of 
the model peptides are kinked between the docked membranes, because these re-
gions are probably not α-helical and thus rather flexible. The distance between the 
docked proteoliposomes might be smaller than 6 nm. In addition, the tetramer formed 
by two iE3 and K3 units, respectively, might interact by its lysine residues on the flanks 
with the membranes. Peptidic connections via tetramer formation, membrane shaping 
through K3 units and interactions of K3 units with apposed membranes are sufficient 
to induce fusion.  
The distance between membranes docked by antiparallel interacting PNA based 
model peptides is estimated to be ~6 nm as well (Section 3.1.1).[113] For PNA recogni-
tion units, no interactions with membranes are known. Therefore, no membrane fusion 
supporting interactions are available as in the case of iE3/K3-LR/TMD peptide hybrids. 
This is reflected by PNA1/SybT and PNA2/SxG peptides, which exhibit less leaflet mix-
ing than model peptides with iE3 and K3 recognition units (compare Figure 3.1.1-1, A 
with Figure 3.1.2-1, A). Generally, leaflet mixing of antiparallel interacting model pep-
tides is probably rather unspecific than related to the typical membrane fusion mecha-
nism (Figure 2.4-1). Antiparallel interacting PNA-LR/TMD peptide hybrids with C-ter-
minal amides are the least fusogenic group of the SNARE mimetics tested in the pre-
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sent study. This is explicable with the reduced degree of peptide insertion due to lack-
ing C-terminal negative charges and therefore, a decreased number of recognition 
sites. Moreover, membrane destabilisation through not inserted peptides leads to pro-
teoliposome aggregation which exacerbates the detection of leaflet mixing by fluores-
cence (Sections 3.3.2 and 3.4.2).  
Parallel coiled-coil formation of E3/K3 based model peptides induces generally 
stronger leaflet mixing than parallel PNA duplex formation. The energy which is re-
leased by E3/K3 assembly is higher than for PNA1/PNA3 duplex formation 
(Tmelt (E3/K3) = 57 °C, Tmelt (PNA1/PNA3) = 46 °C).[15,164] In addition, the released en-
ergy is probably more effectively transferred to membranes via the TMDs, because the 
coiled-coil formation resembles native SNARE recognition more than the formation of 
parallel PNA duplexes (Sections 2.6.2.1 and 2.6.2.2). The C-terminal ends of the 
E3/K3-LRTMD peptide hybrids might exert more force on the membranes to rearrange 
lipids for fusion, because the movement of the TMDs towards the hydrophobic cores 
of the membranes is more distinct.[14]  
Concerning the effects of C-terminal charges induced by the exchange of threonine 
(Syb2) and glycine (Sx1A) through lysine or glutamate on membrane fusion, it is con-
cluded that negative charges have an inhibitory influence on membrane fusion. 
SNARE mimetics with C-terminal glutamates as carboxylic acids (two negative 
charges) lead to less leaflet mixing than the naturally occuring aas threonine and gly-
cine (one negative charge, respectively) and lysines (zwitterionic) (Sections 3.3.1 and 
3.3.3). The energy barrier for the transition of a twofold negative charged glutamate 
from the aqueous medium at the membrane surface into the membranes is higher than 
for onefold negative charged threonine and glycine as well as for zwitterionic lysine 
(Section 3.5.2).[182] Although the energy barrier for the transition of lysine as carboxylic 
acid into the membranes is higher than for native aas, model peptides with C-terminal 
lysine exhibit in most cases stronger membrane fusion (Sections 3.3.1 and 3.1). For 
lysines, it is suggested that these aas interact strongly with membranes and thereby 
destabilise them. The positive charge of the protonated amino group of the side chain 
interacts with the phosphates of the lipids and the residual hydrocarbon chain with the 
lipid tails (snorkelling interaction).[166] Intriguingly, model peptide combinations with 
C-terminal glutamates for Syb-TMDs and lysines for Sx-TMDs are the most fusogenic 
in the present study. This is contradictory, because glutamates hamper fusion due to 
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a high transition energy for the immersion of C-terminal ends into the membranes.[17] 
Initially, it was expected that C-terminal lysines for both TMDs would be the most fuso-
genic combinations because of the strong membrane destabilising intractions of lysine. 
However, the higher leaflet mixing rates for combined C-terminal glutamates and ly-
sines is rather explicable by the experimental setup of the leaflet mixing experiments: 
Liposomes carrying model peptides with C-terminal glutamates are more stable than 
liposomes doped with lysine modified peptides (both as carboxylic acids and as am-
ides). Model peptides based on Syb2 always reside in labelled and Sx1A based mi-
metics in unlabelled proetoliposomes. Thus, for glutamate/lysine combinations stable 
labelled and unstable unlabelled proteoliposomes are present. This is advantageous 
for leaflet mixing detection, because labelled proteoliposomes do not tend to aggre-
gate. Consequently, the dilution of labelled membranes through unlabelled lipids and 
the decrease of the FRET effect is not hampered. Moreover, unlabelled proteolipo-
somes are prone for leaflet mixing processes with stable labelled proetoliposomes due 
to their instability. Tests with C-terminal lysines for Syb-TMDs (unstable labelled pro-
teoliposomes) and glutamates for Sx-TMDs (stable unlabelled proteoliposomes) re-
sulted in much less leaflet mixing (Figure 3.4.5-1). This underlines the assumption of 
hampered leaflet mixing detection through aggregation, because aggregated labelled 
proteoliposomes do not mix efficiently with unlabelled liposomes due to an adverse 
surface/volume ratio, i.e. labelled lipids of the interior of aggregates cannot participate 
in leaflet mixing. On the other hand, if unlabelled proteoliposomes aggregate, the dilu-
tion of labelled proteoliposomes can occur at the surface of the unlabelled aggregates.  
E3/K3-LR/TMD peptide hybrids as C-terminal amides are the most fusogenic 
group in this study. The lacking C-terminal negative charges of carboxylic acid groups 
reduce the energy barrier for the transition of the C-termini from the aqueous environ-
ment into the membranes. Furthermore, E3/K3 recognition exert more force on mem-
branes than the PNA duplex formation. Flawed insertion of model peptides with C-ter-
minal amides might also support membrane fusion, because not inserted peptides ad-
sorb at the surface of the membranes and destabilise them. However, for PNA based 
model peptides, the membrane fusion supporting effect of C-terminal amides is less 
distinct (not all amide combinations show stronger fusion than the carboxylic acid com-
binations, Figure 3.2-2). This is lesser explainable by structural features of the model 
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peptides, but rather by the increased instability and accompanied tendency to aggre-
gate of the labelled proteoliposomes. Especially lysine modified PNA-LR/TMD peptide 
hybrids yield unstable proteoliposomes (Section 3.4.2). Thus, the aggregation exacer-
bates the detection of leaflet mixing and hampers additionally molecular recognition 
(Section 3.2). 
Lysine modified SNARE mimetics might support membrane fusion also by the pres-
ence of C-terminal positive and negative charges. RISSELADA et al. suggested by means 
of computer simulations that attractive forces between the C-termini of Sx-TMDs and 
Syb-TMDs enable a thinning-widening mechanism for membrane fusion (Fig-
ure 2.7-2).[13] However, relative strong membrane fusion is induced for both parallel 
and antiparallel orientation (PNA-LR/TMD peptide hybrids). Therefore, it is not decent 
to conclude by performed leaflet mixing assays that attractions between C-terminal 
lysines support membrane fusion. It is rather reasonable to suggest that the already 
mentioned membrane destabilising effects of C-terminal lysines amplify leaflet mixing 
rates. To shed more light on this issue of SNARE mediated membrane fusion, it is 
necessary to use mixtures of SNARE mimetics with opposing C-terminal charges for 
one proteoliposome population, e.g. PNA1/SybKa and PNA1/SybEa for labelled lipo-
somes as well as PNA3/SxKa and PNA3/SxEa for unlabelled liposomes (parallel 
recognition). The comparison of the same mixtures of modified TMDs in the antiparallel 
recognition mode (PNA1/SybKa and PNA1/SybEa for labelled liposomes as well as 
PNA2/SxKa and PNA2/SxEa for unlabelled liposomes) might clarify if a thinning-wid-
ening mechanism supports membrane fusion.  
E3/K3-LR/TMD peptide hybrids exhibit only docking when reconstituted in membranes 
of slight curvature (GUVs and PSM, Section 3.4.6.2). Moreover, no significant mem-
brane fusion is detected when PNA based model peptides are tested by CPM applying 
plane solid supported membranes (Section 3.5.1). However, when native SNAREs 
(Syb2, Sx1A and SNAP 25) are tested under similar conditions efficient membrane 
fusion was observed.[88,180] Thus, both applied SNARE mimetics (PNA and E3/K3 
based) are less fusogenic than reconstituted native SNAREs. Less fusogenicity might 
be explicable by the absence of C-terminal zippering of the SNARE mimetics. Topo-
logical differences between the recognition units (PNA and E3/K3) and LRs of Syb2 
and Sx1A might prevent zippering into the TMDs (Sections 2.6.2.1 and 2.6.2.2). Con-
sequently, less force is exerted on the membranes and the perturbation of membrane 
Conclusion and Outlook 
 
113 
 
continuity, which is important for fusion, is less distinct. Although SNARE mimetics 
based on coiled-coil forming peptides (E3 and K3) match structural features of native 
SNARE proteins much better than PNA recognition motifs, there are also differences 
in the interface distances of native and artificial recognition motifs. Furthermore, there 
are differences in structural transitions between the recognition units and LRs regard-
ing the heptad registers of the contributing coiled-coil motifs (Appendix, Comparison 
of Native and Artificial Sequences, Figure A-8). An alternative to overcome topological 
problems regarding the transitions of recognition units and LRs might be the deletion 
of arginine (SybLR) and the addition of tyrosine (SxLR). Through these modifications, 
the aas of the LRs proposed for zippering interactions have the same distances to 
artificial recognition motifs than to the native SNARE motifs.[10] Structural conditions for 
C-terminal zippering might be more appropriate for SNARE mimetics which are modi-
fied in this way (Figure 4-1). 
 
 
 
 
 
 
 
 
Figure 4-1 SNARE mimetics with coiled-coil forming peptides as recognition motifs: A) Sequences of 
SNARE mimetics applied in the present study. Possible deletion of arginine is underlined in red. B) 
Adjusted sequences concerning the distances between recognition units and LRs. Possible addition of 
tyrosine is underlined in green. Interacting aas of the LRs (indicated by black solid lines) are separated 
from the recognition units by the same number of aas like in native SNARE proteins.  
 
Before mentioned results are mainly based on bulk leaflet mixing assays. In general, 
these assays have crucial disadvantages regarding assays which detect membrane 
fusion on a single event level. Aggregation and rupture of liposomes influence experi-
mental outcomings. Additionally, average kinetics are detected and the distinction of 
fusion intermediates by TLM, ILM and content mixing is rather indirect and also suffer 
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from average kinetics, aggregation, rupture and leakage.[88] Therefore, the extended 
application of membrane fusion assays enabling the detection of single fusion events 
for herein examined model peptides might help to gain a closer insight into the role of 
TMDs in membrane fusion. Two possible assays for the detection of single fusion 
events base on pore-spanning membranes (PSMs) and colloidal probe microscopy 
(CPM) (Sections 2.6.3.4 and 2.6.1). 
The purity of the applied SNARE mimetics is another crucial aspect in the present 
study. Synthesised peptides were used as crude products with purities in the range of 
15-40 % (Appendix, Chromatography Results, Tables A-1 and A-2). Peptide fragments 
in crude products might interact with the membranes of proteoliposomes. Pep-
tide-membrane interactions might perturb membrane continuity and therefore, support 
leaflet mixing. Thus, it is problematic to confine differences between tested model pep-
tide combinations solely on C-terminal modifications. Impurities have probably influ-
ence on experimental outcomings either. Higher purity degrees would reduce these 
experimental uncertainties (Section 3.4.5).  
Another important aspect of membrane fusion in artificial systems is the degree of 
peptide insertion. For instance, different procedures of peptide insertion might lead to 
different degrees of insertion. Reconstitution protocols must be controlled concerning 
their ability to insert integral model peptides. Moreover, it must be ensured that different 
SNARE mimetics insert at the same level. Otherwise, the comparison of different pep-
tide combinations regarding structural modifications is not meaningful. Unfortunately, 
the determination of SNARE mimetics, which are available for molecular recognition 
between the proteoliposomes, was not successful in the present study (Section 3.4.4).  
Concerning the proteoliposome preparation it is crucial to determine the loss of 
lipid material during extrusion and size exclusion chromatograpy, because losses dif-
ferentiate between the individual formulations. As a consequence, different ratios of 
labelled and unlabelled proteoliposomes are applied which influenced experimental 
outcomings in the present study as well (Section 3.4.3). The usage of two labelled 
liposome samples would be advantageous, because the lipid loss could be easily con-
trolled by means of fluorescence (Section 3.4.1). Time consuming phosphate determi-
nation would be avoided and the fluorescence increase due to unspecific liposome 
rupture could be circumvented.  
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5) Experimental Part 
5.1) Solvents  
DMF, DCM and NMP were obtained from Merck, Fisher Scientific or Carl Roth. Ace-
tonitrile and methanol were purchased from Fisher Scientific. All used solvents were 
of laboratory grade (≥ 99.8 %) or HPLC grade (≥ 99.99 %). Distilled water was filtered 
by the arium® mini ultrapure water system (Sartorius, Germany) prior to use.  
 
5.2) Reagents 
Preloaded Wang resins and the not preloaded Nova PEG Rink amide resin were pur-
chased from Nova Biochem, Switzerland. The Rink amide MBHA resin (not preloaded) 
was obtained from GL Biochem (Schanghai) Ltd., China. Piperidine, DIPEA, acetic 
acid anhydride, HATU, HBTU, Oxyma and trifluoroacetic acid were ordered from Carl 
Roth, Germany. 2,6-lutidine from Acros Organics, USA, was used. HOAt, HOBt, amino 
acid building blocks were purchased from GL Biochem (Schanghai) Ltd., China. DIC 
was from Iris Biotech, Germany. PNA building blocks were obtained from ASM Re-
search Chemicals, Germany. Lipids were acquired from Avanti Polar Lipids, USA. All 
reagents were of the highest grade available. 
 
5.3) General Methods 
5.3.1) Lyophilisation 
Aqueous solutions of peptides were frozen using liquid nitrogen. Frozen probes were 
lyophilised using an Alpha 2-4 CD plus freeze-dryer (Christ, Germany) equipped with 
a high vacuum pump. 
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5.3.2) Reverse Phase Liquid Chromatography 
Analytical ultra-performance liquid chromatography (UPLC) was performed applying 
the Ultimate 3000 system (Thermo Scientific, USA) with the column Ace Excel (RP 
C-18, 100 x 2.1 mm, 2 µm, 100 Å). Linear gradients of solvent A (0.1 % aq. TFA) and 
solvent B1 (acetonitrile + 0.085 % TFA) at 50 °C with a flow rate of 0.4 mL/min were 
performed. Semi-preparative high-performance liquid chromatography (HPLC) was 
performed using a JASCO system (MD 2010 plus detector, DG-2080-53 degasser and 
PU-2080 plus pumps) with the semi-preparative columns Ace (RP C-18, 150 x 10 mm, 
5 µm, 300 Å) or Nucleodur® (RP C-18, 250 x 10 mm, 5 µm, 100 Å). Linear gradients of 
solvent A and solvent B1 or B2 (methanol + 0.1 % TFA) at RT with a flow rate of 
6.5 mL/min (Ace column) or 3 mL/min (Nucleodur column) were performed. Samples 
were dissolved in TFE or water/methanol (6:4, v/v) prior to injection. UV detection was 
conducted at 215 nm, 225 nm, 254 nm and 280 nm. 
 
5.3.3) Size Exclusion Chromatography 
For size exclusion chromatography 150 mg of Sephadex G-50 Superfine column ma-
terial (GE Healthcare, UK) were mixed with fusion buffer (~5 mL). The mixture was 
transferred to a column (0.5 x 15 cm) equipped with a porous polymer bed support at 
the bottom (Bio-Rad, USA). After the addition oflabelled liposomes, coloured fractions 
were collected. 
 
5.4) Solid Phase Peptide Synthesis 
5.4.1) Loading of the First Amino Acid 
In the case of not preloaded amide resins (Nova PEG Rink amide or Rink amide 
MBHA), the first aa was loaded before starting subsequent SPPS cycles. The resin 
(0.13 mmol of available amino groups) was swollen in 5 mL NMP for 30 min and 
washed with NMP, DCM and NMP (each 3 x) using a BD DiscarditTM syringe (10 mL, 
acid/base resistant) with a polyethylene filter. The amino acid building block (5 eq.) and 
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HOBt (5 eq.) were dissolved in 3.5 mL NMP. After the addition of 0.1 mL DIC (4.9 eq.), 
the solution was transferred to the resin. The aa was coupled for 600 s at 40 °C (as-
sisted by the CEM Discover microwave reaction cavity, 20 W). In the case of a positive 
Kaiser test (Section 5.4.2), the coupling reaction was repeated. If a low loading density 
was desired, coupling was performed only once and the remaining amino groups were 
acetylated (Section 5.4.6). Finally, the resin was washed using DMF, DCM and meth-
anol (5 x) and dried in vacuum for further synthesis.  
 
5.4.2) Kaiser Test 
To control the completion of the resin-loading (qualitative), the Kaiser test was per-
formed: Stock solutions of ninhydrin in ethanol (5 g/100 mL) and phenol in ethanol 
(80 g/20 mL) were prepared. Furthermore, 2 mL of a 1 mM aq. potassium cyanide so-
lution was mixed with 98 mL pyridine. Few beads of the resin were washed with etha-
nol, dried and added to a glass test tube. Then, 50 µL of each stock solution were 
mixed and the mixture was added to the resin beads. The formulation was heated on 
a hotplate (120 °C) for 4-6 min. When free amino groups on the resin were available, 
the colourless formulation turned to blue/purple (positive Kaiser test). When the test 
was negative, i.e. all amino groups were occupied by aa building blocks, the formula-
tion turned to yellow (negative Kaiser test). The Kaiser test is useful to determine 
whether the resin-loading must be repeated or not. Resin-loading can only be con-
trolled by the Kaiser test when amide yielding resins were used. 
 
5.4.3) Estimation of the Loading Density 
For determination of the loading density (LD), 5-10 mg of the resin was transferred to 
a graduated flask (10 mL). Then, 2 mL of DMF and 40 µL of DBU were added. As 
reference the same sample without resin was prepared. The samples were gently ag-
itated for 1 h and afterwards, they were filled to 10 mL with acetonitrile. For UV meas-
urements, probes were diluted by a factor of 10 (50 µL sample in 450 µL acetonitrile) 
and were transferred to a quartz cuvette (1 cm x 1 cm). The absorption of the probes 
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was detected at 304 nm (absorption maximum of dibenzofulvene) using the Jasco 
V-550 UV/vis-spectrophotometer (V-500W Spectra Manager software, Fixed Wave-
length Measurement mode). Three measurements (each 5 cycles) of the sample and 
the reference were recorded, respectively. The LD was calculated using following 
equation based on the Lambert-Beer’s law:  
LD =
 (𝐴 − 𝐴0) × 0.01L 
𝜀 × 𝑑 × 𝑚
 
Thereby, LD is the loading density in mmol/g, A is the absorption of the probe, A0 is 
the absorption of the reference, ε is the extinction coefficient of dibenzofulvene at 
304 nm (7624 M-1cm-1), d is the length of the cuvette in cm and m is the mass of the 
used resin in grams.[189] 
 
5.4.4) Synthesis of PNA-LR/TMD Peptide Hybrids 
TMDs for the PNA based model peptides were automatically synthesised via 
Fmoc-solid phase peptide synthesis (Fmoc-SPPS) on a pre-loaded Wang resin 
(0.1 mmol, 0.29-0.38 mmol/g). In the case of C-terminal amide modified compounds, 
a manually pre-loaded Rink amide MBHA (0.36 mmol/g) or Nova PEG Rink amide 
resin (0.18 mmol/g) was used (Section 5.4.1). Syntheses of all TMDs were performed 
at 0.1 mmol scales. Fmoc-SPPS was performed by using a Liberty peptide synthesiser 
equipped with a Discover microwave reaction cavity (CEM, USA): After swelling of the 
resin (60 min in NMP or DMF), the Fmoc deprotection reaction was conducted by a 
mixture of piperidine (20 %, v/v) and HOBt (0.1 M) in NMP (RT → 75 °C for 210 s, 
35 W). Coupling of the aa building blocks was achieved with 0.5 M HBTU/HOBt 
(Vadd = 1 mL, 5 eq.) and 2 M DIPEA (Vadd = 0.5 mL, 10 eq.) stock solutions in NMP 
(RT → 75 °C for 300 s, 23 W). The acetylation (capping) of unreacted amino groups 
was performed by a mixture of acetic acid anhydride (2.3 %, v/v), DIPEA (4.7 %, v/v) 
and HOBt (15 mM) in NMP (RT → 65 °C for 60 s, 40 W). The following aa building 
blocks were used for the preparation of stock solutions in NMP (0.2 M, Vadd = 2.5 mL, 
5 eq.): 
 
(1). 
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- Fmoc-Ala-OH      -   Fmoc-Gly-OH 
- Fmoc-Arg(Pbf)-OH      -   Fmoc-Ile-OH 
- Fmoc-Asn(Trt)-OH      -   Fmoc-Leu-OH 
- Fmoc-Cys(Trt)-OH      -   Fmoc-Lys(Boc)-OH 
- Fmoc-Gln(Trt)-OH      -   Fmoc-Met-OH 
- Fmoc-Phe-OH      -   Fmoc-Trp(Boc)-OH 
- Fmoc-Ser(tBu)-OH      -   Fmoc-Tyr(tBu)-OH 
- Fmoc-Thr(tBu)-OH      -   Fmoc-Val-OH.  
All aas were introduced by double couplings. Special care was taken for the incorpo-
ration of cysteine and arginine residues. For Fmoc-Cys(Trt)-OH, the temperature of 
the microwave assisted coupling, capping and deprotection steps was reduced to 
50 °C to avoid racemisation. Therefore, reaction time for the coupling reaction was 
elongated to 360 s (1. RT for 120 s / 2. RT → 50 °C for 240 s, 25 W). For arginine, the 
reaction time of the coupling step was elongated to 30 min (1. RT for 
25 min / 2. RT → 75 °C for 5 min, 25 W). Capping and deprotection steps were per-
formed as described above. The Fmoc protecting group of the N-terminal aa was not 
cleaved. After synthesis, the resin was filtered off and washed successively with NMP 
and DCM (each 10 x). Then, the resin was dried in vacuum and a test cleavage was 
performed.  
For subsequent manual elongation of the peptide chain with PNA-monomers, 5 μmol 
of the resin bound peptide was transferred into a BD DiscarditTM syringe (2 mL, 
acid/base resistant) equipped with a polyethylene filter. Initially, the resin was washed 
successively with NMP, DCM, methanol and NMP (each 5 x), swollen in NMP for 
60 min and washed again with NMP, DCM and NMP (each 5 x). The following PNA 
monomers were used for decamer formation:  
- Fmoc-adenine(Bhoc)-aeg-OH  
- Fmoc-cytosine(Bhoc)-aeg-OH  
- Fmoc-guanine(Bhoc)-aeg-OH 
- Fmoc-thymine-aeg-OH.  
The coupling cycle was started with Fmoc deprotection using piperidine in NMP (20 %, 
v/v, RT for 2 x 5 min), followed by washing with NMP, DCM and again NMP (each 4 x). 
For each coupling, 27.3 µmol (5.45 eq.) PNA monomers were used. The PNA building 
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blocks were dissolved in stock solutions of the coupling reagents HATU (0.5 M, 
5.30 eq.) and HOAt (2.0 M, 5.45 eq.) in NMP 5 min prior to the addition of the activator 
bases DIPEA (2.0 M, 5.45 eq.) and 2,6-lutidine (2.0 M, 8.20 eq.). Directly after the ad-
dition of the activatior bases the reaction mixture was transferred to the resin. The initial 
concentrations of PNA building blocks and HOAt in the reaction mixture were adjusted 
to 0.27 M, respectively. The concentration of HATU was adjusted to 0.26 M. DIPEA 
and 2,6-lutidine had concentrations of 0.27 M and 0.41 M, respectively. The coupling 
reactions were performed at RT for 60 min. All PNA building blocks were coupled twice. 
After successive washing with NMP, DCM and again NMP (each 3 x), capping with a 
mixture of acetic acid anhydride (10 %, v/v) and 2,6-lutidine (20 %, v/v) in NMP was 
performed (RT for 2 x 5 min). A final washing step with DIPEA in NMP (5 %, v/v), DCM 
and NMP (each 3 x) completed the SPPS cycle. After completing the PNA synthesis, 
the resin was thoroughly washed with NMP and DCM (each 10 x) and dried in vacuum.  
 
5.4.5) Synthesis of E3/K3-LR/TMD Peptide Hybrids 
E3/K3-LR/TMD peptide hybrids were synthesised via automated SPPS using a Liberty 
Blue peptide synthesiser equipped with a Discover microwave reaction cavity (CEM, 
USA). The same resins and aa building blocks as for the synthesis of TMDs of the PNA 
based model peptides were used. The synthesis scale was 0.05 mmol and no capping 
was performed. After swelling of the resin in DMF for 60 min, single couplings were 
applied for the first 10 aa building blocks. Subsequently, building blocks were coupled 
twice. For deprotection, a solution of piperidine (20 %, v/v) and Oxyma (0.1 M) in DMF 
was used. Microwave assisted deprotection was performed in two steps 
(1. RT → 75 °C for 15 s, 155 W / 2. 90 °C for 50 s, 30 W). Stock solutions of 0.2 M aa 
building blocks (Vadd = 1.25 mL, 5 eq.), 0.50 M Oxyma (Vadd = 0.5 mL, 5 eq.) and 
0.25 M DIC (Vadd = 1 mL, 5 eq.) were applied coupling. The coupling steps were con-
ducted in two steps (1. RT → 75 °C for 15 s, 170 W / 2. 90 °C for 110 s, 30 W). Cyste-
ine and arginine were coupled under adjusted conditions to avoid racemization and 
δ-lactam formation (cysteine: 1. RT for 120 s / 2. RT → 50 °C for 240 s, 35 W; arginine: 
1. RT for 1500 s / 2. RT → 75 °C for 120 s, 30 W).[159] After synthesis, the resin was 
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filtered off and washed successively with DMF and DCM (each 10 x). Finally, the resin 
was dried in vacuum and a test cleavage was performed. 
 
5.4.6) Acetylation of K3 and iE3 Peptides 
10 mg of the resin with the corresponding peptide were transferred to a BD DiscarditTM 
syringe (2 mL, acid/base resistant) equipped with a polyethylene filter. The resin was 
swollen in DMF for 30 min and subsequently, 1.5 mL of a solution of acetic acid anhy-
dride (10 %, v/v) and 2,6-lutidine (20 %, v/v) in DMF were added to the resin. Acetyla-
tion was carried out twice under gentle agitation at RT for 5 min. Afterwards, the resin 
was washed in DMF and DCM (each 3 x) and dried in vacuum. 
 
5.4.7) NBD Labelling of K3 Peptides 
N-terminal labelling of the K3 peptides with NBD was conducted at a 1 µmol scale: 
5 µmol NBD-F (0.91 mg, 5 eq.) was dissolved in 95 µL NMP and 5 µL DIPEA (29 eq.) 
were added. The solution was directly transferred to the resin and the reaction was 
performed under light exclusion overnight. The resin was washed in DMF and DCM 
(each 5 x) and dried in vacuum.  
 
5.4.8) Cleavage from the Solid Support 
For the cleavage of the synthesised peptides from the solid support (resin) TFA doped 
with various scavengers was used. Small amounts of the resin (10-30 mg) were trans-
ferred to a BD DiscarditTM syringe (2 mL, acid/base resistant). Subsequently, for pep-
tide cleavage appropriate solutions were added (1-2 mL): 
- TMD:    TFA/EDT/water/TIS (87.5:5:5:2.5, v/v/v/v) 
- aeg-PNA:   TFA/m-cresol/TIS (92.5:5:2.5, v/v/v) 
- E3, K3:   TFA/water/TIS (95:2.5:2.5, v/v/v) 
- PNA-LR/TMD:  TFA/EDT/m-cresol/TIS (87.5:5:5:2.5, v/v/v/v)  
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- E3/K3-LR/TMD:  TFA/EDT/water/TIS (94:2.5:2.5:1, v/v/v/v) 
- Cys-E3/SybT: TFA/aq. TCEP (10 mM)/water/TIS (88:5:5:2, v/v/v/v).[190] 
Cleavage from the resin was carried out at RT under gentle agitation for 2 h. Then, the 
cleavage mixture was filtered and the solution was concentrated by using a nitrogen 
stream. The peptides were precipitated as white solids by the addition of cold (-20 °C) 
diethylether. The resulting suspension was centrifugated and the supernatant was dis-
carded. The solid was washed with diethylether (4 x) and dried under air. Finally, the 
crude products were dissolved in TFE/water (1:3, v/v) and lyophilised. All compounds 
were used without further purification for membrane fusion assays. 
 
5.5) Preparation of Model Membranes 
5.5.1) Large Unilamellar Vesicles 
Preparation of stock solutions: 
Stock solutions of the unlabelled lipids 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine 
(DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and cholesterol 
were prepared in chloroform (20 mg/mL, respectively). The same solvent was used for 
the labelled lipids NBD-DOPE and Rh-DOPE (2 mg/mL, respectively). For model pep-
tide stock solutions TFE was used and concentrations were determined photometri-
cally (Section 5.6.6). 
Preparation of peptide/lipid films: 
Lipid and peptide stock solutions were added to a pre-mixed solution of chloroform and 
TFE yielding a chloroform/TFE ratio of 1:1 (v/v) and a peptide/lipid ratio of 1:200 (n/n). 
The lipid composition for the preparation of unlabelled (proteo-)liposomes was 
DOPC/DOPE/cholesterol (50:25:25, n/n/n) and the total amount of lipids was 
nlipids = 2.5 µmol (npeptides = 12.5 nmol). The films for the labelled proteoliposomes were 
composed of DOPC, DOPE, cholesterol, NBD-DOPE and Rh-DOPE (50:22:25:1.5:1.5, 
n/n/n/n/n) and the corresponding model peptides. The removal of solvents was per-
formed above the main transition temperatures (Tm) of the used lipids (50 °C) by ap-
plying a nitrogen stream. The resulting thin peptide/lipid films at the test tube walls 
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were incubated under reduced pressure at 50 °C for 12 h to remove residual organic 
solvent.  
Preparation of LUVs via extrusion: 
Organic solvent free peptide/lipid films were hydrated by adding 500 µL of the fusion 
buffer (20 mM HEPES, 100 mM KCl, 1 mM EDTA, 1 mM DTT, pH = 7.4) and 3-6 glass 
beads (clipids = 5 mM, cpeptides = 25 µM). The samples were incubated under gentle ag-
itation at 50 °C for 1-2 h. Hydrated films were treated in a sonication bath for 15-30 s 
and agitated mechanically (vortexer for 5 s) to remove remaining films from the test 
tube walls. Hydration of the films resulted in turbid suspensions which were extruded 
at least 21 times through a polycarbonate membrane (100 nm nominal pore diameter) 
by using a LiposoFast mini-extruder (Avestin, Canada) to produce almost clear (pro-
teo-)liposome suspensions.[93] 
 
5.5.2) Preparation of Pore Spanning Membranes and Pro-
teoliposomes of Different Sizes 
Porous (pore diameter of 1.2 µm) silicon nitride slides were coated by thin layers of 
titanium and gold. The gold surface was functionalised by using a solution of 6-mer-
capto-1-hexanol in n-propanol (0.1 mM). GUVs with a lipid composition of 
POPE/POPS/DOPC/cholesterol/Atto488-DPPE (19:10:50:20:1, n/n/n/n/n) and a pep-
tide/lipid ratio of 1:250 were prepared by detergent removal and subsequent electrofor-
mation on indium tin oxide slides applying a sinusoidal voltage (1.6 Vp-p, 12 Hz for 3 h). 
The obtained GUV suspension was directly added onto the porous slides and was 
incubated at RT for 30 min. The bilayer formation was controlled fluorometrically using 
a confocal laser microscope. LUVs for the membrane fusion experiments on PSMs 
were also prepared by detergent removal from a micellar peptide/lipid/detergent mix-
ture by using size exclusion chromatography and subsequent extrusion with polycar-
bonate membranes with nominal pore diameters of 400 nm. The lipid composition and 
peptide/lipid ratio were equal to GUVs but as labelled lipids 1 mol-% TxR-DHPE was 
used.[88] SUVs for accompanying leaflet mixing assays were obtained through deter-
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gent depletion of the peptide/lipid/detergent mixture by using size exclusion chroma-
tography.[9,191,192] One proteoliposome sample was prepared with Atto488-DPPE and 
the other sample with Texas Red-DHPE (1 mol-%, respectively).  
 
5.5.3) Preparation of Solid Supported Membranes and Col-
loidal Probe Supported Membranes 
LUVs with the lipid composition of DOPC/DOPE/cholesterol/NBD-DOPE (50:24:25:1, 
n/n/n/n) and a peptide/lipid ratio of 1:200 were prepared according to the protocol de-
scribed in Section 5.5.1. The obtained LUV suspension was added to a glass-bottom 
(borosilicate) dish and was incubated at RT for 2 h. Afterwards, the excess of lipo-
somes was rinsed by HEPES buffer (20 mM HEPES, 100 mM KCl, 1 mM EDTA, 1 mM 
DTT, pH = 7.4). The coverage of the solid support was controlled with confocal laser 
microscopy and AFM imaging. For the preparation of the membrane coated colloidal 
probes, a glass (borosilicate) microsphere (diameter of 15 µm) was attached to a tip-
less cantilever using a micromanipulator and epoxy resin. Afterwards, the cantilever 
was cleaned in an argon plasma for 30 s. Direct before starting the measurements, the 
colloidal probe was incubated in the LUV suspension (80-100 µL, ~5 mM in HEPES 
buffer) in a hanging droplet at RT for 15 min. The excess of proteoliposomes was re-
moved by rinsing with HEPES buffer.[180]  
 
5.6) Modification of AFM tips and Peptide Attachment 
Commercially available AFM tips were coated by a 30-50 nm thick gold layer applying 
vapor disposition. When the cantilever approached the solid supported membrane 
doped with Cys-E3/SybT (peptide/lipid of 1:200) covalent bonds between the gold sur-
face of the tip and the thiol groups  of N-terminal cysteines were formed (thioate 
bonds). Bond formation was detected through force events in force-distance 
curves.[184,185] 
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5.7) Analytical Methods 
5.7.1) Mass spectrometry 
Electrospray ionisation mass spectra (ESI-MS) were obtained by using the maXis 
mass spectrometer (Bruker, USA) with a time of flight (TOF) analyser. High resolution 
mass spectra (HR-MS) with a measuring accuracy of < 5 ppm were received. Cations 
were detected in the range of 300-2900 m/z. Data analysis was realised by the Bruker 
Compass DataAnalysis 4.0 software. 
 
5.7.2) Dynamic Light Scattering 
Size determination of (proteo-)liposomes by dynamic light scattering (DLS) was per-
formed using the DynaPro Titan (Wyatt) or the Zetasizer Nano S (Malvern) device. The 
(proteo-)liposome concentration was equal to the applied concentration during the leaf-
let mixing assays (185 µM with regard to lipids before extrusion, lipid loss through ex-
trusion was 15-50 %): The DynaPro Titan operated at 90° concerning the detection of 
scattered laser light (right angle detection). Measurements were performed at 25 °C, 
the laser power was adjusted to 3-4 % and 50 measurements per sample were rec-
orded. Data analysis was conducted with the Dynamics 6.9.1 software. The 
Zetasizer Nano S operated at 173° concerning the detection angle (back angle detec-
tion). Measurements were carried out at 25 °C, the laser power was automatically ad-
justed through an attenuator and three measurements per sample were performed 
(correlation delay time of 63 s). The control of the device and data capture were con-
ducted by the Zetasizer Nano software. 
 
5.7.3) Nano Tracking Analysis 
Another technique applied for the determination of liposome sizes was the Nano track-
ing analysis (NTA). An optical microscope equipped with a LM14 measuring chamber 
and a LM10 HS CMOS camera (NanoSight Ltd., UK) was used. For the measure-
ments, the (proteo-)liposome suspensions were diluted to a lipid concentration of 1 µM 
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(loss of lipids during extrusion not considered). Three samples of the examined (pro-
teo-)liposome suspensions were measured. Camera sensitivity was adjusted to 13-14. 
Videos of 30 s were captured at RT. Thereby, more than 200 (proteo-)liposomes were 
tracked and analysed by the NTA 2.3 Analytical software.  
 
5.7.4) Phosphate Determination 
10 µL of (proteo)-liposome suspensions (10 µL water as reference) were diluted with 
190 µL water. 200 µL of perchloric acid (70 % aq. solution) were added and lipids were 
digested at 220 °C for 1 h (usage of a metal block on a hotplate). For the calibration 
curves, mixtures of water and an aq. solution of sodium dihydrogenphosphate mono-
hydrate (89 mg/L) were prepared following Table 5.7.4-1. Each sample was prepared 
twice. 700 µL of the freshly prepared reagents A (aq. solution of 0.45 % (w/v) ammo-
nium molybdate and 12.6 % (w/v) perchloric acid) and reagent B (aq. solution of 1.7 % 
(w/v) sodium ascorbate) were transferred to the digested samples and to the mixtures 
for the calibration curves, respectively. All samples were thoroughly mixed and heated 
at 80 °C for 7 min by using a water bath.[193]  
 
Table 5.7.4-1 Mixtures of water and phosphate solution for calibration curves. 
 
After cooling down, 300 µL of the samples were transferred to UV-Star® 96 well micro-
plates (Greiner Bio-One, Germany) and the absorption of phosphomolybdate com-
plexes was determined at 820 nm using the CLARIOstar microplate reader (BMG Lab-
tech, Germany). For the calibration curves, detected absorption was plotted against 
the assumed mass of phosphorus. The obtained linear function was used to determine 
V(H2O) [µL] V(NaH2PO4∙H2O) [µL] m(P) [µg] 
100.0 0.0 0.00 
62.5 37.5 0.75 
50.0 50.0 1.00 
37.5 62.5 1.25 
25.0 75.0 1.50 
0.0 100.0 2.00 
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the mass of phosphorus of the (proteo-)liposome samples. The control of the device 
and data capture were conducted by the CLARIOstar software.  
 
5.7.5) SDS-PAGE 
For sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) hand 
casted mini gels (thickness of 0.75 mm) were used. Mixtures for resolving and stacking 
gels were prepared according to Table 5.7.5-1. 
 
Table 5.7.5-1 Compositions of resolving and stacking gels. Given amounts are sufficient for two gels. 
Remarks: a, b) Ratio of acrylamide and methylenebisacrylamide of the aq. 40 % stock solutions. 
 
The polymerisation of acrylamides was started by APS and TEMED just before trans-
ferring the mixtures into the gel chambers. For stacking gels, ~1.5 cm at the top of the 
chambers were kept free. After the addition of the stacking gel, a comb for the gel 
pockets was fixed. When polymerisation was completed, gels were stored at 4 °C in 
paper towels which were soaked by the running buffer. For SDS-PAGE runs, gels were 
fixed in a Mini PROTEAN Tetra Cell electrophoresis chamber (Bio-Rad, USA) which 
was filled with the NovexTM tricine SDS running buffer (ThermoFisher Scientific, USA). 
As marker for the identification of peptides the Color Marker Ultra-low Range 
(1060-26600 Da, Sigma-Aldrich, USA) was used. 20 µL of the proteoliposome samples 
(after ultra-centrifugation, Section 5.7.8) were mixed with 5 µL of the NovexTM tricine 
SDS sample buffer (ThermoFisher Scientific, USA) and were filled into the gel pockets. 
The runs were performed at U = 200 V. The peptide bands were stained by using a 
commercially available rapid silver staining kit (Sigma-Aldrich, USA). 
component composition resolving gel stacking gel 
Ethylene glycol pure (≥ 99 %) 2.4 mL - 
Gel buffer 3 M Tris-HCl + 0,4 % SDS (w/v) 2.0 mL 1.0 mL 
acryl/bisacryl aq. 40 % (w/v) 3.6 mL (19:1, w/w)a 0.5 mL (29:1, w/w)b 
water - - 2.5 mL 
Vtotal - 8 mL 4 mL 
APS 40 % in water (w/v)  8 µL 4 µL 
TEMED pure (≥ 99 %) 12 µL 16 µL 
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5.7.6) UV-Spectroscopy 
The concentrations of the model peptide stock solutions were determined by using the 
V-650 UV/vis-spectrophotometer equipped with the ETCS-761 temperature controller 
(JASCO, Germany). Data were captured by the V-650 Spectra Manager software. All 
measurements were performed at 25 °C and the sample cell was flushed with nitrogen. 
The absorption was detected for 300s and the last 100 measured points were aver-
aged and used for the calculation of the concentrations. The molar extinction coeffi-
cients of the PNA-LR/TMD peptide hybrids were estimated by the summation of the 
molar extinction coefficients of aeg-PNA monomers (nucleobases), tryptophans, tyro-
sines and cysteins at 260 nm.[194] For E3/K3 based model peptides, the estimation of 
the molar extinction coefficients was conducted considering solely aas at 280 nm (Ta-
ble 5.7.6-1).[195]  
 
Table 5.7.6-1 Molar extinction coefficients of the nucleobases and aas.  
nucleobases/aas ε260 nm [M-1cm-1] ε280 nm [M-1cm-1] 
cytosine 6600 - 
guanine 11700 - 
thymine 8600 - 
adenine 13700 - 
tryptophan 3400 5700 
tyrosine 500 1300 
cysteine 400 120 
 
The summation of the molar extinction coefficients of the nucleobases and/or aas 
yielded following molar extinction coefficients for the different model peptide groups 
(Table 5.7.6-2). 
 
Table 5.7.6-2 Molar extinction coefficients of the model peptides. 
 
model peptides ε260 nm [M-1cm-1] ε280 nm [M-1cm-1] 
PNA-SybX(a) 111700 - 
PNA-SxY(a) 104800 - 
(i)E3-SybX(a) - 14100 
K3-SxY(a) - 12100 
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The concentrations of peptide stock solutions were calculated from the Lambert-Beer’s 
law: 
𝑐 =
𝐴
𝜀 × 𝑑
 
Thereby, c is the concentration of the peptides in mol/L, A is the detected absorption 
at 260 nm or 280 nm, ε is the estimated molar extinction coefficient in M-1cm-1 and d is 
the length of the quartz-cuvette in cm. 
 
5.7.7) Spectrofluorimetry 
Fluorescence spectra were obtained by applying the FP-6200 spectrofluorometer 
equipped with the ETC-272T temperature controller (JASCO, Germany). All measure-
ments were conducted at 25 °C and the sample cell was flushed with nitrogen. The 
samples were excited at 460 nm. Emission spectra and time course measurements of 
emission were detected by using the parameters of Table 5.7.7-1. The control of the 
device and data capture were performed by the FP-6200 Spectra Manager software. 
 
Table 5.7.7-1 Standard parameters for spectrofluorimetry. 
 
5.7.7.1) Total Leaflet Mixing (TLM) Assay  
The FRET donor NBD-DOPE (emission maximum at 535 nm) and the FRET acceptor 
Rh-DOPE (emission maximum at 585 nm) were used as fluorescent probes. The 
FRET effect between NBD and Rh was exploited to detect leaflet mixing. 10 µL of 
parameter spectrum measurement time course measurement 
detection wavelength(s) 500-610 nm 535 nm 
response fast 1 s 
data pitch  1 nm 1 s 
sensitivity high high 
bandwidth 5 nm (em.) / 5 nm (ex.) 5 nm (em.) / 5 nm (ex.) 
scanning speed 125 nm/min - 
measurement time - 1200 s 
(2). 
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labelled and 40 µL of unlabelled (proteo-)liposomes (preparation described in Section 
5.5.1) were mixed in a quartz cuvette filled with 1300 µL fusion buffer (20 mM HEPES, 
100 mM KCl, 1 mM EDTA, 1 mM DTT (pH = 7.4)) and equipped with a stirrer. Lipid 
concentrations of the (proteo-)liposome suspensions were estimated by standard 
phosphate determination assays (Section 5.7.4): the concentrations of the labelled 
proteoliposome samples were in the range of 3.0-4.0 mM (20-40 % lipid loss through 
extrusion) and the concentrations of the unlabelled samples were in the range of 
2.5-4.3 mM (15-50 % lipid loss through extrusion). The total lipid concentration in the 
cuvette was estimated to be between 90 and 160 µM. The change of the donor emis-
sion intensity was plotted as: 
𝐹norm TLM =  
𝐹𝑡 TLM − 𝐹min TLM
𝐹max TLM −  𝐹0 TLM
 
Thereby, Fnorm TLM is the normalised NBD fluorescence in %, Ft TLM is the detected flu-
orescence after the addition of unlabelled (proteo-)liposomes at the time t, Fmin TLM is 
the minimal detected fluorescence of the time course measurements, Fmax TLM (from 
spectrum measurements) is the maximal fluorescence after the addition of 30 µL de-
tergent (10 % aq. Triton X-100, v/v, Carl Roth) and F0 TLM (from spectrum measure-
ments) is the fluorescence of labelled proteoliposomes before the addition of unla-
belled liposomes at 535 nm. Leaflet mixing was detected for 1200 s and the detergent 
was added in several rounds until no further increase of NBD emission was detected 
(1st round: 30 µL, 2nd: 20 µL, 3rd: 20 µL). 
 
5.7.7.2) Inner Leaflet Mixing (ILM) Assay 
100 µL of a suspension of labelled proteoliposomes (3.0-4.0 mM) were diluted with 
200 µL fusion buffer. NBD fluorescence at 535 nm was detected for ~60 s. Then, 
100 µL of a freshly prepared solution of sodium dithionite (DT) in fusion buffer (50 mM) 
were added. After decrease and subsequent stabilisation of the NBD emission, the 
excess of DT was removed by size exclusion chromatography (Section 5.3.3). The 
NBD reduction was carried out immediately before starting the ILM measurements. 
(3). 
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Standard normalisation of ILM measurements over time was conducted by using fol-
lowing equation: 
𝐹norm ILM =  
𝐹𝑡 ILM −  𝐹min ILM
𝐹max TLM −  𝐹0 ILM
 
Thereby, Fnorm ILM is the normalised NBD fluorescence in %, Ft ILM is the detected fluo-
rescence after the addition of unlabelled (proteo-)liposomes at the time t, Fmin ILM is the 
minimal detected fluorescence of the time course measurements, Fmax TLM (from spec-
trum measurements) is the maximal fluorescence of DT-untreated labelled liposomes 
after the addition of 30 µL detergent (10 % aq. Triton X-100, v/v), i.e. fluorescence de-
rives from both leaflets, and F0 ILM (from spectrum measurements) is the fluorescence 
of DT-treated labelled proteoliposomes before unlabelled (proteo-)liposomes were 
added, i.e. fluorescence derives solely from inner leaflets. Leaflet mixing was detected 
for 1200 s and the detergent was added in several rounds until no further increase of 
NBD emission was detected (1st round: 30 µL, 2nd: 20 µL, 3rd: 20 µL). An alternative 
mode for the normalisation of ILM measurements is given by the following equation:  
𝐹norm ILM =  
𝐹𝑡 ILM −  𝐹min ILM
𝐹max ILM −  𝐹0 ILM
 
The detected fluorescence values are the same as described for equation 4 except for 
Fmax ILM (from spectrum measurements), which is the maximal fluorescence of 
DT-treated labelled proteoliposomes after the addition of 30 µL (or more) detergent, 
i.e. fluorescence derives solely from the inner leaflets. This mode of normalisation is 
useful to increase the resolution of ILM assays (Section 3.4.1). 
 
 
 
 
(4). 
(5). 
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5.7.7.3) Standard Deviation 
Both TLM and ILM assays were performed three times with different (preoteo-)lipo-
some samples (same peptide probes). The standard deviation S was calculated by:  
𝑆 = √
1
𝑛(𝑛 − 1)
× ∑(𝑥t − ?̅?)2
𝑡
 
Thereby, 𝑛 is the number of individual measurements, 𝑥t are the measured data of 
individual mesurements at the time t and ?̅? is the average of the measured data at the 
time t. Standard deviations were multiplied by the Student’s factor t = 3.182 (n = 3, 
95 % certainty). 
 
5.7.7.4) Trigger of Membrane Fusion by Soluble Peptidic Components 
For the leaflet mixing assays concerning the examination of the membrane fusion trig-
gering effect of soluble peptidic components, solely time course measurements 
(1600 s) were performed. 10 µL of the labelled proteoliposomes were added to 
1300 µL fusion buffer and the fluorescence was detected for ~120 s. Subsequently, 
40 µL of unlabelled proteoliposomes were added. After stabilisation of the NBD fluo-
rescence, soluble peptidic components (0.5 mM) in different levels of excess (4, 24 
and 40 eq.) concerning the amount of membrane anchored model peptides in the cu-
vette (1.25 nmol, peptide loss through extrusion was not considered) were added. Ap-
proximately 1200 s after the addition of peptidic components, the detergent was added 
until no further increase of NBD fluorescence was observed (30 µL or more of 10 % 
aq. Triton X.-100, v/v) Measurements were normalised by: 
𝐹norm TLM =  
𝐹𝑡 TLM −  𝐹0 TLM
𝐹max 𝑇𝐿𝑀 −  𝐹0 TLM
 
Thereby, Fnorm TLM is the normalised NBD fluorescence in %, Ft TLM is the detected flu-
orescence after the addition of unlabelled proteoliposomes at the time t, F0 TLM is the 
averaged fluorescence before the addition of unlabelled proteoliposomes, Fmax TLM is 
the averaged fluorescence after the last addition of detergent. ILM assays were not 
performed. 
(7). 
(6). 
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5.7.7.5) Determination of Lipid Loss Through Detection of the Fluo-
rescence of Rh-DOPE 
Another option for the estimation of the loss of lipid material beside the standard phos-
phate test (Section 5.7.4) is the detection of the Rh fluorescence at 585 nm (excitation 
at 560 nm). For the estimation of lipid loss during extrusion, 2 µL of the MLV suspen-
sion (5 mM) before extrusion and 2 µL of the LUV suspension after extrusion were 
taken. For the estimation of the lipid loss during size exclusion chromatography, 10 µL 
of a diluted LUV suspension (1.25 mM, lipid loss through extrusion not considered) 
before size exclusion chromatography and 10.0-12.5 µL (depending on the volume of 
the collected coloured LUV suspension) after size exclusion chromatography were 
used. For fluorescence measurements (spectrum measurements, 575-610 nm) sam-
ples were diluted with 1300 µL fusion buffer. The detected intensity values of the fluo-
rescence at 585 nm were directly used to estimate the loss of lipid material (Section 
3.4.1).  
 
5.7.7.6) Proteoliposome Stability Test 
Labelled proteoliposome suspensions were treated with sodium dithionite (DT) and the 
fluorescence of NBD-DOPE was detected as described for ILM assays (Section 
5.7.7.2). The stability of fluorescence signals before and after the addition of DT 
(50 mM) was evaluated by the slopes of the fluorescence curves. The slope before the 
addition of DT (Sbefore) was calculated by using the intensity values of fluorescence at 
0 s and 30 s after starting the measurement (F1(0 s) and F2(30 s)). The slope after the 
addition of DT (Safter) was calculated by using the intensity values at 120 s and 150 s 
after the addition of DT (F1(120 s) and F2(150 s)). Sbefore and Safter were calculated by 
equation 8:  
𝑆before/after =  
𝐹2 − 𝐹1
30s
 
When Sbefore was > 0.020 a.u./s, proteoliposomes were evaluated as unstable. When 
Sbefore was < 0.020 a.u./s, proteoliposomes were evaluated as stable. For 
Safter < −0.040 a.u./s, proteoliposomes were designated as unstable. For 
(8). 
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Safter > −0.040 a.u./s, proteoliposomes were designated as stable. Values given in Ta-
ble 3.4.2-1 were averaged over three measurements.  
 
5.7.7.7) Peptide Insertion Test Based on Fluorescent Probes 
100 µL of proteoliposomes (cpeptides = 25 µM), 100 µL of liposomes or 100 µL of the 
fusion buffer were mixed with 10 µL of the NBD-K3 solution in fusion buffer 
(cNBD-K3 = 250 µM), respectively. All three mixtures were prepared twice and were gen-
tly agitated at RT for 1 h. For the removal of unbound NBD-K3, one half of the mixtures 
was dialysed using the Slide-A-Lyzer MINI (Thermo Scientific, USA) dialysis chambers 
with a MWCO of 20 kDa. Samples were dialysed against 14 mL fusion buffer. After 3 h 
the buffer solution was exchanged and dialysis was resumed overnight. The other half 
of samples was not dialysed. The not dialysed mixtures of proteoliposomes/NBD-K3, 
liposomes/NBD-K3 and fusion buffer/NBD-K3 were used to determine calibration 
curves. For that, a serial dilution of seven samples with known concentrations (each 
diluted with fusion buffer by the factor of two) was prepared. The calibration for each 
mixture was necessary, because NBD fluorescence is highly influenced by the hydro-
phobicity of the medium.[173] Moreover, the fusion buffer/NBD-K3 mixture served as 
control for the efficiency of dialysis concerning the fluorescent NBD-K3 peptides. The 
liposome/NBD-K3 mixture was used to evaluate the affinity of NBD-K3 to model mem-
branes. The fluorescence at 535 nm was detected by spectrum measurements 
(500-600 nm) and was used to calculate the concentration of bound (not removed by 
dialysis) NBD-K3 with the help of the determined linear calibration curves. 
 
5.7.8) Peptide Insertion Test Based on Ultra-Centrifugation 
Centrifuge tubes were thoroughly cleaned with an aq. solution of 2 % (v/v) Hell-
manex III (Hellma, Germany). After rinsing with ultra-pure water, tubes were dried. 
50 µL of a solution of 80 % Histodenz (Sigma-Aldrich, USA) in fusion buffer (w/v) were 
mixed with 50 µL of the proteoliposome suspensions (2.5-4.0 mM). For control exper-
iments, both proteoliposomes with threefold amounts of peptides (37.5 nmol, pep-
tide/lipid ratio of 1:67 (n/n)) and liposomes were prepared (for preparation see Section 
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5.5.1). The liposomes were mixed with peptides dissolved in TFE (12.5 nmol). The 
individual mixtures were overlayed with 50 µL of a 30 % Histodenz solution (w/v) and 
30 µL of fusion buffer. Thereby, it was important that layers were not mixed with each 
other. The samples were centrifuged at 4 °C with 50000 rpm (350000 g) for 1.5 h in 
the Centrikon T-1065 centrifuge (Kontron Instruments, Germany) by using a TST60.4 
rotor (rmax = 125 mm). After centrifugation, samples were aliquoted (20 µL) and pre-
pared for SDS-PAGE (Section 5.6.5). 
 
5.8) Calculation of the Rate of Winding of α-Helical 
Coiled Coils 
The distance for an entire turn of coiled-coil forming α-helices around each other is 
known as pitch (P). P depends on the radius of the coiled coil (r0), the number of aas 
per helical turn (α) and the axial rise per aa (h) of the single α-helices. The relationship 
between P, r0 and α is given by:  
𝑃 =
2π
𝛥𝑡
× √ℎ2 − (𝑟0 × 𝛥𝑡)2 
Thereby, Δt is the twist differential and is calculated by equation 10:  
𝛥𝑡 = 2π ×
1
1
𝛼 −
1
3.5
 
α is typically 3.6 and thus, Δt is −791.68.[119] Furthermore, h for α-helices is 0.15 nm. 
The radii r0 of the E3/K3 coiled coil and the Syb2/Sx1A coiled coil of the SNARE com-
plex were determined by NMR solution and crystal structures by using the Pymol 
0.99rc6 software.[120,127] Three distance (diameter) measurements between homoge-
neously distributed Cα-atoms of the peptide backbones were performed and averaged. 
The calculated values for the pitches of E3/K3 and Syb2/Sx1A coiled coils were used 
to calculate the number of aas per pitch. Subsequently, 360° were divided by these 
numbers of aas yielding the turning angle per aa which was used as a value for the 
rate of winding of the coiled coils.  
(9). 
(10). 
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5.9) Analytical Data  
5.9.1) Transmembrane Domains  
Peptides without recognition motifs were synthesised as described in Section 5.4.5. 
Cleaved peptides were dissolved in methanol/TFE/formic acid (10/10/1, v/v/v) for mass 
spectrometric measurements. 
Syb2-TMD 
H-KRKYWWKNLKMMIILGVICAIILIIIIVYFST-OH  
[C190H308N42O38S3, 3884.99] 
MS (ESI) m/z:  777.9 [M+5H]5+, 972.1 [M+4H]4+, 1295.8 [M+3H]3+, 
1943.1 [M+2H]2+, deconvoluted 3884.3 [M]. 
HR-MS (ESI) m/z:  calcd. for C190H313N42O38S3 [M+5H]5+ 777.8608, 
found 777.8604; 
calcd. for C190H312N42O38S3 [M+4H]4+ 972.0742, 
found 972.0750; 
calcd. for C190H311N42O38S3 [M+3H]3+ 1295.7631, 
found 1295.7646. 
 
Sx1A-TMD 
H-KYQSKARRKKIMIIICCVILGIIIASTIGGIFG-OH 
[C165H288N44O39S3, 3608.57] 
MS (ESI) m/z:  722.6 [M+5H]5+, 903.0 [M+4H]4+, 1203.7 [M+3H]3+, deconvo-
luted 3608.1 [M]. 
HR-MS (ESI) m/z:  calcd. for C165H293N44O39S3 [M+5H]5+ 722.6299, 
found 722.6288; 
calcd. for C165H292N44O39S3 [M+4H]4+ 903.0355, 
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found 903.0351; 
calcd. for C165H291N44O39S3 [M+3H]3+ 1203.7116, 
found 1203.7115. 
 
5.9.2) Acetylated iE3 and K3 Peptides 
Peptides were synthesised according to the protocols described in Sections 5.4.5 and 
5.4.6. Cleaved peptides were dissolved in methanol/formic acid (10:1, v/v) for mass 
spectrometric measurements. 
Ac-iE3 
Ac-KELAAIEKELAAIEKELAAIE-NH2  
[C104H179N25O34, 2323.72] 
HPLC (Nucleodur column, RP-C18, 250 mm x 10 mm, 5 µm, 100 Å, gra-
dient: 60-100 % of solvent B2 for 40 min): tR = 18.2 min. 
MS (ESI) m/z:  581.8 [M+4H]4+, 775.4 [M+3H]3+, 1162.7 [M+2H]2+, deconvoluted 
2323.3 [M]. 
HR-MS (ESI) m/z:  calcd. for C104H183N25O34 [M+4H]4+ 581.8342, 
found 581.8329; 
calcd. for C104H182N25O34 [M+3H]3+ 775.4431, 
found 775.4441; 
calcd. for C104H181N25O34 [M+2H]2+ 1162.6611, 
found 1162.6603. 
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Ac-K3 
Ac-KIAALKEKIAALKEKIAALKE-NH2  
[C107H194N28O28, 2320.90] 
HPLC (Nucleodur column, RP-C18, 250 mm x 10 mm, 5 µm, 100 Å, gradient: 40-80 % 
of solvent B2 for 40 min): tR = 23.8 min. 
MS (ESI) m/z:  465.1 [M+5H]5+, 581.1 [M+4H]4+, 774.5 [M+3H]3+, 
1161.2 [M+2H]2+, deconvoluted 2320.5 [M]. 
HR-MS (ESI) m/z:  calcd. for C107H199N28O28 [M+5H]5+ 465.1002, 
found 465.1000; 
calcd. for C107H198N28O28 [M+4H]4+ 581.1234, 
found 581.1236; 
calcd. for C107H197N28O28 [M+3H]3+ 774.4955, 
found 774.4958; 
calcd. for C107H196N28O28 [M+2H]2+ 1161.2396, 
found 1161.2390. 
 
5.9.3) NBD Labelled K3 Peptide 
The peptide was synthesised as described in Sections 5.4.5 and 5.4.7. The cleaved 
peptide was dissolved in methanol/formic acid (10:1, v/v) for mass spectrometric meas-
urements. 
NBD-K3 
 
 
 
 
[C111H193N31O30, 2441.95] 
HPLC (Nucleodur column, RP-C18, 250 mm x 10 mm, 5 µm, 100 Å, gradient: 40-80 % 
of solvent B2 for 40 min): tR = 25.0 min. 
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MS (ESI) m/z:  489.3 [M+5H]5+, 611.4 [M+4H]4+, 814.9 [M+3H]3+, 
1221.8 [M+2H]2+, deconvoluted 2441.5 [M]. 
HR-MS (ESI) m/z:  calcd. for C111H198N31O30 [M+5H]5+ 489.2984, 
found 489.2980; 
calcd. for C111H197N31O30 [M+4H]4+ 611.3712, 
found 611.3722; 
calcd. for C111H196N31O30 [M+3H]3+ 814.8259, 
found 814.8262; 
calcd. for C111H195N31O30 [M+2H]2+ 1221.7352, 
found 1221.7351. 
 
5.9.4) PNA-LR/TMD Peptide Hybrids 
Peptides were synthesised according to the protocol described in Section 5.4.4. 
Cleaved peptides were dissolved in methanol/TFE/formic acid (4:1:1, v/v/v) for mass 
spectrometric analysis. 
 
5.9.4.1) PNA1/SybX(a) Peptides 
PNA1/SybT 
 
 
 
[C298H441N99O68S3, 6594.61] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
60-90 % of solvent B1 for 15 min): tR = 11.0 min. 
MS (ESI) m/z:  943.1 [M+7H]7+, 1099.9 [M+6H]6+, 1319.9 [M+5H]5+, deconvoluted 
6594.3 [M]. 
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HR-MS (ESI) m/z:  calcd. for C298H447N99O68S3 [M+6H]6+ 1100.0632,  
found 1100.0649; 
calcd. for C298H446N99O68S3 [M+5H]5+ 1319.8744,  
found 1319.8776.  
 
PNA1/SybE 
 
 
 
[C299H441N99O69S3, 6622.62] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
60-90 % of solvent B1 for 15 min): tR = 9.2 min. 
MS (ESI) m/z:  1104.7 [M+6H]6+, 1325.5 [M+5H]5+, 1656.6 [M+4H]4+, deconvolu-
ted 6622.3. 
HR-MS (ESI) m/z:  calcd. for C299H448N99O69S3 [M+7H]7+ 947.0545,  
found 947.0532;  
calcd. for C299H447N99O69S3 [M+6H]6+ 1104.7290,  
found 1104.7321; 
calcd. for C299H446N99O69S3 [M+5H]5+ 1325.4734,  
found 1325.4758; 
calcd. for C299H445N99O69S3 [M+4H]4+ 1656.5899,  
found 1656.5881. 
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PNA1/SybK 
 
 
 
[C300H446N100O67S3, 6621.68] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
60-90 % of solvent B1 for 15 min): tR = 7.9 min. 
MS (ESI) m/z:  1104.6 [M+6H]6+, 1325.3 [M+5H]5+, deconvoluted 6621.4 [M].  
HR-MS (ESI) m/z:  calcd. for C300H452N100O67S3 [M+6H]6+ 1104.5711,  
found 1104.5814; 
calcd. for C300H451N100O67S3 [M+5H]5+ 1325.2838,  
found 1325.2857. 
 
PNA1/SybTa 
 
 
 
[C298H442N100O67S3, 6593.63] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
65-95 % of solvent B1 for 15 min): tR = 8.9 min.  
MS (ESI) m/z:  942.9 [M+7H]7+, 1099.9 [M+6H]6+, 1319.7 [M+5H]5+, 
1649.3 [M+4H]4+, deconvoluted 6593.4 [M]. 
 
HR-MS (ESI) m/z:  calcd. for C298H449N100O67S3 [M+7H]7+ 942.9146,  
found 942.9113; 
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calcd. for C298H448N100O67S3 [M+6H]6+ 1099.8992,  
found 1099.9003; 
calcd. for C298H447N100O67S3 [M+5H]5+ 1319.6776,  
found 1319.6800; 
calcd. for C298H446N100O67S3 [M+4H]4+ 1649.3451,  
found 1649.3463. 
 
PNA1/SybEa 
 
 
 
[C299H442N100O68S3, 6621.64] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
60-90 % of solvent B1 for 15 min): tR = 9.8 min.  
MS (ESI) m/z:  1104.6 [M+6H]6+, 1325.3 [M+5H]5+, 1656.1 [M+4H]4+, deconvolu-
ted 6621.4 [M]. 
HR-MS (ESI) m/z:  calcd. for C299H448N100O68S3 [M+6H]6+ 1104.5650,  
found 1104.5688;  
calcd. for C299H447N100O68S3 [M+5H]5+ 1325.2766,  
found 1325.2761. 
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PNA1/SybKa 
 
 
 
[C300H447N101O66S3, 6620.70] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
60-90 % of solvent B1 for 15 min): tR = 8.2 min.  
MS (ESI) m/z:  1104.4 [M+6H]6+, 1325.3 [M+5H]5+, 1656.1 [M+4H]4+, deconvolu-
ted 6620.4 [M].  
HR-MS (ESI) m/z: calcd. for C300H453N101O66S3 [M+6H]6+ 1104.4071,  
found 1104.4072; 
calcd. for C300H452N101O66S3 [M+5H]5+ 1325.0870,  
found 1325.0889; 
calcd. for C300H451N101O66S3 [M+4H]4+ 1656.1070,  
found 1656.1077. 
 
5.9.4.2) PNA1/SxK Peptide 
PNA1/SxK 
 
 
 
[C277H430N102O69S3, 6389.31] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 8.8 min.  
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MS (ESI) m/z:  1065.9 [M+6H]6+, 1278.9 [M+5H]5+, 1598.3 [M+4H]4+, deconvolu-
ted 6389.3 [M].  
HR-MS (ESI) m/z:  calcd. for C277H436N102O69S3 [M+6H]6+ 1065.8828,  
found 1065.8835; 
calcd. for C277H435N102O69S3 [M+5H]5+ 1278.8579,  
found 1278.8592; 
calcd. for C277H434N102O69S3 [M+4H]4+ 1598.3206,  
found 1598,3185. 
 
5.9.4.3) PNA2/SxY(a) Peptides 
PNA2/SxG 
 
 
 
[C273H421N101O69S3, 6318.19] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.9 min.  
MS (ESI) m/z:  1054.0 [M+6H]6+, 1264.4 [M+5H]5+, 1580.3 [M+4H]4+, deconvolu-
ted 6318.2 [M].  
HR-MS (ESI) m/z:  calcd. for C273H427N101O69S3 [M+6H]6+ 1054.0372,  
found 1054.0387; 
calcd. for C273H426N101O69S3 [M+5H]5+ 1264.6432,  
found 1264.6500; 
calcd. for C273H425N101O69S3 [M+4H]4+ 1580.5522,  
found 1580.5538. 
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PNA2/SxE 
 
 
 
[C276H425N101O71S3, 6390.25] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.1 min.  
MS (ESI) m/z:  913.8 [M+7H]7+, 1065.9 [M+6H]6+, 1279.1 [M+5H]5+, 
1598.6 [M+4H]4+, deconvoluted 6390.2 [M].  
HR-MS (ESI) m/z:  calcd. for C276H431N101O71S3 [M+6H]6+ 1066.0408,  
found 1066.0440; 
calcd. for C276H430N101O71S3 [M+5H]5+ 1279.0474,  
found 1279.0512. 
 
PNA2/SxK 
 
 
 
[C277H430N102O69S3, 6389.31] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.0 min.  
MS (ESI) m/z:  799.7 [M+8H]8+, 913.8 [M+7H]7+, 1065.8 [M+6H]6+, 
1278.9 [M+5H]5+, deconvoluted 6389.3 [M]. 
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HR-MS (ESI) m/z:  calcd. for C277H436N102O69S3 [M+6H]6+ 1065.8828,  
found 1065.8837; 
calcd. for C277H435N102O69S3 [M+5H]5+ 1278.8579,  
found 1278.8564. 
 
PNA2/SxGa 
 
 
 
[C273H422N102O68S3, 6317.21] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 10.3 min.  
MS (ESI) m/z:  1053.9 [M+6H]6+, 1264.4 [M+5H]5+, 1580.3 [M+4H]4+, deconvolu-
ted 6317.2 [M].  
HR-MS (ESI) m/z:  calcd. for C273H428N102O68S3 [M+6H]6+ 1053.8732,  
found 1053.8737; 
calcd. for C273H427N102O68S3 [M+5H]5+ 1264.4464,  
found 1264.4470; 
calcd. for C273H426N102O68S3 [M+4H]4+ 1580.3062,  
found 1580.3079. 
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PNA2/SxEa 
 
 
 
[C276H426N102O70S3, 6389.27] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.9 min.  
MS (ESI) m/z:  1065.9 [M+6H]6+, 1278.6 [M+5H]5+, 1598.3 [M+4H]4+, deconvolu-
ted 6389.2 [M].  
HR-MS (ESI) m/z:  calcd. for C276H432N102O70S3 [M+6H]6+ 1065.8767,  
found 1065.8779; 
calcd. for C276H431N102O70S3 [M+5H]5+ 1278.8506,  
found 1278.8522; 
calcd. for C276H430N102O70S3 [M+4H]4+ 1598.3115,  
found 1598.3121. 
 
PNA2/SxKa 
 
 
 
[C277H431N103O68S3, 6388.33] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.1 min.  
MS (ESI) m/z:  913.6 [M+7H]7+, 1065.7 [M+6H]6+, 1278.7 [M+5H]5+, deconvoluted 
6388.3 [M].  
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HR-MS (ESI) m/z:  calcd. for C277H438N103O68S3 [M+7H]7+ 913.6172,  
found 913.6145; 
calcd. for C277H437N103O68S3 [M+6H]6+ 1065.7188,  
found 1065.7213; 
calcd. for C277H436N103O68S3 [M+5H]5+ 1278.6611,  
found 1278.6716. 
 
5.9.4.4) PNA3/SxY(a) Peptides 
PNA3/SxG 
 
 
 
[C273H421N101O69S3, 6318.19] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 10.0 min.  
MS (ESI) m/z:  1053.9 [M+6H]6+, 1264.7 [M+5H]5+, 1580.6 [M+4H]4+, deconvolu-
ted 6318.2 [M].  
HR-MS (ESI) m/z:  calcd. for C273H427N101O69S3 [M+6H]6+ 1054.0372,  
found 1054.0395; 
calcd. for C273H426N101O69S3 [M+5H]5+ 1264.6432,  
found 1264.6470; 
calcd. for C273H425N101O69S3 [M+4H]4+ 1580.5522,  
found 1580.5537. 
 
 
 
 
Experimental Part 
 
149 
 
PNA3/SxE 
 
 
 
[C276H425N101O71S3, 6390.25] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.3 min.  
MS (ESI) m/z:  913.9 [M+7H]7+, 1066.1 [M+6H]6+, 1278.7 [M+5H]5+, deconvoluted 
6390.2 [M].  
HR-MS (ESI) m/z:  calcd. for C276H431N101O71S3 [M+6H]6+ 1066.0408,  
found 1066.0416; 
calcd. for C276H430N101O71S3 [M+5H]5+ 1279.0474,  
found 1279.0484. 
 
PNA3/SxK 
 
 
 
[C277H430N102O69S3, 6389.31] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.0 min.  
MS (ESI) m/z:  799.7 [M+8H]8+, 913.8 [M+7H]7+, 1065.8 [M+6H]6+, 
1278.9 [M+5H]5+, deconvoluted 6389.3 [M].  
HR-MS (ESI) m/z:  calcd. for C277H438N102O69S3 [M+8H]8+ 799.6639,  
found 799.6655; 
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calcd. for C277H437N102O69S3 [M+7H]7+ 913.7577,  
found 913.7606; 
calcd. for C277H436N102O69S3 [M+6H]6+ 1065.8828,  
found 1065.8847; 
calcd. for C277H435N102O69S3 [M+5H]5+ 1278.8579,  
found 1278.8611. 
 
PNA3/SxGa 
 
 
 
[C273H422N102O68S3, 6317.21] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 10.4 min.  
MS (ESI) m/z:  1053.9 [M+6H]6+, 1264.4 [M+5H]5+, 1580.3 [M+4H]4+, deconvolu-
ted 6317.2 [M].  
HR-MS (ESI) m/z:  calcd. for C273H428N102O68S3 [M+6H]6+ 1053.8732,  
found 1053.8739; 
calcd. for C273H427N102O68S3 [M+5H]5+ 1264.4464,  
found 1264.4474; 
calcd. for C273H426N102O68S3 [M+4H]4+ 1580.3062,  
found 1580.3062. 
 
 
 
 
Experimental Part 
 
151 
 
PNA3/SxEa 
 
 
 
[C276H426N102O70S3, 6389.27] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.8 min.  
MS (ESI) m/z:  1065.9 [M+6H]6+, 1278.6 [M+5H]5+, 1598.3 [M+4H]4+, deconvolu-
ted 6389.2 [M].  
HR-MS (ESI) m/z:  calcd. for C276H432N102O70S3 [M+6H]6+ 1065.8767,  
found 1065.8766; 
calcd. for C276H431N102O70S3 [M+5H]5+ 1278.8506,  
found 1278.8511; 
calcd. for C276H430N102O70S3 [M+4H]4+ 1598.3115,  
found 1598.3120. 
 
PNA3/SxKa 
 
 
 
[C277H431N103O68S3, 6388.33] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.2 min.  
MS (ESI) m/z:  1065.7 [M+6H]6+, 1278.6 [M+5H]5+, 1598.1 [M+4H]4+, deconvolu-
ted 6388.3 [M].  
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HR-MS (ESI) m/z:  calcd. for C277H437N103O68S3 [M+6H]6+ 1065.7188,  
found 1065.7191; 
calcd. for C277H436N103O68S3 [M+5H]5+ 1278.6611,  
found 1278.6637; 
calcd. for C277H435N103O68S3 [M+4H]4+ 1598.0746,  
found 1598.0733. 
 
5.9.5) E3/K3-LR/TMD Peptide Hybrids 
Synthesis of peptides was conducted according to Section 5.4.5 and after cleavage 
from the resin, peptides were dissolved in methanol/TFE/formic acid (4:1:1, v/v/v) for 
mass spectrometric analysis.  
 
5.9.5.1) (i)E3/SybX(a) Peptides and Cys-E3/SybT 
E3/SybT 
H-G-(EIAALEK)3-RKYWWKNLKMMIILGVICAIILIIIIVYFST-OH  
[C288H473N65O71S3, 6078.52] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
70-90 % of solvent B1 for 15 min): tR = 10.0 min.  
MS (ESI) m/z:  869.2 [M+7H]7+, 1013.9 [M+6H]6+, 1216.5 [M+5H]5+, 
1520.4 [M+4H]4+, deconvoluted 6078.5 [M].  
HR-MS (ESI) m/z:  calcd. for C288H480N65O71S3 [M+7H]7+ 869.3597,  
found 869.3597; 
calcd. for C288H479N65O71S3 [M+6H]6+ 1014.0851,  
found 1014.0848; 
calcd. for C288H478N65O71S3 [M+5H]5+ 1216.7006,  
found 1216.7006; 
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calcd. for C288H477N65O71S3 [M+4H]4+ 1520.6239,  
found 1520.6232. 
 
iE3/SybT 
H-G-(KELAAIE)3-RKYWWKNLKMMIILGVICAIILIIIIVYFST-OH  
[C288H473N65O71S3, 6078.52] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, two-step gra-
dient: 70-85 % and 85-95 % of solvent B1 for 10 min (1st step) and 5 min (2nd step)): 
tR = 13.0 min.  
MS (ESI) m/z:  1014.1 [M+6H]6+, 1216.7 [M+5H]5+, 1520.6 [M+4H]4+, deconvolu-
ted 6078.5 [M].  
HR-MS (ESI) m/z:  calcd. for C288H479N65O71S3 [M+6H]6+ 1014.0851,  
found 1014.0825; 
calcd. for C288H478N65O71S3 [M+5H]5+ 1216.7006,  
found 1216.6974; 
calcd. for C288H477N65O71S3 [M+4H]4+ 1520.6239,  
found 1520.6203. 
 
Cys-E3/SybT 
H-CG-(EIAALEK)3-RKYWWKNLKMMIILGVICAIILIIIIVYFST-OH  
[C291H478N66O72S4, 6181.66] 
MS (ESI) m/z:  884.1 [M+7H]7+, 1031.3 [M+6H]6+, 1237.4 [M+5H]5+, 
1546.5 [M+4H]4+, deconvoluted 6181.5 [M].  
HR-MS (ESI) m/z:  calcd. for C291H485N66O72S4 [M+7H]7+ 884.0752,  
found 884.0753; 
calcd. for C291H484N66O72S4 [M+6H]6+ 1031.2532,  
found 1031.2539; 
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calcd. for C291H483N66O72S4 [M+5H]5+ 1237.3024,  
found 1237.3032; 
calcd. for C291H482N66O72S4 [M+4H]4+ 1546.3762,  
found 1546.3764. 
 
E3/SybE 
H-G-(EIAALEK)3-RKYWWKNLKMMIILGVICAIILIIIIVYFSE-OH  
[C289H473N65O72S3, 6106.53] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
70-90 % of solvent B1 for 15 min): tR = 7.5 min.  
MS (ESI) m/z:  1018.7 [M+6H]6+, 1222.3 [M+5H]5+, 1527.6 [M+4H]4+, deconvolu-
ted 6106.5 [M].  
HR-MS (ESI) m/z:  calcd. for C289H479N65O72S3 [M+6H]6+ 1018.7509,  
found 1018.7493; 
calcd. for C289H478N65O72S3 [M+5H]5+ 1222.2996,  
found 1222.3000; 
 
E3/SybK 
H-G-(EIAALEK)3-RKYWWKNLKMMIILGVICAIILIIIIVYFSK-OH  
[C290H478N66O70S3, 6105.59] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
60-90 % of solvent B1 for 15 min): tR = 10.2 min.  
MS (ESI) m/z:  873.2 [M+7H]7+, 1018.4 [M+6H]6+, 1221.9 [M+5H]5+, deconvoluted 
6105.5 [M].  
HR-MS (ESI) m/z:  calcd. for C290H485N66O70S3 [M+7H]7+ 873.2236,  
found 873.2220; 
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calcd. for C290H484N66O70S3 [M+6H]6+ 1018.5934,  
found 1018.5934; 
calcd. for C290H483N66O70S3 [M+5H]5+ 1222.1101,  
found 1222.1115. 
 
E3/SybTa 
H-G-(EIAALEK)3-RKYWWKNLKMMIILGVICAIILIIIIVYFST-NH2  
[C288H474N66O70S3, 6077.53] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
70-90 % of solvent B1 for 15 min): tR = 11.3 min.  
MS (ESI) m/z:  869.1 [M+7H]7+, 1013.8 [M+6H]6+, 1216.5 [M+5H]5+, 
1520.1 [M+4H]4+, deconvoluted 6077.5 [M].  
HR-MS (ESI) m/z:  calcd. for C288H480N66O70S3 [M+6H]6+ 1013.9211,  
found 1013.9206; 
calcd. for C288H479N66O70S3 [M+5H]5+ 1216.5038,  
found 1216.5037; 
calcd. for C288H478N66O70S3 [M+4H]4+ 1520.3779,  
found 1520.3775. 
 
E3/SybEa 
H-G-(EIAALEK)3-RKYWWKNLKMMIILGVICAIILIIIIVYFSE-NH2  
[C289H474N66O71S3, 6105.54] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
70-90 % of solvent B1 for 15 min): tR = 8.4 min.  
MS (ESI) m/z:  873.2 [M+7H]7+, 1018.6 [M+6H]6+, 1221.9 [M+5H]5+, 
1527.4 [M+4H]4+, deconvoluted 6105.5 [M].  
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HR-MS (ESI) m/z:  calcd. for C289H481N66O71S3 [M+7H]7+ 873.2184,  
found 873.2159; 
calcd. for C289H480N66O71S3 [M+6H]6+ 1018.5869,  
found 1018.5859; 
calcd. for C289H479N66O71S3 [M+5H]5+ 1222.1028,  
found 1222.1035; 
calcd. for C289H478N66O71S3 [M+4H]4+ 1527.3762,  
found 1527.3762. 
 
E3/SybKa 
H-G-(EIAALEK)3-RKYWWKNLKMMIILGVICAIILIIIIVYFSK-NH2  
[C290H479N67O69S3, 6104,60] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
60-90 % of solvent B1 for 15 min): tR = 10.8 min.  
MS (ESI) m/z:  872.9 [M+7H]7+, 1018.3 [M+6H]6+, 1221.7 [M+5H]5+, 
1526.9 [M+4H]4+, deconvoluted 6104.5 [M].  
 
HR-MS (ESI) m/z:  calcd. for C290H486N67O69S3 [M+7H]7+ 873.0830,  
found 873.0813; 
calcd. for C290H485N67O69S3 [M+6H]6+ 1018.4289,  
found 1018.4285; 
calcd. for C290H484N67O69S3 [M+5H]5+ 1221.9133,  
found 1221.9133; 
calcd. for C290H483N67O69S3 [M+4H]4+ 1527.1398,  
found 1527.1382. 
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5.9.5.2) K3/SxY(a) Peptides 
K3/SxG 
H-WWG-(KIAALKE)3-QSKARRKKIMIIICCVILGIIIASTIGGIFG-OH 
[C279H479N73O66S3, 6008.53] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 10.9 min.  
MS (ESI) m/z:  859.2 [M+7H]7+, 1002.3 [M+6H]6+, 1202.5 [M+5H]5+, 
1502.9 [M+4H]4+, deconvoluted 6008.5 [M].  
HR-MS (ESI) m/z:  calcd. for C279H486N73O66S3 [M+7H]7+ 859.3735,  
found 859.3713; 
calcd. for C279H485N73O66S3 [M+6H]6+ 1002.4345,  
found 1002.4339; 
calcd. for C279H484N73O66S3 [M+5H]5+ 1202.7200,  
found 1202.7192; 
calcd. for C279H483N73O66S3 [M+4H]4+ 1503.1481,  
found 1503.1473. 
 
K3/SxE 
H-WWG-(KIAALKE)3-QSKARRKKIMIIICCVILGIIIASTIGGIFE-OH 
[C282H483N73O68S3, 6080.59] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 10.2 min.  
MS (ESI) m/z:  761.1 [M+8H]8+, 869.5 [M+7H]7+, 1014.3 [M+6H]6+, 
1217.1 [M+5H]5+,1521.2 [M+4H]4+, deconvoluted 6080.6 [M].  
HR-MS (ESI) m/z:  calcd. for C282H491N73O68S3 [M+8H]8+ 761.0786,  
found 761.0786; 
calcd. for C282H490N73O68S3 [M+7H]7+ 869.6622,  
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found 869.6622; 
calcd. for C282H489N73O68S3 [M+6H]6+ 1014.4380,  
found 1014.4381; 
calcd. for C282H488N73O68S3 [M+5H]5+ 1217.1242,  
found 1271.1241. 
 
K3/SxK 
H-WWG-(KIAALKE)3-QSKARRKKIMIIICCVILGIIIASTIGGIFK-OH 
[C283H488N74O66S3, 6079.65] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 9.3 min.  
MS (ESI) m/z:  869.5 [M+7H]7+, 1014.3 [M+6H]6+, 1216.7 [M+5H]5+, 
1520.9 [M+4H]4+, deconvoluted 6079.6 [M].  
HR-MS (ESI) m/z:  calcd. for C283H495N74O66S3 [M+7H]7+ 869.5268,  
found 869.5245; 
calcd. for C283H494N74O66S3 [M+6H]6+ 1014.2801,  
found 1014.2791; 
calcd. for C283H493N74O66S3 [M+5H]5+ 1216.9347,  
found 1216.9345; 
calcd. for C283H492N74O66S3 [M+4H]4+ 1520.9165,  
found 1520.9131. 
 
K3/SxGa 
H-WWG-(KIAALKE)3-QSKARRKKIMIIICCVILGIIIASTIGGIFG-NH2 
[C279H480N74O65S3, 6007.54] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 11.4 min.  
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MS (ESI) m/z:  859.2 [M+7H]7+, 1002.1 [M+6H]6+, 1202.5 [M+5H]5+, 
1502.9 [M+4H]4+, deconvoluted 6007.6 [M].  
HR-MS (ESI) m/z:  calcd. for C279H487N74O65S3 [M+7H]7+ 859.2329,  
found 859.2314; 
calcd. for C279H486N74O65S3 [M+6H]6+ 1002.2705,  
found 1002.2695; 
calcd. for C279H485N74O65S3 [M+5H]5+ 1202.5231,  
found 1202.5229; 
calcd. for C279H484N74O65S3 [M+4H]4+ 1502.9021,  
found 1502.8964. 
 
K3/SxEa 
H-WWG-(KIAALKE)3-QSKARRKKIMIIICCVILGIIIASTIGGIFE-NH2 
[C282H484N74O67S3, 6079.61] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 10.6 min.  
MS (ESI) m/z:  761.0 [M+8H]8+, 869.4 [M+7H]7+, 1014.1 [M+6H]6+, 
1216.9 [M+5H]5+, deconvoluted 6079.6 [M].  
HR-MS (ESI) m/z:  calcd. for C282H492N74O67S3 [M+8H]8+ 760.9573,  
found 760.9540; 
calcd. for C282H491N74O67S3 [M+7H]7+ 869.5216,  
found 869.5200; 
calcd. for C282H490N74O67S3 [M+6H]6+ 1014.2740,  
found 1014.2732; 
calcd. for C282H489N74O67S3 [M+5H]5+ 1216.9269,  
found 1216.9269. 
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K3/SxKa 
H-WWG-(KIAALKE)3-QSKARRKKIMIIICCVILGIIIASTIGGIFK-NH2 
[C283H489N75O65S3, 6078.67] 
UPLC (ACE Excel 2 column, RP-C18, 100 mm x 2.1 mm, 2 µm, 100 Å, gradient: 
45-70 % of solvent B1 for 15 min): tR = 10.1 min.  
MS (ESI) m/z:  676.4 [M+9H]9+, 760.7 [M+8H]8+, 869.4 [M+7H]7+, 
1013.9 [M+6H]6+, 1216.7 [M+5H]5+, 1520.7 [M+4H]4+,  
deconvoluted 6078.7 [M].  
HR-MS (ESI) m/z:  calcd. for C283H497N75O65S3 [M+8H]8+ 760.8389,  
found 760.8400; 
calcd. for C283H496N75O65S3 [M+7H]7+ 869.3863,  
found 869.3864; 
calcd. for C283H495N75O65S3 [M+6H]6+ 1014.1161,  
found 1014.1162; 
calcd. for C283H494N75O65S3 [M+5H]5+ 1216.7379,  
found 1216.7369. 
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Solid Phase Peptide Synthesis: Fmoc-Deprotection 
 
 
 
 
 
 
 
 
 
 
 
Figure A-1 Fmoc-deprotection through piperidine. The deprotection product can be monitored by 
means of UV-spectroscopy. Thus, it is possible to detect the effectiveness of the deprotection reaction 
(based on ref. 159). 
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Solid Phase Peptide Synthesis: Active Ester Formation 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-2 Reaction scheme of aa activation through the formation of N-hydroxylamine active esters and peptide bond formation (highlighted in red): A) Acti-
vation via DIC/Oxyma. B) Activation via benzotriazoles/base(s) (based on ref. 196 and 197).  
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Solid Phase Peptide Synthesis: Acetylation (Capping) 
 
 
 
 
 
 
 
 
 
Figure A-3 Acetylation (capping) of resin bound peptides (Rpep), which have not reacted with the incom-
ing aa building block during the coupling reaction. Acetylated peptides are excluded from further SPPS 
cycles (Raa1, Raa2: aa residues), (based on ref. 159). 
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Solid Phase Peptide Synthesis: Cleavage of the Peptide from the Resin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-4 After finished SPPS, the peptide must be cleaved from the solid support (resin). Depend-
ing on the applied resin, it is possible to introduce C-terminal A) carboxylic acid groups or B) amide 
groups. 
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Solid Phase Peptide Synthesis: Scavenger Reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-5 Cleavage of an exemplary pentameric peptide with typical residual protecting groups (tBu, 
Boc, Trt, Pbf) from the resin (R). During cleavage reactions under acidic conditions, cations emerge 
from the protecting groups. Thus, scavenger reagents (e.g. water, TIS and EDT) are added to TFA to 
transfer cations into unreactive substances. Water acts as a nucleophile, TIS hydrogenates trityl cations 
and EDT has reducing properties to avoid oxidation of methionine residues (not shown). Furthermore, 
EDT can react as a nucleophile (Nu) with carbocations (based on ref. 159, 198 and 199).  
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Solid Phase Peptide Synthesis: Aspartimide Formation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-6 Aspartimide formation under basic conditions during Fmoc-deprotection (piperidine acts as 
catalyst) and subsequent reactions. Aspartimide formation is facilitated when Raa1 = glycine: A) Nucle-
ophilic attack of the N-terminal amino group on carbonyl carbons of the aspartimide ring (sequence 
termination). Formation of diketopiperazine (2) is preferred over the formation of a seven-membered 
ring (1). B) Nucleophilic attack of the secondary amino group of piperidine on carbonyl carbons yielding 
piperidine-peptide adducts (X = OtBu, -NH2; Rpep = C-terminal peptide linked to solid support; Raa1, 
Raa2 = aa residues), (based on ref. 159, 160 and 200). 
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Solid Phase Peptide Synthesis: Racemisation Reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-7 Possible racemisation reactions during the coupling reaction: A) Racemisation via the for-
mation of oxazolone derivatives of C-terminal activated aa. However, oxazolone formation is unlikely 
concerning a single aa. It is more probable, if peptide fragments are C-terminal activated. B) Racemi-
sation of a cysteine building blocks during the activation reaction, if bases (e.g. DIPEA) are used which 
deprotonate the α-carbon. A similar reaction is conceivable during the deprotection with piperidine. El-
evated temperatures facilitate deprotonation as well (based on ref. 159 and 201).  
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Comparison of Native and Artificial Sequences 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-8 Comparison of sequences of the SNARE core complex components (Syb2, Sx1A, SNAP 25 (Sn1 and Sn2)) with sequences of the SNARE mimetics 
(E3-SybLR/TMD and K3-SxLR/TMD): The 16 in plane interacting aas (-7 – 8) of the four SNARE core complex components are given in red, respectively. The 
corresponding aas of the E3 and K3 recognition units are also highlighted in red. The hydrophobic and hydrophilic interactions, which are typical for coiled coils, 
are highlighted by solid and dashed lines, respectively. Possible interactions due to spatial proximity within the LRs/TMDs are also given as solid lines (based 
on ref. 10, 16 and 127).  
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Chromatography Results of PNA-LR/TMD Peptide Hybrids 
 
Table A-1 Overview of analytical UPLC runs: Purities of PNA-LR/TMD peptide hybrids were determined 
by the integration of chromatograms.  
Remarks: mp: main peak. 
 
 
 
 
 
 
 
sample 
purity 
[%] 
areatotal 
[a.u.] 
time rangetotal 
[min] 
areamp 
[a.u.] 
time rangemp 
[min] 
PNA1/SybT 24.1 114.1 1.5-14.1 27.5 10.7-11.3 
PNA2/SxG 14.6 1061.0 1.5-18.6 154.6 9.6-10.3 
PNA3/SxG 24.8 93.6 1.5-12.8 23.2 9.8-10.4 
PNA1/SybE 16.8 411.2 1.5-14.7 69.2 8.9-9.5 
PNA2/SxE 21.9 1322.0 1.5-18.5 288.9 8.9-9.5 
PNA3/SxE 34.4 329.4 1.5-17.0 113.4 9.1-9.7 
PNA1/SybK 21.2 293.0 1.5-14.8 62.0 7.8-8.2 
PNA1/SxK 14.0 1429.0 1.5-19.0 200.2 8.6-9.2 
PNA2/SxK 14.3 605.7 1.5-18.4 86.8 8.7-9.2 
PNA3/SxK 16.7 119.5 1.5-16.0 20.0 8.8-9.2 
PNA1/SybTa 32.3 510.4 1.5-13.4 164.7 8.7-9.3 
PNA2/SxGa 28.5 302.3 1.5-17.6 86.3 10.0-10.7 
PNA3/SxGa 14.8 986.9 1.5-18.4 145.9 10.3-11.0 
PNA1/SybEa 38.0 71.2 1.5-13.2 27.0 9.6-10.0 
PNA2/SxEa 24.7 256.3 1.5-17.3 63.4 9.6-10.3 
PNA3/SxEa 29.2 205.8 1.5-16.4 60.0 9.5-10.2 
PNA1/SybKa 26.1 598.0 1.5-15.0 156.2 7.8-8.6 
PNA2/SxKa 22.4 375.7 1.5-18.3 84.1 8.9-9.5 
PNA3/SxKa 33.0 64.8 1.5-15.1 21.4 8.9-9.5 
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Figure A-9 Chromatograms of PNA1/SybX(a) peptides measured by analytical UPLC. The detection 
wavelength was 215 nm. Black arrows indicate the total integrated area and red arrows the integrated 
area of the main peak (raw data were edited by using the OriginPro 8.5G software). 
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Figure A-10 Chromatograms of PNA2/SxY(a) peptides measured by analytical UPLC. The detection 
wavelength was 215 nm. Black arrows indicate the total integrated area and red arrows the integrated 
area of the main peak (raw data were edited by using the OriginPro 8.5G software). 
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Figure A-11 Chromatograms of PNA3/SxY(a) peptides measured by analytical UPLC. The detection 
wavelength was 215 nm. Black arrows indicate the total integrated area and red arrows the integrated 
area of the main peak (raw data were edited by using the OriginPro 8.5G software). 
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Figure A-12 Chromatogram of the PNA1/SxK peptide measured by analytical UPLC. The detection 
wavelength was 215 nm. Black arrows indicate the total integrated area and red arrows the integrated 
area of the main peak (raw data were edited by using the OriginPro 8.5G software). 
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Chromatography Results of E3/K3-LR/TMD Peptide Hybrids 
 
Table A-2 Overview of analytical UPLC runs: Purities of (i)E3/K3-LR/TMD peptide hybrids were deter-
mined by integration of the chromatograms. E3/SybKHPLC and K3/SxEHPLC samples were purified by 
semi-preparative HPLC. 
Remarks: mp: main peak. 
 
 
 
 
 
 
 
sample 
purity 
[%] 
areatotal 
[a.u.] 
time rangetotal  
[min] 
areamp 
[a.u.] 
time rangemp 
[min] 
E3/SybT 40.5 402.0 1.5-15.1 163.0 9.5-10.4 
iE3/SybT 18.8 1289.0 1.5-19.7 242.3 12.3-13.7 
K3/SxG 28.0 764.7 1.5-17.2 213.8 10.4-11.4 
E3/SybE 42.9 507.8 1.5-13.7 217.9 7.0-8.0 
K3/SxE 30.9 1327.0 1.5-18.9 410.3 9.7-10.6 
K3/SxEHPLC 44.8 949.8 1.5-19.1 425.1 9.6-10.5 
E3/SybK 18.3 1209.0 1.5-18.7 221.0 9.9-10.5 
E3/SybKHPLC 61.2 126.9 1.5-15.1 77.6 12.2-12.7 
K3/SxK 22.1 2429.0 1.5-19.5 535.6 8.8-9.7 
E3/SybTa 27.9 204.0 1.5-17.2 57.0 10,8-11.7 
K3/SxGa 25.6 294.7 1.5-18.6 59.8 11.1-11.7 
E3/SybEa 29.8 568.4 1.5-14.6 169.6 7.9-8.9 
K3/SxEa 25.6 810.9 1.5-18.6 207.7 10.2-11.0 
E3/SybKa 32.0 354.8 1.5-14.2 113.4 10.5-11.1 
K3/SxKa 20.9 229.2 1.5-19.0 47.8 9.8-10.3 
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Figure A-13 Chromatograms of (i)E3/SybX(a) peptides measured by analytical UPLC. The detection 
wavelength was 215 nm. Black arrows indicate the total integrated area and red arrows the integrated 
area of the main peak (raw data were edited by using the OriginPro 8.5G software). 
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Figure A-14 Chromatograms of K3/SxY(a) peptides measured by analytical UPLC. The detection wave-
length was 215 nm. Black arrows indicate the total integrated area and red arrows the integrated area 
of the main peak (raw data were edited by using the OriginPro 8.5G software). 
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Loss of Lipid Material During Proteoliposome Preparation and Size Exclusion 
Chromatography 
 
Table A-3 Comparison of the lipid loss of liposomes decorated with PNA-LR/TMD peptide hybrids. 
Losses were determined by means of phosphate tests. 
Remarks: a-b) Loss of lipids: a) calculated by using the supposed mass of phosphorus before extrusion 
(1.16 µg) and measured masses of phosphorus after extrusion (2nd column). b) calculated by using 
measured masses of phosphorus before and after size exclusion chromatography (values are not 
shown). c) Actual lipid ratios between labelled (PNA1/SybX(a)) and unlabelled (PNA/SxY(a)) proteolipo-
somes during leaflet mixing assays deviates from the supposed ratio of 1 to 4. d-e) Loss of lipids calcu-
lated by using measured masses of phosphorus before extrusion (value is not shown) and after extru-
sion (2nd column): d) 31 % and e) 41 %. Abbreviations: extr.: extrusion, size ex.: size exclusion chroma-
tography. 
sample m(P) after extr. 
[µg] 
loss (extr.) 
[%]a 
loss (size ex.) 
[%]b 
lipid ratioc 
PNA1/SybT 0.78 33 78 - 
PNA2/SxG 0.79 32 - 1.0 to 4.0 
PNA3/SxG 0.84 28 - 1.0 to 4.3 
PNA1/SybE 0.77 34 55 - 
PNA2/SxE 0.84 28 - 1.0 to 4.4 
PNA3/SxE 0.83 28 - 1.0 to 4.3 
PNA1/SybK 0.93 20 61 - 
PNA1/SxK 0.79 32 - 1.0 to 3.4 
PNA2/SxK 0.98 16 - 1.0 to 4.2 
PNA3/SxK 0.74 36 - 1.0 to 3.2 
PNA1/SybTa 0.74 37d 74 - 
PNA2/SxGa 0.75 36 - 1.0 to 4.1 
PNA3/SxGa 0.79 32 - 1.0 to 4.3 
PNA1/SybEa 0.67 42 43 - 
PNA2/SxEa 0.76 35 - 1.0 to 3.6 
PNA3/SxEa 0.89 23 - 1.0 to 3.0 
PNA1/SybKa 0.79 32e 85 - 
PNA2/SxKa 0.67 42 - 1.0 to 3.4 
PNA3/SxKa 0.84 28 - 1.0 to 4.3 
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Table A-4 Loss of lipids during proteoliposome preparation determined by means of phosphate tests 
and Rh emission. 
Remarks: a-b) Loss of lipids: a) calculated by using the supposed mass of phosphorus before extrusion 
(1.16 µg) and masses of phosphorus after extrusion. b) calculated by using the measured masses of 
phosphorus before and after extrusion. c) Loss of lipids was calculated by the decrease of emission 
intensity at 585 nm of Rh-DOPE before and after extrusion. 
 
 
 
 
 
 
 
 
 
sample 
loss determined by PO4 test 
[%]a 
loss determined by Rh em. 
[%]c 
PNA1/SybK 41 31 
PNA1/Syba 31 42 
PNA1/SybKa 
32 
46 
41b 
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Table A-5 Comparison of lipid loss of liposomes decorated with E3/K3-LR/TMD peptide hybrids deter-
mined by means of phosphate tests. 
Remarks: a-b) Loss of lipids: a) calculated by using the supposed mass of phosphorus before extrusion 
(1.16 µg) and measured masses of phosphorus after extrusion (2nd column). b) calculated by using the 
measured masses of phosphorus before and after size exclusion chromatography (values are not 
shown). c) Actual lipid ratios between labelled ((i)E3/SybX(a)) and unlabelled (K3/SxY(a)) (proteo-)lipo-
somes during leaflet mixing assays deviate from the supposed ratio of 1 to 4. Abbreviations: extr.: ex-
trusion, size ex.: size exclusion chromatography. 
 
 
 
 
sample 
m(P) after extr. 
[µg] 
loss (extr.) 
[%]a 
loss (size ex.) 
[%]b 
lipid ratioc 
E3/SybT 0.83 28 48 - 
K3/SxG 0.58 50 - 1.0 to 2.8 
Liposomes 1.10 6 - 1.0 to 5.3 
iE3/SybT 0.81 30 58 - 
K3/SxG 0.59 49 - 1.0 to 2.9 
Liposomes (1.23) (-6) - (1.0 to 6.0) 
iE3/SybT 0.99 15 44 - 
K3/SxG 0.77 33 - 1.0 to 3.1 
Liposomes (1.37) (-18) - (1.0 to 5.5) 
E3/SybE 0.85 27 59 - 
K3/SxE 0.65 44 - 1.0 to 3.0 
Liposomes 0.92 21 - 1.0 to 4.3 
E3/SybK 0.91 22 47 - 
K3/SxK 0.83 28 - 1.0 to 3.7 
Liposomes (1.33) (-14) - (1.0 to 5.8) 
E3/SybK 1.14 1 58 - 
K3/SxK 0.82 29 - 1.0 to 2.9 
Liposomes (1.41) (-22) - (1.0 to 4.9) 
E3/SybTa 0.82 29 65 - 
K3/SxGa 0.78 33 - 1.0 to 3.8 
Liposomes 0.98 15 - 1.0 to 4.8 
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Determination of Proteoliposome Size 
 
Table A-6 Collection of sizes given as diameters of liposomes decorated with PNA-LR/TMD peptide hybrids. 
Remarks: By DLS measurements ascertained hydrodynamic diameters of liposomes carrying PNA-LR/TMD peptide hybrids. Liposomes with PNA1/SybX(a) 
peptides were labelled, those with PNA2/SxY and PNA3/SxY(a) peptides were unlabelled. Only stable proteoliposomes, i.e. proteoliposome suspensions without 
visible turbidity within 60 min after preparation, were measured: a) Three different values for the diameter are presented: “Main size” states the size of the main 
fraction (biggest bin) of the calculated size distribution histogram. “Weighted” and “not weighted” states the weighted and not weighted average of the calculated 
size distribution histogram. b) “Age” indicates the time ranges between proteoliposome preparation and DLS measurements. c) Used devices for size determi-
nation. Red lines represent the results of Section 3.4.6. 
 
sample size [nm] averagea ageb   PdI n(extrusions) devicec 
PNA1/SybT 190 / 210 main size / weighted 3 months  0.183 21 Malvern Zetasizer Nano S 
PNA1/SybE 77 not weighted 3 d - 31 DynaPro Titan 
PNA1/SybE 87 not weighted 3 d - 31 DynaPro Titan 
PNA1/SybE 190 / 203 main size / weighted 3 months  0.172 21 Malvern Zetasizer Nano S 
PNA1/SybK 126 not weighted few hours - 31 DynaPro Titan 
PNA1/SybEa 164 / 180 main size / weighted 20 d   0.205 21 Malvern Zetasizer Nano S 
PNA2/SxG 150 not weighted 3 d - 31 DynaPro Titan 
PNA3/SxG 141 not weighted 3 d - 31 DynaPro Titan 
PNA3/SxG 190 / 209 main size / weighted 3 months  0.177 21 Malvern Zetasizer Nano S 
PNA3/SxE 164 / 169 main size / weighted 4 months  0.168 21 Malvern Zetasizer Nano S 
PNA3/SxEa 142 / 317 main size / weighted 2 months  0.287 21 Malvern Zetasizer Nano S 
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Table A-7 Collection of sizes given as diameters of liposomes decorated with E3/K3-LR/TMD peptide hybrids. 
Remarks: By DLS and NTA measurements ascertained hydrodynamic diameters of liposomes carrying E3/K3-LR/TMD peptide hybrids. Liposomes with 
E3/SybX(a) peptides were labelled, those with K3/SxY(a) were unlabelled: a-b) Like in table A-6. c) Aggregation was determined by visible turbidity 60 min after 
(proteo-)liposome preparation. d) Used devices for size determination. The E3/SybKHPLC was prepared by HPLC purified peptides. Red lines represent the 
results of Section 3.4.6.
sample size [nm] averagea ageb   PdI aggregationc method/deviced 
E3/SybT 164 / 183 main size / weighted 5 months 0.143 no DLS / Malvern Zetasizer Nano S 
E3/SybT 107±56 / 158 main size / not weighted 2 d  no NTA / NanoSight 
E3/SybE 164 / 190 main size / weighted 4 months  0.147 no DLS / Malvern Zetasizer Nano S 
E3/SybK 100 not weighted 1 d  no DLS / DynaPro Titan 
E3/SybK 122 / 137 main size / weighted 17 d   0.089 no DLS / Malvern Zetasizer Nano S 
E3/SybKHPLC 122 / 131 main size / weighted 17 d   0.133 no DLS / Malvern Zetasizer Nano S 
E3/SybTa 93±64 / 145 main size / not weighted few hours  yes NTA / NanoSight 
E3/SybKa 126 not weighted few hours  yes DLS / DynaPro Titan 
K3/SxG 111±48 / 128 main size / not weighted few hours  yes NTA / NanoSight 
K3/SxE 142 / 158 main size / weighted 17 d   0.141 no DLS / Malvern Zetasizer Nano S 
K3/SxK 102±31 / 114 main size / not weighted few hours  yes NTA / NanoSight 
K3/SxEa 430 not weighted few hours  yes DLS / DynaPro Titan 
K3/SxEa 1320 not weigthed 1 d  yes DLS / DynaPro Titan 
liposomes 98 not weighted few hours  no DLS / DynaPro Titan 
liposomes 109 not weighted 1 d  no DLS / DynaPro Titan 
liposomes 109±50 / 167 main size / not weighted 2 d  no NTA / NanoSight 
liposomes 164 / 166 main size / weighted 4 months  0.077 no DLS / Malvern Zetasizer Nano S 
lab. liposomes 122 / 141 main size / weighted 4 months 0.118 no DLS / Malvern Zetasizer Nano S 
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7) Abbreviations 
aa Amino acid 
Ac2O Acetic acid anhydride 
aeg-PNA Aminoethylglycine-peptide nucleic acid 
AFM   Atomic force microscopy 
a.u. / AU  Arbitrary unit 
APS   Ammonium persulfate 
aq.   Aqueous 
Bhoc   Benzhydryloxycarbonyl 
Boc   tert-Butoxycarbonyl 
BLM   Black lipid membranes 
bp Base pair 
CCD Charge-coupled device 
CGMD Coarse-grained molecular dynamics 
CMC Critcal micelle concentration 
CMOS Complementary metal-oxide-semiconductor 
CPM Colloidal probe microscopy 
Cpx Complexin 
cryoTEM Cryogenic transmission electron microscopy 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DHPE 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine 
DIC   Diisopropylcarbodiimide 
DIPEA Diisopropylethylamine 
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DLS Dynamic light scattering 
DMF N,N-Dimethylformamide 
DNA Desoxyribonucleic acid 
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine 
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine  
DPPE   1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine 
DPA   Dipicolinic acid 
DSC Differential scanning microscopy 
DT Sodium dithionite 
DTT Dithiothreitol 
EDT 1,2-ethanedithiol 
EDTA Ethylendiaminetetraacetate 
EPR Electron paramagnetic resonance 
eq. Equivalents 
ER Endoplasmic reticulum 
FCS Fluorescence correlation spectroscopy 
FCCS Fluorescence cross correlation spectroscopy 
FFEM Freeze fracture electron microscopy 
FLIC Fluorescence interference contrast 
Fmoc Fluorenylmethoxycarbonyl 
FP Fusion peptide 
FTIR Fourier-transform infrared spectroscopy 
FRAP Fluorescence recovery after photobleaching 
FRET Förster resonance energy transfer 
Abbreviations 
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GUV Giant unilamellar vesicle 
HA Hemagglutinin 
HATU 2-(1H-9-azabenzotriazole-1-yl)-1,1,3,3-tetramethylaminium hex-
afluorophosphate 
HBTU 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluoro-
phosphate 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HOAt   1-hydroxy-7-aza-1H-benzotriazole 
HOBt 1-hydroxybenzotriazol 
HPLC High performance liquid chromatography 
ILM Inner leaflet mixing 
KIH   Knob-into-hole 
LD Loading density 
LPC Lysophosphatidylcholine 
LR Linker region 
LSCM Laser scanning confocal microscopy 
LUV Large unilamellar vesicles 
MF Microfluorimetry 
MLV Multilamellar vesicles 
MWCO  Molecular weight cut-off 
NMP   N-methyl-2-pyrrolidone 
NSF   N-ethylmaleimide-sensitive factor 
NTA   Nano tracking analysis  
NBD   Nitrobenzoxadiazol 
Pbf   2,2,4,6,7-pentamethyl-dihydrobenzofurane-5-sulfonyl 
Abbreviations 
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PC   Phosphatidylcholine 
PdI   Polydispersity index 
PIP2/3   Phosphatidylinositol-bis/tris-phosphate 
POPC   1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPE   1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine 
POPS 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocserine 
PS Phosphatidylserine 
PSM Pore spanning membrane 
Rh Lissamine rhodamine B 
RM Recognition motif 
RNA Ribonucleic acid 
RT Room temperature 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SF Spectrofluorimetry 
SNARE Soluble N-ethylmaleimide-sensitive factor (NSF) attachment pro-
tein receptor 
SM protein  Sec and Munc protein 
SPT   Single particle tracking 
SUV   Small unilamellar vesicles 
SNAP 25  25 kDa synaptosome-associated protein 
SRB   Sulforhodamine B 
SV   Synaptic vesicle 
Syb2   Synaptobrevin 2 
SybLR/TMD  Linker region and transmembrane domain of synaptobrevin 2 
Abbreviations 
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Syt   Synaptotagmin 
Sx1A   Syntaxin 1A 
SxLR/TMD  Linker region and transmembrane domain of syntaxin 1A 
tBu   tert-butyl 
TCEP   Tris-carboxyethylphosphine 
TEMED  Tetramethylethylendiamine 
TFA   Trifluoroacetic acid 
TFE   2,2,2-trifluoroethanol 
TIRF   Total internal reflection fluorescence 
TIS   Triisopropylsilane 
TLM   Total leaflet mixing 
TMD   Transmembrane domain 
TOF   Time of flight 
Tris   Tris(hydroxymethyl)aminomethane 
Trt   Trityl 
TxR   Texas Red 
UPLC   Ultra performance liquid chromatography 
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